Australia Medical Devices Report

Published on February 2017 | Categories: Documents | Downloads: 33 | Comments: 0 | Views: 272
of 153
Download PDF   Embed   Report

Comments

Content


AUSTRALIA
Medical Devices Report
Q2 2014
Australia Medical Devices Report
ISSN 2053-8030
© Copyright 2014 Espicom Business Intelligence
All rights reserved. No part of this publication may be reproduced or used in any form or by any means graphic, electronic or
mechanical, including photocopying, recording, taping or storage in information retrieval systems without the express permission of
the publisher.
Every care has been taken to ensure that the information contained in this report is correct. The publisher accepts no liability for
decisions made on the basis of information contained herein.
British Library Cataloguing in Publication Data.
A catalogue record for this report is available from the British Library.
© Espicom Business Intelligence
CONTENTS
Espicom Industry View ....................................................................................................... 7
SWOT .................................................................................................................................... 9
Medical Device Market ............................................................................................................................... 9
Political ................................................................................................................................................. 10
Economic ............................................................................................................................................... 11
Business Environment .............................................................................................................................. 12
Industry Forecast .............................................................................................................. 14
Medical Device Market Forecast ................................................................................................................ 14
Table: Projected Medical Device Market, 2013-2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Table: Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Table: Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Consumables Market Forecast ................................................................................................................... 31
Table: Consumables Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Table: Consumables Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Table: Consumables Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Diagnostic Imaging Market Forecast .......................................................................................................... 36
Table: Diagnostic Imaging Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Table: Diagnostic Imaging Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
Table: Diagnostic Imaging Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Dental Products Market Forecast ............................................................................................................... 42
Table: Dental Products Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Table: Dental Products Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Table: Dental Products Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Orthopaedics & Prosthetics Market Forecast ................................................................................................ 46
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
Table: Orthopaedics & Prosthetics Market, 2009-2018 (USmn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Patient Aids Market Forecast ..................................................................................................................... 49
Table: Patient Aids Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Table: Patient Aids Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Table: Patient Aids Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Other Medical Devices Market Forecast ...................................................................................................... 53
Table: Other Medical Devices Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
Table: Other Medical Devices Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
Table: Other Medical Devices Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
Annual Medical Device Imports ................................................................................................................. 59
Table: Medical Device Imports By Product Area, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Table: Medical Device Imports By Product Area 2008-2012 (US$000s, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 4
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Table: Medical Device Imports By Product Area, 2008-2012 (% Distribution) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Table: Leading Medical Device Suppliers By Product Area (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
Table: Leading Medical Device Suppliers By Product Area (% Distribution) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Table: Top 20 Medical Device Suppliers (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
Table: Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Table: Detailed Medical Device Import Trends By Product Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
Table: Detailed Leading Medical Device Suppliers By Product Area (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
Monthly Medical Device Imports ................................................................................................................ 80
Table: Monthly Medical Device Imports By Product Area, September 2010-October 2013 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Annual Medical Device Exports ................................................................................................................. 83
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
Table: Medical Device Exports By Product Area, 2008-2012 (% Distribution) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
Table: Leading Medical Device Destinations By Product Area (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
Table: Leading Medical Device Destinations By Product Area (% Distribution) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Table: Top 20 Medical Device Destinations (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
Table: Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Table: Detailed Medical Device Export Trends By Product Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
Table: Detailed Leading Medical Device Destinations By Product Area (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
Table: Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Monthly Medical Device Exports .............................................................................................................. 106
Table: Monthly Medical Device Exports By Product Area, September 2010-October 2013 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Macroeconomic Forecasts ............................................................................................. 108
Ongoing Misallocation Of Capital Increases Risks ..................................................................................... 110
Increasing Pressures For Greater Macro-Prudential Rules .......................................................................... 111
Table: Australia - Economic Activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
Industry Risk Reward Ratings ........................................................................................ 114
Table: Asia Pacific Medical Device Risk/Reward Ratings, Q214 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
Market Overview ............................................................................................................. 116
Medical Device Market Overview ............................................................................................................. 116
Table: Medical Device Market, Key Ratios . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Table: Medical Device Market By Product Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Healthcare Overview .............................................................................................................................. 119
Health Status ....................................................................................................................................... 119
Healthcare System ................................................................................................................................ 119
Healthcare Funding .............................................................................................................................. 121
Healthcare Resources ........................................................................................................................... 122
Table: Diagnostic Imaging Technology By Type, 2006-2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Table: Diagnostic Imaging Technology Per Million Population By Type, 2006-2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Healthcare Activity ............................................................................................................................... 124
Healthcare Personnel ........................................................................................................................... 124
Key Data ............................................................................................................................................ 124
Table: Key Data, 2008-2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 5
Industry Trends & Developments .................................................................................. 127
Industry Trends & Developments .............................................................................................................. 127
Regulatory Development ................................................................................................ 132
Medical Device Regulations .................................................................................................................... 132
Competent Authority ............................................................................................................................. 132
Regulations ......................................................................................................................................... 132
Australia New Zealand Therapeutic Products Authority .............................................................................. 134
Competitive Landscape .................................................................................................. 136
Domestic Medical Device Production ........................................................................................................ 136
National Medical Device Manufacturers .................................................................................................... 136
Multinational Medical Device Manufacturers ............................................................................................. 140
Multinational Market Activity .................................................................................................................. 142
Table: Multinational Market Activity, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Methodology .................................................................................................................... 144
Medical Device Market Methodology ....................................................................................................... 144
Trade Code Classifications .................................................................................................................... 145
Table: Used HS Trade Codes, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
Table: Rearranged HS Trade Codes, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
Risk/Reward Ratings Methodology .......................................................................................................... 150
Table: Medical Devices Risk/Reward Ratings Indicators, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Sources .............................................................................................................................................. 152
Contact .............................................................................................................................................. 153
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 6
Espicom Industry View
Espicom Industry View: The Australian market has performed well in recent years, driven by a strongly-
growing economy and the requirements of an increasingly elderly population. However, a weakening of the
Australian dollar over the next five years is expected to bring the momentum in the market to a halt.
Headline Industry Forecasts

At US$4.8bn, the market ranks amongst the top 20 largest in the world, while per capita spending is on a
par with European markets such as the Netherlands or Finland. Growth for the 2013-2018 period is
expected to be subdued; estimated at a CAGR of 0.1% in US$ terms which will raise the market to US
$4,836.5mn by 2018.

Since 2001, medical device imports have seen a period of sustained rapid growth. In 2012, imports
reached a new high of US$4,523.6mn, rising by 3.9% over 2011. In CAGR terms, growth was 10.8%
between 2007 and 2012. The running annual total reached US$4.6bn in the 12 months to October 2013,
representing y-on-y growth of 2.2%.

Medical device exports bounced back strongly from the dip in 2009, recording strong growth over the
2010-2012 period. In 2012, exports rose by 10.5% to reach US$1,696.0mn. The running annual total
reached US$1.7bn in the 12 months to October 2013, representing y-on-y growth of 1.7%. In 2012, the
balance of trade deficit edged up to US$2,828mn.
• Australia has a large number of small manufacturers, mostly making hospital consumables and supplies.
Production is generally high quality, but low tech; advanced products are almost always imported. The
majority of production is consumed locally.
Headline Industry Risk/Reward Rating

Australia is the most attractive market in the Asia Pacific region for commercialising a medical device,
according to BMI Espicom's Medical Device Risk/Reward Ratings (RRRs). The country's overall score
for Q214 is 75.8 out of 100, which is marginally ahead of Japan (75.7).
Headline Healthcare Overview

Australia's population stands at over 23mn and is currently growing at an annual rate of 1.3%. The
population aged 65 years and over represents 14.3% of the total and Australian life expectancy is
amongst the world's highest at 80.0 years for men and 84.5 years for women.

In 2013, Espicom estimates Australian healthcare expenditure at US$138.1bn, equal to US$5,917 per
capita. Australia has long had a relatively high level of health spending and in 2013 it stood at 9.1% of
GDP, having grown at a CAGR of 0.6% over the 2008-2013 period. Spending in US$ per capita terms
has doubled since 2003.

The number of hospitals is increasing, with an additional nine opening in 2013 to take the total to 1,363.
The number of hospital beds remains steady at 3.8 per thousand population. The number of doctors is
also rising in line with population growth, reaching almost 80,000 in 2013, a rate of 3.4 physicians per
thousand population.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 7
Headline Industry Trends & Developments

Medical device imports grew by 1.2% in US dollar terms in the three months to October 2013, with
growth led by the patient aids and orthopaedics & prosthetics segments which grew by 15.1% and 4.1%
respectively.

Medical device exports grew by 1.7% in US dollar terms in the three months to October 2013, with
growth led by a 17.2% increase in the other medical devices segment.

In August 2011, after months of negotiation, the Commonwealth Government signed an agreement with
all States and Territories to formalise the National Health Reform plan. Designed to improve funding to
hospitals and to reduce patient waiting times, the plan will see the Commonwealth Government invest at
least A$16.4bn (US$16.0bn) in additional funding for public hospitals over the period 2014-15 to
2019-20. The Commonwealth Government will match 45% of efficient growth funding from July 2014,
and 50% of efficient growth from July 2017.

According to the MTAA (Medical Technology Association of Australia), the Australian industry includes
over 500 medical technology companies with products listed on the Australian Register of Therapeutic
Goods (ARTG). It employs around 19,000 people with turnover of around A$10.8bn in 2010-11,
although this includes distribution activity.
BMI Political View: A Newspoll's December 8 popularity poll reflected the significant decline in the
popularity of Liberal-National Coalition and Prime Minister Tony Abbott since they were elected into
parliament on September 7 2013. The lack of progress on items such as carbon tax and mineral resource
rent tax (although largely due to opposition parties holding the agenda hostage) have certainly shook
voters' confidence in the new government to deliver and weighed on the party's popularity. While these polls
have no consequence on the government's decisions or policies, further declines in popularity could reignite
internal struggles within the coalition and cause more policy paralysis.
BMI Economic View: Several domestic and external factors have served to boost the level of economic
activity in Australia. While BMI revised its GDP growth forecasts for 2014 to 2.0% from 1.8% previously,
this change masks its concerns for the ever-growing risks within the Australian economy. Given that an
increasing proportion of capital is being invested in the housing sector despite the weak performance of
business spending, (a turnaround in which is required to generate wage growth), this misallocation of
capital increases the economy's vulnerability to external shocks, on top of the ongoing weakness in the
mining sector.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 8
SWOT
Medical Device Market
SWOT Analysis

Strengths

One of world's top 20 medical device markets

High per capita spending

Market is predominantly supplied by imports

Universal health coverage

An ageing and affluent population
Weaknesses

Market fragmentation due to vast geographic size

Market limited by population size
Opportunities

Receptive to new technologies

Strong academic R&D community

Government support for manufacturing sector

Imports rising

National Health Reform plan supporting investment in healthcare
Threats

Continued focus on cost containment in the public healthcare sector
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 9
Political
SWOT Analysis

Strengths

Australia is a mature democracy with a broadly stable party system.

Economic stability over recent years supports the current political system and radical
groups are unlikely to gain substantial support.
Weaknesses

As one of the region's largest and most stable states, the country attracts many
refugees and economic migrants. The issue is a key source of domestic tension and
has been hotly debated in parliament in recent times as the capsizing of a boat led to
the death of a number of refugees. The issue continues to be debated in the federal
parliament with no sign of political parties co-operating to find an alternative that
would ensure the safe passage and fair processing of the refugees, while reducing the
possibility of people smuggling.

The fragility of the state governments' finances compared to the large infrastructure
projects that they need to undertake has led to questions with regards to the
compatibility of the federal-state system with the country's current development
needs.
Opportunities

Australia has historically enjoyed close military ties with the US. However, with the
rise of regional economic powers such as China, it will need to balance competing
military and economic ties.
Threats

Australia's early support for the US 'War on Terror', among other things, has made
Australians abroad a target for Islamic extremists.

Australia's close alliance with the US, particularly under John Howard, has left a
lingering feeling among some Asian governments that it is America's 'deputy sheriff'
in the region.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 10
Economic
SWOT Analysis

Strengths

A free-market economy supported by a highly educated workforce.

Blessed with rich natural resources, Australia's economic activity has been
augmented by demand for commodity exports and the investments made in the
mining sector.
Weaknesses

The persistent current account deficit increases vulnerability to capital flows and, by
extension, currency volatility.

The export basket is highly concentrated in commodities, and consequently exposes
the economy and currency to fluctuations in world prices for metals, coal and
agricultural goods.
Opportunities

The rapid expansion of Asian economies in recent years offers new opportunities for
diversifying trading ties from core European markets.

A low level of government debt has provided a certain amount of flexibility in fiscal
policy to support domestic demand through the downturn.
Threats

The high level of private sector debt - especially mortgage loans - fuelled by overseas
funding poses a threat to sustained growth.

A collapse in exports from a drop in resource demand from China and other resource-
hungry countries would severely impact headline GDP growth.

Australia is vulnerable to extreme weather that may lead to droughts and floods,
which have become increasingly severe in past years as a result of global climate
change.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 11
Business Environment
SWOT Analysis

Strengths

A highly educated workforce and comparatively modern transport infrastructure
underpin economic prospects.

A number of free trade agreements with countries such as New Zealand, Thailand and
the US serve as a boon for trading activities.
Weaknesses

Despite its openness, Australia requires the Foreign Investment Review Board to
approve any commercial real estate investment by a foreign company or individual
valued at US$5mn or more.

With a population of just over 22mn, the domestic consumer base is small by regional
standards.
Opportunities

Australia is currently in talks with China, Malaysia, the Gulf Co-operation Council,
Indonesia, India, Japan and South Korea regarding potential bilateral free trade
agreements. It is also part of negotiations for the Trans-Pacific Partnership and a
regional south pacific pact, PACER plus.

Upgrade and expansion of urban infrastructure will be needed to sustain population
growth in Australia's main cities, providing opportunities for public-private
partnerships in the future. The government is also targeting infrastructure
improvements to rural areas.

More healthcare infrastructure will be needed to support the ageing population, and
with the introduction of the federal government's National Disability Insurance
Scheme, the industry is likely to see increasing demand for services.
Threats

Corporate taxes for foreign investors in Australia remain higher than in other
countries, and it seems unlikely that the government will succeed to reduce the rates
in the near future.

Recent investment proposals by Chinese firms regarding the agricultural and resource
extraction sector have raised fears that strategic assets will be lost to foreign players.
This has led to more conditions attached to the sale agreements, which is likely to
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 12
SWOT Analysis - Continued
reduce the attractiveness of these assets. It remains to be seen if the recent
implementation of a database to increase transparency around foreign-owned
Australian assets will spur more regulation.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 13
Industry Forecast
Medical Device Market Forecast
Past Performance 2008-2013
The Australian market has performed well in recent years, driven by a strongly-growing economy and the
requirements of an increasingly elderly population. Growth for the 2008-2013 period is estimated at a
CAGR of 7.8% in US$ terms, but 4.0% when measured in Australian dollars. Strong growth, of 15.9% and
18.2% was recorded in 2010 and 2011, but this was primarily a result of exchange rate volatility.
Medical Device Market, 2009-2018 % Change
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 14
CAGR Of The Historical Medical Device Market By Product Area
%
Source: BMI Espicom
Future Performance 2013-2018
A weakening of the Australian dollar over the next five years is expected to result in a reversal of the
growth trend experienced over the 2008-2012 period, with the market projected to stagnate in US dollar
terms, but growing by 6.0% when measured in local currency.
A CAGR for 2013-2018 of 0.1% is projected to take the overall market to US$4,836.5mn by 2018, equal to
US$196 per capita. This will place Australia amongst the top 20 largest markets in the world by 2018.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 15
Table: Projected Medical Device Market, 2013-2018

Total (US$mn) Per Capita (US$) Total (Local Currency mn) Per Capita (Local
Currency)

2013 4,814.3 207.4 4,815.7 207.5
2014 4,542.0 193.3 5,074.9 215.9
2015 4,246.5 178.5 5,375.3 225.9
2016 4,278.5 177.6 5,704.6 236.8
2017 4,547.9 186.5 6,063.9 248.7
2018 4,836.5 196.0 6,448.7 261.4
Source: BMI Espicom
Projected Medical Device Market, 2013-2018
US$mn
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 16
CAGR Of The Projected Medical Device Market By Product Area ,
2013-2018
%
Source: BMI Espicom
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$mn)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

CONSUMABLES 457.5 468.1 529.4 649.0 648.4 646.8 598.3 548.5 542.0 565.2 589.9

BANDAGES &
DRESSINGS
114.5 112.5 138.6 189.0 151.0 150.0 138.1 125.9 123.7 128.1 132.6
Medical dressings
(adhesive)
50.6 48.4 56.6 71.1 70.1 70.5 65.7 60.6 60.3 63.2 66.2
Medical dressings (non-
adhesive)
64.0 64.1 82.0 117.8 80.9 79.5 72.4 65.3 63.4 64.9 66.4

SUTURING MATERIALS 61.5 60.2 62.1 76.7 92.7 95.4 90.9 85.7 87.0 93.2 99.8

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 17
Detailed Medical Device Market By Product Area, 2008-2018 (US$mn) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
SYRINGES, NEEDLES &
CATHETERS
257.1 256.9 263.4 307.4 327.3 322.7 294.8 266.7 260.0 267.3 274.8
Syringes (with/without
needles)
36.4 45.5 47.5 52.0 51.9 52.6 49.3 45.9 45.9 48.5 51.2
Tubular metal needles/
needles for sutures
28.5 32.4 30.7 36.2 38.4 38.4 35.6 32.7 32.3 33.7 35.1
Other needles,
catheters, cannulae etc
192.1 179.1 185.2 219.2 237.0 231.7 209.8 188.2 181.8 185.1 188.5

OTHER
CONSUMABLES
24.4 38.5 65.3 75.9 77.4 78.8 74.6 70.2 71.3 76.6 82.7
Blood-grouping
reagents
6.5 4.3 4.9 6.8 5.5 5.4 5.0 4.5 4.4 4.5 4.7
First-aid boxes & kits 2.9 2.4 3.7 4.6 6.9 8.0 8.6 9.1 10.4 12.6 15.2
Ostomy products 0.9 18.3 36.9 36.8 41.4 40.5 36.7 33.0 31.9 32.5 33.2
Surgical gloves 14.1 13.4 19.8 27.6 23.5 24.9 24.3 23.5 24.6 27.0 29.7

DIAGNOSTIC IMAGING 498.0 510.5 587.4 640.5 726.3 735.2 690.0 641.6 642.9 679.8 719.1

ELECTRODIAGNOSTIC
APPARATUS
242.2 252.9 288.0 313.0 328.6 335.9 318.3 298.8 302.3 322.8 344.7
Electrocardiographs 9.9 10.0 13.3 15.5 15.1 15.6 14.9 14.0 14.3 15.3 16.5
Ultrasound 76.7 80.7 84.2 90.6 89.5 89.8 83.4 76.8 76.2 79.6 83.2
MRI 27.4 46.3 52.2 56.0 72.8 77.5 76.5 74.7 78.5 87.0 96.4
Scintigraphic apparatus 2.2 1.7 4.0 3.5 4.1 4.4 4.4 4.4 4.6 5.2 5.9
Other electrodiagnostic
apparatus
126.0 114.3 134.3 147.4 147.2 148.6 139.1 129.0 128.8 135.6 142.7

RADIATION
APPARATUS
119.5 128.3 147.8 154.1 218.9 221.9 208.4 193.9 194.3 205.5 217.4
CT scanners 23.7 32.8 43.6 64.3 93.4 97.1 93.5 89.1 91.5 99.0 107.1
Other medical x-ray
apparatus
88.0 94.1 101.4 86.6 116.9 116.3 107.3 97.9 96.2 99.7 103.4
A, B, C ray apparatus 7.8 1.4 2.8 3.2 8.6 8.4 7.6 6.9 6.7 6.8 6.9

IMAGING PARTS &
ACCESSORIES
136.3 129.3 151.6 173.4 178.7 177.4 163.3 148.9 146.2 151.5 157.0
Contrast media 26.8 25.2 31.1 32.1 33.9 33.3 30.3 27.3 26.5 27.2 27.8
Medical x-ray film (flat) 21.0 22.0 23.4 25.5 23.5 22.4 19.8 17.3 16.3 16.1 16.0
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 18
Detailed Medical Device Market By Product Area, 2008-2018 (US$mn) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Medical x-ray film
(rolled)
0.3 0.2 0.2 0.2 0.4 0.4 0.4 0.3 0.4 0.4 0.4
X-ray tubes 16.8 18.5 19.9 21.5 24.8 25.3 24.0 22.5 22.7 24.2 25.7
Other imaging parts &
accessories
71.4 63.4 77.1 94.1 96.1 96.0 88.8 81.4 80.4 83.7 87.1

DENTAL PRODUCTS 172.2 186.8 205.1 226.0 240.0 247.1 236.2 224.0 229.2 247.7 268.1

CAPITAL EQUIPMENT 20.3 25.6 35.7 28.4 28.8 30.1 29.1 27.9 28.9 31.5 34.4
Dental drills 1.7 3.1 3.5 2.4 2.1 2.0 1.8 1.6 1.6 1.6 1.6
Dental chairs 8.6 8.5 12.7 10.2 9.2 9.3 8.6 7.9 7.9 8.2 8.6
Dental x-ray 9.9 14.0 19.5 15.8 17.5 18.8 18.7 18.3 19.4 21.7 24.2

INSTRUMENTS &
SUPPLIES
151.9 161.2 169.4 197.7 211.2 217.1 207.1 196.0 200.3 216.1 233.7
Dental cements 32.2 34.2 37.0 53.6 59.8 64.3 64.2 63.5 67.7 76.0 85.4
Dental instruments 74.0 81.6 78.0 87.1 92.5 90.7 82.4 74.2 71.9 73.5 75.1
Teeth & other fittings 45.7 45.3 54.4 57.0 59.0 62.0 60.4 58.3 60.7 66.6 73.1
Artificial teeth 5.3 5.5 11.4 12.5 13.5 13.6 12.6 11.6 11.5 12.1 12.6
Other dental fittings 40.4 39.8 43.0 44.5 45.4 48.4 47.8 46.7 49.1 54.5 60.5

ORTHOPAEDICS &
PROSTHETICS
539.8 557.2 656.7 850.6 835.0 864.7 829.8 788.3 806.7 870.5 939.5

FIXATION DEVICES 141.2 110.4 134.4 219.9 201.5 204.2 191.8 178.3 178.5 188.5 198.9
ARTIFICIAL JOINTS 171.0 156.6 194.2 245.0 280.2 294.4 286.6 276.2 286.6 313.5 343.0
OTHER ARTIFICIAL
BODY PARTS
227.6 290.2 328.0 385.7 353.3 366.0 351.3 333.8 341.6 368.5 397.6

PATIENT AIDS 626.8 551.6 682.5 810.0 787.8 792.1 738.8 683.6 681.7 717.2 755.0

PORTABLE AIDS 475.3 408.5 470.3 576.4 563.1 562.5 521.1 478.7 473.9 494.8 516.8
Hearing aids 111.8 96.4 116.8 143.4 138.1 139.0 129.8 120.6 120.7 127.4 134.4
Pacemakers 121.5 116.6 130.9 147.2 177.8 181.5 171.6 160.6 161.9 172.0 182.8
Other portable aids 242.1 195.5 222.6 285.8 247.1 242.0 219.6 197.5 191.3 195.4 199.6
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 19
Detailed Medical Device Market By Product Area, 2008-2018 (US$mn) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

THERAPEUTIC
APPLIANCES
151.4 143.1 212.2 233.6 224.7 229.7 217.8 204.9 207.8 222.4 238.2
Mechano-therapy
apparatus
63.8 54.0 61.3 70.2 81.2 80.0 73.0 65.9 64.1 65.7 67.4
Therapeutic respiration
apparatus
87.7 89.1 150.9 163.4 143.5 149.7 144.8 139.0 143.7 156.6 170.7

OTHERS 1,011.8 1,054.0 1,195.3 1,381.0 1,493.9 1,528.3 1,448.9 1,360.6 1,376.1 1,467.5 1,564.9

WHEELCHAIRS 26.5 24.4 28.0 31.2 32.2 32.7 30.7 28.7 28.8 30.5 32.4
Wheelchairs, not
mechanically propelled
11.2 10.0 10.7 12.9 13.4 14.1 13.6 13.1 13.5 14.7 16.1
Wheelchairs,
mechanically propelled
15.3 14.4 17.3 18.3 18.8 18.6 17.1 15.6 15.3 15.8 16.3

OPHTHALMIC
INSTRUMENTS
65.1 65.8 68.5 85.3 96.5 98.8 93.7 88.0 89.0 95.0 101.3

HOSPITAL FURNITURE 41.0 35.0 41.6 50.1 58.6 59.5 55.9 52.0 52.1 55.0 58.1

MEDICAL, SURGICAL
STERILISERS
16.5 17.3 18.9 20.3 22.4 22.5 20.9 19.2 19.0 19.8 20.7

ULTRA-VIOLET OR
INFRA-RED RAY
APPARATUS
1.8 1.5 2.4 2.3 4.0 4.2 4.0 3.8 3.9 4.3 4.6

OTHER INSTRUMENTS
& APPLIANCES
860.9 910.0 1,035.9 1,191.8 1,280.1 1,310.8 1,243.8 1,169.0 1,183.3 1,262.9 1,347.7
Anaesthetic apparatus
and instruments
86.5 91.4 98.4 96.2 120.7 121.7 113.7 105.1 104.7 109.9 115.3

TOTAL 3,306.0 3,328.2 3,856.4 4,557.1 4,731.4 4,814.3 4,542.0 4,246.5 4,278.5 4,547.9 4,836.5
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 20
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

CONSUMABLES 21.3 21.4 23.8 28.7 28.3 27.9 25.5 23.1 22.5 23.2 23.9

BANDAGES &
DRESSINGS
5.3 5.1 6.2 8.4 6.6 6.5 5.9 5.3 5.1 5.3 5.4
Medical dressings
(adhesive)
2.3 2.2 2.5 3.1 3.1 3.0 2.8 2.5 2.5 2.6 2.7
Medical dressings (non-
adhesive)
3.0 2.9 3.7 5.2 3.5 3.4 3.1 2.7 2.6 2.7 2.7

SUTURING MATERIALS 2.9 2.7 2.8 3.4 4.0 4.1 3.9 3.6 3.6 3.8 4.0

SYRINGES, NEEDLES &
CATHETERS
11.9 11.7 11.8 13.6 14.3 13.9 12.5 11.2 10.8 11.0 11.1
Syringes (with/without
needles)
1.7 2.1 2.1 2.3 2.3 2.3 2.1 1.9 1.9 2.0 2.1
Tubular metal needles/
needles for sutures
1.3 1.5 1.4 1.6 1.7 1.7 1.5 1.4 1.3 1.4 1.4
Other needles,
catheters, cannulae etc
8.9 8.2 8.3 9.7 10.3 10.0 8.9 7.9 7.5 7.6 7.6

OTHER
CONSUMABLES
1.1 1.8 2.9 3.4 3.4 3.4 3.2 2.9 3.0 3.1 3.4
Blood-grouping
reagents
0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2
First-aid boxes & kits 0.1 0.1 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.6
Ostomy products 0.0 0.8 1.7 1.6 1.8 1.7 1.6 1.4 1.3 1.3 1.3
Surgical gloves 0.7 0.6 0.9 1.2 1.0 1.1 1.0 1.0 1.0 1.1 1.2

DIAGNOSTIC IMAGING 23.1 23.3 26.4 28.3 31.7 31.7 29.4 27.0 26.7 27.9 29.1

ELECTRODIAGNOSTIC
APPARATUS
11.3 11.5 12.9 13.8 14.3 14.5 13.5 12.6 12.6 13.2 14.0
Electrocardiographs 0.5 0.5 0.6 0.7 0.7 0.7 0.6 0.6 0.6 0.6 0.7
Ultrasound 3.6 3.7 3.8 4.0 3.9 3.9 3.5 3.2 3.2 3.3 3.4
MRI 1.3 2.1 2.3 2.5 3.2 3.3 3.3 3.1 3.3 3.6 3.9
Scintigraphic apparatus 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 21
Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Other electrodiagnostic
apparatus
5.9 5.2 6.0 6.5 6.4 6.4 5.9 5.4 5.3 5.6 5.8

RADIATION
APPARATUS
5.6 5.9 6.6 6.8 9.6 9.6 8.9 8.1 8.1 8.4 8.8
CT scanners 1.1 1.5 2.0 2.8 4.1 4.2 4.0 3.7 3.8 4.1 4.3
Other medical x-ray
apparatus
4.1 4.3 4.6 3.8 5.1 5.0 4.6 4.1 4.0 4.1 4.2
A, B, C ray apparatus 0.4 0.1 0.1 0.1 0.4 0.4 0.3 0.3 0.3 0.3 0.3

IMAGING PARTS &
ACCESSORIES
6.3 5.9 6.8 7.7 7.8 7.6 6.9 6.3 6.1 6.2 6.4
Contrast media 1.2 1.2 1.4 1.4 1.5 1.4 1.3 1.1 1.1 1.1 1.1
Medical x-ray film (flat) 1.0 1.0 1.0 1.1 1.0 1.0 0.8 0.7 0.7 0.7 0.6
Medical x-ray film
(rolled)
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
X-ray tubes 0.8 0.8 0.9 1.0 1.1 1.1 1.0 0.9 0.9 1.0 1.0
Other imaging parts &
accessories
3.3 2.9 3.5 4.2 4.2 4.1 3.8 3.4 3.3 3.4 3.5

DENTAL PRODUCTS 8.0 8.5 9.2 10.0 10.5 10.6 10.0 9.4 9.5 10.2 10.9

CAPITAL EQUIPMENT 0.9 1.2 1.6 1.3 1.3 1.3 1.2 1.2 1.2 1.3 1.4
Dental drills 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Dental chairs 0.4 0.4 0.6 0.5 0.4 0.4 0.4 0.3 0.3 0.3 0.3
Dental x-ray 0.5 0.6 0.9 0.7 0.8 0.8 0.8 0.8 0.8 0.9 1.0

INSTRUMENTS &
SUPPLIES
7.1 7.4 7.6 8.7 9.2 9.4 8.8 8.2 8.3 8.9 9.5
Dental cements 1.5 1.6 1.7 2.4 2.6 2.8 2.7 2.7 2.8 3.1 3.5
Dental instruments 3.4 3.7 3.5 3.9 4.0 3.9 3.5 3.1 3.0 3.0 3.0
Teeth & other fittings 2.1 2.1 2.4 2.5 2.6 2.7 2.6 2.5 2.5 2.7 3.0
Artificial teeth 0.2 0.3 0.5 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.5
Other dental fittings 1.9 1.8 1.9 2.0 2.0 2.1 2.0 2.0 2.0 2.2 2.5

ORTHOPAEDICS &
PROSTHETICS
25.1 25.4 29.5 37.6 36.4 37.2 35.3 33.1 33.5 35.7 38.1
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 22
Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

FIXATION DEVICES 6.6 5.0 6.0 9.7 8.8 8.8 8.2 7.5 7.4 7.7 8.1
ARTIFICIAL JOINTS 7.9 7.1 8.7 10.8 12.2 12.7 12.2 11.6 11.9 12.9 13.9
OTHER ARTIFICIAL
BODY PARTS
10.6 13.3 14.7 17.1 15.4 15.8 14.9 14.0 14.2 15.1 16.1

PATIENT AIDS 29.1 25.2 30.6 35.8 34.4 34.1 31.4 28.7 28.3 29.4 30.6

PORTABLE AIDS 22.1 18.7 21.1 25.5 24.6 24.2 22.2 20.1 19.7 20.3 20.9
Hearing aids 5.2 4.4 5.2 6.3 6.0 6.0 5.5 5.1 5.0 5.2 5.4
Pacemakers 5.6 5.3 5.9 6.5 7.8 7.8 7.3 6.8 6.7 7.1 7.4
Other portable aids 11.3 8.9 10.0 12.6 10.8 10.4 9.3 8.3 7.9 8.0 8.1

THERAPEUTIC
APPLIANCES
7.0 6.5 9.5 10.3 9.8 9.9 9.3 8.6 8.6 9.1 9.7
Mechano-therapy
apparatus
3.0 2.5 2.8 3.1 3.5 3.4 3.1 2.8 2.7 2.7 2.7
Therapeutic respiration
apparatus
4.1 4.1 6.8 7.2 6.3 6.4 6.2 5.8 6.0 6.4 6.9

OTHERS 47.0 48.1 53.7 61.1 65.2 65.8 61.6 57.2 57.1 60.2 63.4

WHEELCHAIRS 1.2 1.1 1.3 1.4 1.4 1.4 1.3 1.2 1.2 1.3 1.3
Wheelchairs, not
mechanically propelled
0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.5 0.6 0.6 0.7
Wheelchairs,
mechanically propelled
0.7 0.7 0.8 0.8 0.8 0.8 0.7 0.7 0.6 0.6 0.7

OPHTHALMIC
INSTRUMENTS
3.0 3.0 3.1 3.8 4.2 4.3 4.0 3.7 3.7 3.9 4.1

HOSPITAL FURNITURE 1.9 1.6 1.9 2.2 2.6 2.6 2.4 2.2 2.2 2.3 2.4

MEDICAL, SURGICAL
STERILISERS
0.8 0.8 0.8 0.9 1.0 1.0 0.9 0.8 0.8 0.8 0.8

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 23
Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
ULTRA-VIOLET OR
INFRA-RED RAY
APPARATUS
0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2

OTHER INSTRUMENTS
& APPLIANCES
40.0 41.5 46.5 52.7 55.9 56.5 52.9 49.1 49.1 51.8 54.6
Anaesthetic apparatus
and instruments
4.0 4.2 4.4 4.3 5.3 5.2 4.8 4.4 4.3 4.5 4.7

TOTAL 153.7 152.0 173.2 201.6 206.4 207.4 193.3 178.5 177.6 186.5 196.0
Source: BMI Espicom
Table: Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

CONSUMABLES 13.8 14.1 13.7 14.2 13.7 13.4 13.2 12.9 12.7 12.4 12.2

BANDAGES &
DRESSINGS
3.5 3.4 3.6 4.1 3.2 3.1 3.0 3.0 2.9 2.8 2.7
Medical dressings
(adhesive)
1.5 1.5 1.5 1.6 1.5 1.5 1.4 1.4 1.4 1.4 1.4
Medical dressings (non-
adhesive)
1.9 1.9 2.1 2.6 1.7 1.7 1.6 1.5 1.5 1.4 1.4

SUTURING MATERIALS 1.9 1.8 1.6 1.7 2.0 2.0 2.0 2.0 2.0 2.0 2.1

SYRINGES, NEEDLES &
CATHETERS
7.8 7.7 6.8 6.7 6.9 6.7 6.5 6.3 6.1 5.9 5.7
Syringes (with/without
needles)
1.1 1.4 1.2 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1
Tubular metal needles/
needles for sutures
0.9 1.0 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.7 0.7
Other needles,
catheters, cannulae etc
5.8 5.4 4.8 4.8 5.0 4.8 4.6 4.4 4.2 4.1 3.9

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 24
Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
OTHER
CONSUMABLES
0.7 1.2 1.7 1.7 1.6 1.6 1.6 1.7 1.7 1.7 1.7
Blood-grouping
reagents
0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
First-aid boxes & kits 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.3
Ostomy products 0.0 0.5 1.0 0.8 0.9 0.8 0.8 0.8 0.7 0.7 0.7
Surgical gloves 0.4 0.4 0.5 0.6 0.5 0.5 0.5 0.6 0.6 0.6 0.6

DIAGNOSTIC IMAGING 15.1 15.3 15.2 14.1 15.3 15.3 15.2 15.1 15.0 14.9 14.9

ELECTRODIAGNOSTIC
APPARATUS
7.3 7.6 7.5 6.9 6.9 7.0 7.0 7.0 7.1 7.1 7.1
Electrocardiographs 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Ultrasound 2.3 2.4 2.2 2.0 1.9 1.9 1.8 1.8 1.8 1.8 1.7
MRI 0.8 1.4 1.4 1.2 1.5 1.6 1.7 1.8 1.8 1.9 2.0
Scintigraphic apparatus 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Other electrodiagnostic
apparatus
3.8 3.4 3.5 3.2 3.1 3.1 3.1 3.0 3.0 3.0 3.0

RADIATION
APPARATUS
3.6 3.9 3.8 3.4 4.6 4.6 4.6 4.6 4.5 4.5 4.5
CT scanners 0.7 1.0 1.1 1.4 2.0 2.0 2.1 2.1 2.1 2.2 2.2
Other medical x-ray
apparatus
2.7 2.8 2.6 1.9 2.5 2.4 2.4 2.3 2.2 2.2 2.1
A, B, C ray apparatus 0.2 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.1

IMAGING PARTS &
ACCESSORIES
4.1 3.9 3.9 3.8 3.8 3.7 3.6 3.5 3.4 3.3 3.2
Contrast media 0.8 0.8 0.8 0.7 0.7 0.7 0.7 0.6 0.6 0.6 0.6
Medical x-ray film (flat) 0.6 0.7 0.6 0.6 0.5 0.5 0.4 0.4 0.4 0.4 0.3
Medical x-ray film
(rolled)
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
X-ray tubes 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Other imaging parts &
accessories
2.2 1.9 2.0 2.1 2.0 2.0 2.0 1.9 1.9 1.8 1.8

DENTAL PRODUCTS 5.2 5.6 5.3 5.0 5.1 5.1 5.2 5.3 5.4 5.4 5.5

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 25
Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAPITAL EQUIPMENT 0.6 0.8 0.9 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.7
Dental drills 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Dental chairs 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2
Dental x-ray 0.3 0.4 0.5 0.3 0.4 0.4 0.4 0.4 0.5 0.5 0.5

INSTRUMENTS &
SUPPLIES
4.6 4.8 4.4 4.3 4.5 4.5 4.6 4.6 4.7 4.8 4.8
Dental cements 1.0 1.0 1.0 1.2 1.3 1.3 1.4 1.5 1.6 1.7 1.8
Dental instruments 2.2 2.5 2.0 1.9 2.0 1.9 1.8 1.7 1.7 1.6 1.6
Teeth & other fittings 1.4 1.4 1.4 1.3 1.2 1.3 1.3 1.4 1.4 1.5 1.5
Artificial teeth 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Other dental fittings 1.2 1.2 1.1 1.0 1.0 1.0 1.1 1.1 1.1 1.2 1.3

ORTHOPAEDICS &
PROSTHETICS
16.3 16.7 17.0 18.7 17.6 18.0 18.3 18.6 18.9 19.1 19.4

FIXATION DEVICES 4.3 3.3 3.5 4.8 4.3 4.2 4.2 4.2 4.2 4.1 4.1
ARTIFICIAL JOINTS 5.2 4.7 5.0 5.4 5.9 6.1 6.3 6.5 6.7 6.9 7.1
OTHER ARTIFICIAL
BODY PARTS
6.9 8.7 8.5 8.5 7.5 7.6 7.7 7.9 8.0 8.1 8.2

PATIENT AIDS 19.0 16.6 17.7 17.8 16.7 16.5 16.3 16.1 15.9 15.8 15.6

PORTABLE AIDS 14.4 12.3 12.2 12.6 11.9 11.7 11.5 11.3 11.1 10.9 10.7
Hearing aids 3.4 2.9 3.0 3.1 2.9 2.9 2.9 2.8 2.8 2.8 2.8
Pacemakers 3.7 3.5 3.4 3.2 3.8 3.8 3.8 3.8 3.8 3.8 3.8
Other portable aids 7.3 5.9 5.8 6.3 5.2 5.0 4.8 4.7 4.5 4.3 4.1

THERAPEUTIC
APPLIANCES
4.6 4.3 5.5 5.1 4.8 4.8 4.8 4.8 4.9 4.9 4.9
Mechano-therapy
apparatus
1.9 1.6 1.6 1.5 1.7 1.7 1.6 1.6 1.5 1.4 1.4
Therapeutic respiration
apparatus
2.7 2.7 3.9 3.6 3.0 3.1 3.2 3.3 3.4 3.4 3.5

OTHERS 30.6 31.7 31.0 30.3 31.6 31.7 31.9 32.0 32.2 32.3 32.4
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 26
Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

WHEELCHAIRS 0.8 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7
Wheelchairs, not
mechanically propelled
0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Wheelchairs,
mechanically propelled
0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3

OPHTHALMIC
INSTRUMENTS
2.0 2.0 1.8 1.9 2.0 2.1 2.1 2.1 2.1 2.1 2.1

HOSPITAL FURNITURE 1.2 1.1 1.1 1.1 1.2 1.2 1.2 1.2 1.2 1.2 1.2

MEDICAL, SURGICAL
STERILISERS
0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.5 0.4 0.4 0.4

ULTRA-VIOLET OR
INFRA-RED RAY
APPARATUS
0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1

OTHER INSTRUMENTS
& APPLIANCES
26.0 27.3 26.9 26.2 27.1 27.2 27.4 27.5 27.7 27.8 27.9
Anaesthetic apparatus
and instruments
2.6 2.7 2.6 2.1 2.6 2.5 2.5 2.5 2.4 2.4 2.4

TOTAL 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 27
Table: Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change)

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

CONSUMABLES 2.3 13.1 22.6 -0.1 -0.2 -7.5 -8.3 -1.2 4.3 4.4

BANDAGES & DRESSINGS -1.7 23.2 36.3 -20.1 -0.6 -7.9 -8.8 -1.8 3.6 3.6
Medical dressings
(adhesive)
-4.2 16.9 25.6 -1.5 0.6 -6.8 -7.7 -0.6 4.8 4.8
Medical dressings (non-
adhesive)
0.2 27.9 43.7 -31.3 -1.7 -8.9 -9.8 -2.9 2.4 2.4

SUTURING MATERIALS -2.1 3.2 23.5 20.9 2.8 -4.7 -5.7 1.6 7.1 7.1

SYRINGES, NEEDLES &
CATHETERS
-0.1 2.5 16.7 6.5 -1.4 -8.6 -9.5 -2.5 2.8 2.8
Syringes (with/without
needles)
24.9 4.4 9.5 -0.2 1.3 -6.1 -7.0 0.1 5.6 5.6
Tubular metal needles/
needles for sutures
13.4 -5.0 17.8 6.2 -0.1 -7.4 -8.2 -1.1 4.3 4.2
Other needles, catheters,
cannulae etc
-6.8 3.4 18.4 8.1 -2.2 -9.4 -10.3 -3.4 1.9 1.8

OTHER CONSUMABLES 57.7 69.7 16.2 2.0 1.9 -5.3 -6.0 1.6 7.5 7.9
Blood-grouping reagents -32.8 13.4 38.1 -19.2 -1.2 -8.5 -9.3 -2.3 3.0 3.0
First-aid boxes & kits -14.8 51.0 24.6 50.5 15.7 7.3 6.2 14.3 20.5 20.5
Ostomy products 1,823.6 102.0 -0.1 12.4 -2.2 -9.3 -10.2 -3.3 2.0 2.0
Surgical gloves -4.9 47.5 39.7 -14.8 5.6 -2.2 -3.2 4.3 9.9 9.9

DIAGNOSTIC IMAGING 2.5 15.1 9.0 13.4 1.2 -6.2 -7.0 0.2 5.7 5.8

ELECTRODIAGNOSTIC
APPARATUS
4.4 13.9 8.7 5.0 2.2 -5.2 -6.1 1.2 6.7 6.8
Electrocardiographs 0.2 33.6 16.3 -2.5 3.0 -4.6 -5.5 1.8 7.3 7.3
Ultrasound 5.2 4.3 7.7 -1.3 0.3 -7.0 -7.9 -0.9 4.5 4.5
MRI 69.2 12.8 7.1 30.1 6.5 -1.4 -2.4 5.1 10.9 10.8
Scintigraphic apparatus -23.5 134.0 -12.8 16.8 8.0 0.0 -1.0 6.6 12.4 12.4
Other electrodiagnostic
apparatus
-9.3 17.5 9.8 -0.2 1.0 -6.4 -7.3 -0.1 5.3 5.3
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 28
Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change) - Continued

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

RADIATION APPARATUS 7.3 15.2 4.3 42.1 1.3 -6.1 -7.0 0.2 5.7 5.8
CT scanners 38.1 33.1 47.3 45.4 3.9 -3.7 -4.7 2.6 8.2 8.2
Other medical x-ray
apparatus
6.9 7.7 -14.5 35.0 -0.5 -7.8 -8.7 -1.7 3.6 3.6
A, B, C ray apparatus -81.5 94.8 15.1 166.8 -2.1 -9.3 -10.1 -3.2 2.1 2.1

IMAGING PARTS &
ACCESSORIES
-5.1 17.3 14.4 3.0 -0.7 -8.0 -8.8 -1.8 3.6 3.6
Contrast media -5.9 23.2 3.3 5.5 -1.7 -9.0 -9.9 -2.9 2.3 2.3
Medical x-ray film (flat) 4.7 6.4 9.1 -7.8 -4.7 -11.7 -12.6 -5.9 -0.7 -0.7
Medical x-ray film (rolled) -28.8 -18.1 29.3 95.0 2.1 -5.4 -6.2 1.0 6.5 6.5
X-ray tubes 10.1 7.3 8.3 15.2 2.2 -5.3 -6.2 1.0 6.5 6.5
Other imaging parts &
accessories
-11.2 21.6 22.0 2.2 -0.1 -7.4 -8.3 -1.3 4.1 4.1

DENTAL PRODUCTS 8.5 9.8 10.2 6.2 2.9 -4.4 -5.2 2.3 8.1 8.3

CAPITAL EQUIPMENT 26.5 39.3 -20.5 1.6 4.3 -3.2 -4.1 3.4 9.2 9.3
Dental drills 77.7 13.8 -32.4 -14.0 -2.3 -9.5 -10.3 -3.4 1.8 1.8
Dental chairs -1.2 48.3 -19.4 -9.4 0.4 -7.0 -7.9 -0.8 4.6 4.6
Dental x-ray 41.6 39.5 -19.1 11.0 7.2 -0.7 -1.7 5.9 11.6 11.6

INSTRUMENTS &
SUPPLIES
6.1 5.1 16.7 6.9 2.8 -4.6 -5.3 2.2 7.9 8.1
Dental cements 6.3 8.0 44.8 11.6 7.7 -0.2 -1.1 6.5 12.3 12.3
Dental instruments 10.3 -4.5 11.7 6.2 -1.9 -9.1 -10.0 -3.1 2.2 2.2
Teeth & other fittings -0.8 20.0 4.8 3.4 5.1 -2.5 -3.5 4.0 9.7 9.8
Artificial teeth 4.5 105.6 10.0 8.1 0.4 -7.0 -7.9 -0.8 4.6 4.5
Other dental fittings -1.5 8.1 3.4 2.1 6.5 -1.3 -2.3 5.2 11.0 10.9

ORTHOPAEDICS &
PROSTHETICS
3.2 17.9 29.5 -1.8 3.6 -4.0 -5.0 2.3 7.9 7.9

FIXATION DEVICES -21.8 21.8 63.6 -8.4 1.4 -6.1 -7.0 0.1 5.6 5.6
ARTIFICIAL JOINTS -8.4 24.1 26.1 14.4 5.1 -2.6 -3.6 3.8 9.4 9.4
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 29
Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change) - Continued

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
OTHER ARTIFICIAL BODY
PARTS
27.5 13.0 17.6 -8.4 3.6 -4.0 -5.0 2.3 7.9 7.9

PATIENT AIDS -12.0 23.7 18.7 -2.7 0.5 -6.7 -7.5 -0.3 5.2 5.3

PORTABLE AIDS -14.1 15.1 22.6 -2.3 -0.1 -7.4 -8.1 -1.0 4.4 4.4
Hearing aids -13.7 21.1 22.8 -3.7 0.6 -6.6 -7.1 0.1 5.5 5.5
Pacemakers -4.0 12.3 12.4 20.8 2.1 -5.5 -6.4 0.8 6.3 6.3
Other portable aids -19.2 13.9 28.4 -13.5 -2.1 -9.2 -10.1 -3.1 2.1 2.1

THERAPEUTIC
APPLIANCES
-5.5 48.3 10.1 -3.8 2.2 -5.2 -5.9 1.4 7.0 7.1
Mechano-therapy apparatus -15.4 13.6 14.5 15.8 -1.5 -8.8 -9.7 -2.7 2.6 2.6
Therapeutic respiration
apparatus
1.6 69.4 8.3 -12.2 4.3 -3.3 -4.0 3.4 9.0 9.0

OTHERS 4.2 13.4 15.5 8.2 2.3 -5.2 -6.1 1.1 6.6 6.6

WHEELCHAIRS -7.9 14.8 11.5 3.2 1.5 -5.9 -6.8 0.5 6.0 6.1
Wheelchairs, not
mechanically propelled
-11.1 7.3 21.0 3.9 4.7 -3.0 -4.0 3.4 9.0 9.0
Wheelchairs, mechanically
propelled
-5.6 19.9 5.6 2.7 -0.8 -8.1 -9.0 -2.0 3.4 3.4

OPHTHALMIC
INSTRUMENTS
1.1 4.0 24.6 13.2 2.3 -5.2 -6.1 1.2 6.7 6.7

HOSPITAL FURNITURE -14.8 19.1 20.4 17.0 1.4 -6.0 -7.0 0.2 5.7 5.6

MEDICAL, SURGICAL
STERILISERS
5.0 9.1 7.6 10.5 0.2 -7.2 -8.1 -1.0 4.4 4.4

ULTRA-VIOLET OR INFRA-
RED RAY APPARATUS
-14.5 56.5 -5.7 75.3 4.1 -3.6 -4.5 2.8 8.4 8.4

OTHER INSTRUMENTS &
APPLIANCES
5.7 13.8 15.0 7.4 2.4 -5.1 -6.0 1.2 6.7 6.7
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 30
Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change) - Continued

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Anaesthetic apparatus and
instruments
5.7 7.7 -2.3 25.6 0.8 -6.6 -7.5 -0.4 5.0 5.0

TOTAL 0.7 15.9 18.2 3.8 1.8 -5.7 -6.5 0.8 6.3 6.3
Source: BMI Espicom
Consumables Market Forecast
The Australian market for consumable products is estimated at US$646.8mn in 2013, equal to US$27.9 per
capita and 13.4% of the total market. Within this, syringes, needles & catheters account for US$322.7mn
and bandages & dressings for US$150.0mn.
There is some local production of items such as bandages and syringes, but this tends to be for export. As a
result, the market is largely reliant on imports. The principal supplier is the USA, followed by China,
Ireland and Germany.
The sector grew at a CAGR of 7.2% over the 2008-2013 period. Espicom projects a CAGR of -1.8% for the
2013-2018 period, with the market declining to US$589.9mn by 2018, equal to US$23.9 per capita.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 31
Table: Consumables Market, 2008-2018 (US$mn)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

CONSUMABLES 457.5 468.1 529.4 649.0 648.4 646.8 598.3 548.5 542.0 565.2 589.9 7.2 -1.8

BANDAGES &
DRESSINGS 114.5 112.5 138.6 189.0 151.0 150.0 138.1 125.9 123.7 128.1 132.6 5.5 -2.4
Medical dressings
(adhesive) 50.6 48.4 56.6 71.1 70.1 70.5 65.7 60.6 60.3 63.2 66.2 6.9 -1.3
Medical dressings
(non-adhesive) 64.0 64.1 82.0 117.8 80.9 79.5 72.4 65.3 63.4 64.9 66.4 4.5 -3.5

SUTURING
MATERIALS 61.5 60.2 62.1 76.7 92.7 95.4 90.9 85.7 87.0 93.2 99.8 9.2 0.9

SYRINGES,
NEEDLES &
CATHETERS 257.1 256.9 263.4 307.4 327.3 322.7 294.8 266.7 260.0 267.3 274.8 4.6 -3.2
Syringes (with/
without needles) 36.4 45.5 47.5 52.0 51.9 52.6 49.3 45.9 45.9 48.5 51.2 7.6 -0.5
Tubular metal
needles/needles
for sutures 28.5 32.4 30.7 36.2 38.4 38.4 35.6 32.7 32.3 33.7 35.1 6.1 -1.8
Other needles,
catheters,
cannulae etc 192.1 179.1 185.2 219.2 237.0 231.7 209.8 188.2 181.8 185.1 188.5 3.8 -4.0

OTHER
CONSUMABLES 24.4 38.5 65.3 75.9 77.4 78.8 74.6 70.2 71.3 76.6 82.7 26.4 1.0
Blood-grouping
reagents 6.5 4.3 4.9 6.8 5.5 5.4 5.0 4.5 4.4 4.5 4.7 -3.4 -3.0
First-aid boxes &
kits 2.9 2.4 3.7 4.6 6.9 8.0 8.6 9.1 10.4 12.6 15.2 22.8 13.6
Ostomy products 0.9 18.3 36.9 36.8 41.4 40.5 36.7 33.0 31.9 32.5 33.2 111.9 -3.9
Surgical gloves 14.1 13.4 19.8 27.6 23.5 24.9 24.3 23.5 24.6 27.0 29.7 12.0 3.6
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 32
Table: Consumables Market, 2008-2018 (US$ Per Capita)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

CONSUMABLES 21.3 21.4 23.8 28.7 28.3 27.9 25.5 23.1 22.5 23.2 23.9 5.6 -3.0

BANDAGES &
DRESSINGS 5.3 5.1 6.2 8.4 6.6 6.5 5.9 5.3 5.1 5.3 5.4 4.0 -3.6
Medical dressings
(adhesive) 2.3 2.2 2.5 3.1 3.1 3.0 2.8 2.5 2.5 2.6 2.7 5.3 -2.4
Medical dressings
(non-adhesive) 3.0 2.9 3.7 5.2 3.5 3.4 3.1 2.7 2.6 2.7 2.7 2.9 -4.7

SUTURING
MATERIALS 2.9 2.7 2.8 3.4 4.0 4.1 3.9 3.6 3.6 3.8 4.0 7.5 -0.3

SYRINGES,
NEEDLES &
CATHETERS 11.9 11.7 11.8 13.6 14.3 13.9 12.5 11.2 10.8 11.0 11.1 3.1 -4.3
Syringes (with/
without needles) 1.7 2.1 2.1 2.3 2.3 2.3 2.1 1.9 1.9 2.0 2.1 6.0 -1.7
Tubular metal
needles/needles
for sutures 1.3 1.5 1.4 1.6 1.7 1.7 1.5 1.4 1.3 1.4 1.4 4.5 -3.0
Other needles,
catheters,
cannulae etc 8.9 8.2 8.3 9.7 10.3 10.0 8.9 7.9 7.5 7.6 7.6 2.2 -5.2

OTHER
CONSUMABLES 1.1 1.8 2.9 3.4 3.4 3.4 3.2 2.9 3.0 3.1 3.4 24.5 -0.3
Blood-grouping
reagents 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 -4.9 -4.1
First-aid boxes &
kits 0.1 0.1 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.6 20.9 12.2
Ostomy products 0.0 0.8 1.7 1.6 1.8 1.7 1.6 1.4 1.3 1.3 1.3 108.7 -5.1
Surgical gloves 0.7 0.6 0.9 1.2 1.0 1.1 1.0 1.0 1.0 1.1 1.2 10.3 2.3
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 33
Table: Consumables Market, 2009-2018 (US$mn % Change)

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

CONSUMABLES 2.3 13.1 22.6 -0.1 -0.2 -7.5 -8.3 -1.2 4.3 4.4

BANDAGES & DRESSINGS -1.7 23.2 36.3 -20.1 -0.6 -7.9 -8.8 -1.8 3.6 3.6
Medical dressings
(adhesive) -4.2 16.9 25.6 -1.5 0.6 -6.8 -7.7 -0.6 4.8 4.8
Medical dressings (non-
adhesive) 0.2 27.9 43.7 -31.3 -1.7 -8.9 -9.8 -2.9 2.4 2.4

SUTURING MATERIALS -2.1 3.2 23.5 20.9 2.8 -4.7 -5.7 1.6 7.1 7.1

SYRINGES, NEEDLES &
CATHETERS -0.1 2.5 16.7 6.5 -1.4 -8.6 -9.5 -2.5 2.8 2.8
Syringes (with/without
needles) 24.9 4.4 9.5 -0.2 1.3 -6.1 -7.0 0.1 5.6 5.6
Tubular metal needles/
needles for sutures 13.4 -5.0 17.8 6.2 -0.1 -7.4 -8.2 -1.1 4.3 4.2
Other needles, catheters,
cannulae etc -6.8 3.4 18.4 8.1 -2.2 -9.4 -10.3 -3.4 1.9 1.8

OTHER CONSUMABLES 57.7 69.7 16.2 2.0 1.9 -5.3 -6.0 1.6 7.5 7.9
Blood-grouping reagents -32.8 13.4 38.1 -19.2 -1.2 -8.5 -9.3 -2.3 3.0 3.0
First-aid boxes & kits -14.8 51.0 24.6 50.5 15.7 7.3 6.2 14.3 20.5 20.5
Ostomy products 1,823.6 102.0 -0.1 12.4 -2.2 -9.3 -10.2 -3.3 2.0 2.0
Surgical gloves -4.9 47.5 39.7 -14.8 5.6 -2.2 -3.2 4.3 9.9 9.9
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 34
Consumables Market 2008-2018
US$mn
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 35
Consumables Market, 2009--2018
US$mn CAGR
Source: BMI Espicom
Diagnostic Imaging Market Forecast
The Australian market for diagnostic imaging is estimated at US$735.2mn in 2013, equal to US$31.7 per
capita and 15.3% of the total market. Within the sector, electrodiagnostic apparatus accounts for US
$335.9mn and X-ray/other radiation apparatus for a further US$221.9mn. Almost all requirements are
imported. These are supplied primarily from the USA, Germany and China.
The sector grew strongly over the 2008-13 period, at a CAGR of 6.5%. Within this, high tech areas such as
MRI and CT were the best performers. A slowdown in growth across the diagnostic sector is expected,
however; Espicom projects a CAGR of 0.4% for the 2013-18 period. This will take the market to US
$719.1mn by 2018, equal to US$29.1 per capita. The only growth will remain in the high tech areas, notably
MRI and scintigraphic apparatus.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 36
Electrodiagnostic Apparatus Sector
The market for electrodiagnostic apparatus is estimated at US$335.9mn in 2013, equal to US$31.7 per
capita. Almost all of the market is imported.
Other electrodiagnostic apparatus, including patient monitoring equipment, is the largest segment within the
electrodiagnostic market, with sales of US$148.6mn in 2013, followed by ultrasound apparatus with sales of
US$89.8mn and MRI units to a value of US$77.5mn. The electrodiagnostic apparatus market increased at a
CAGR of 6.8% between 2008 and 2013, with the strongest growth (23.1%) coming in the MRI segment.
A slowdown in growth to a CAGR of just 0.5% is forecast to take the market to US$719.1mn over the
2013-2018 period, with scintigraphic apparatus expected to have the highest growth at 5.9%.
Radiation Apparatus Sector
The market for radiation apparatus, including X-ray apparatus and CT scanners, totals an estimated US
$221.9mn in 2013. Other medical X-ray apparatus forms the largest sector of the market, with sales
estimated at US$116.3mn in 2013, followed by CT scanners at US$97.1mn. Almost all of the market is
imported.
The market increased at an estimated CAGR of 13.2% over the 2008-2013 period. Demand for CT scanners
increased significantly over the period, rising at a CAGR of 32.6%.
The sector is projected to show a small decline over the 2013-2018 period, with the only area expected to
show any growth being the CT scanner segment which is forecast to increase at a CAGR of just under 2%.
Imaging Parts & Accessories Sector
The market for imaging parts & accessories is estimated at US$177.4mn in 2013, equal to US$7.6 per
capita. The market is almost entirely reliant upon imports.
The market increased at an estimated CAGR of 5.4% between 2008 and 2013, with all segments registering
growth. Both the rolled X-ray film and X-ray tube segments achieved a CAGR of 8.5% over the period.
Looking ahead, the sector is expected to shrink at a CAGR of 2.4% between 2013 and 2018 with only the
rolled X-ray film and X-ray tube segments forecast to achieve any growth at all.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 37
Table: Diagnostic Imaging Market, 2008-2018 (US$mn)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

DIAGNOSTIC IMAGING 498.0 510.5 587.4 640.5 726.3 735.2 690.0 641.6 642.9 679.8 719.1 8.1 -0.4

ELECTRODIAGNOSTIC
APPARATUS 242.2 252.9 288.0 313.0 328.6 335.9 318.3 298.8 302.3 322.8 344.7 6.8 0.5
Electrocardiographs 9.9 10.0 13.3 15.5 15.1 15.6 14.9 14.0 14.3 15.3 16.5 9.4 1.1
Ultrasound 76.7 80.7 84.2 90.6 89.5 89.8 83.4 76.8 76.2 79.6 83.2 3.2 -1.5
MRI 27.4 46.3 52.2 56.0 72.8 77.5 76.5 74.7 78.5 87.0 96.4 23.1 4.5
Scintigraphic apparatus 2.2 1.7 4.0 3.5 4.1 4.4 4.4 4.4 4.6 5.2 5.9 14.5 5.9
Other electrodiagnostic
apparatus 126.0 114.3 134.3 147.4 147.2 148.6 139.1 129.0 128.8 135.6 142.7 3.4 -0.8

RADIATION
APPARATUS 119.5 128.3 147.8 154.1 218.9 221.9 208.4 193.9 194.3 205.5 217.4 13.16 -0.41
CT scanners 23.7 32.8 43.6 64.3 93.4 97.1 93.5 89.1 91.5 99.0 107.1 32.55 1.98
Other medical x-ray
apparatus 88.0 94.1 101.4 86.6 116.9 116.3 107.3 97.9 96.2 99.7 103.4 5.73 -2.34
A, B, C ray apparatus 7.8 1.4 2.8 3.2 8.6 8.4 7.6 6.9 6.7 6.8 6.9 1.61 -3.81

IMAGING PARTS &
ACCESSORIES 136.3 129.3 151.6 173.4 178.7 177.4 163.3 148.9 146.2 151.5 157.0 5.4 -2.4
Contrast media 26.8 25.2 31.1 32.1 33.9 33.3 30.3 27.3 26.5 27.2 27.8 4.4 -3.6
Medical x-ray film (flat) 21.0 22.0 23.4 25.5 23.5 22.4 19.8 17.3 16.3 16.1 16.0 1.3 -6.5
Medical x-ray film
(rolled) 0.3 0.2 0.2 0.2 0.4 0.4 0.4 0.3 0.4 0.4 0.4 8.5 0.3
X-ray tubes 16.8 18.5 19.9 21.5 24.8 25.3 24.0 22.5 22.7 24.2 25.7 8.5 0.3
Other imaging parts &
accessories 71.4 63.4 77.1 94.1 96.1 96.0 88.8 81.4 80.4 83.7 87.1 6.1 -1.9
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 38
Table: Diagnostic Imaging Market, 2008-2018 (US$ Per Capita)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

DIAGNOSTIC IMAGING 23.1 23.3 26.4 28.3 31.7 31.7 29.4 27.0 26.7 27.9 29.1 6.5 -1.6

ELECTRODIAGNOSTIC
APPARATUS 11.3 11.5 12.9 13.8 14.3 14.5 13.5 12.6 12.6 13.2 14.0 5.1 -0.7
Electrocardiographs 0.5 0.5 0.6 0.7 0.7 0.7 0.6 0.6 0.6 0.6 0.7 7.7 -0.1
Ultrasound 3.6 3.7 3.8 4.0 3.9 3.9 3.5 3.2 3.2 3.3 3.4 1.6 -2.7
MRI 1.3 2.1 2.3 2.5 3.2 3.3 3.3 3.1 3.3 3.6 3.9 21.3 3.2
Scintigraphic apparatus 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 12.8 4.7
Other electrodiagnostic
apparatus 5.9 5.2 6.0 6.5 6.4 6.4 5.9 5.4 5.3 5.6 5.8 1.8 -2.0

RADIATION
APPARATUS 5.6 5.9 6.6 6.8 9.6 9.6 8.9 8.1 8.1 8.4 8.8 11.46 -1.61
CT scanners 1.1 1.5 2.0 2.8 4.1 4.2 4.0 3.7 3.8 4.1 4.3 30.55 0.74
Other medical x-ray
apparatus 4.1 4.3 4.6 3.8 5.1 5.0 4.6 4.1 4.0 4.1 4.2 4.14 -3.52
A, B, C ray apparatus 0.4 0.1 0.1 0.1 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.07 -4.97

IMAGING PARTS &
ACCESSORIES 6.3 5.9 6.8 7.7 7.8 7.6 6.9 6.3 6.1 6.2 6.4 3.8 -3.6
Contrast media 1.2 1.2 1.4 1.4 1.5 1.4 1.3 1.1 1.1 1.1 1.1 2.9 -4.7
Medical x-ray film (flat) 1.0 1.0 1.0 1.1 1.0 1.0 0.8 0.7 0.7 0.7 0.6 -0.2 -7.6
Medical x-ray film
(rolled) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 -0.9
X-ray tubes 0.8 0.8 0.9 1.0 1.1 1.1 1.0 0.9 0.9 1.0 1.0 6.9 -0.9
Other imaging parts &
accessories 3.3 2.9 3.5 4.2 4.2 4.1 3.8 3.4 3.3 3.4 3.5 4.5 -3.1
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 39
Table: Diagnostic Imaging Market, 2009-2018 (US$mn % Change)

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

DIAGNOSTIC IMAGING 2.5 15.1 9.0 13.4 1.2 -6.2 -7.0 0.2 5.7 5.8

ELECTRODIAGNOSTIC
APPARATUS 4.4 13.9 8.7 5.0 2.2 -5.2 -6.1 1.2 6.7 6.8
Electrocardiographs 0.2 33.6 16.3 -2.5 3.0 -4.6 -5.5 1.8 7.3 7.3
Ultrasound 5.2 4.3 7.7 -1.3 0.3 -7.0 -7.9 -0.9 4.5 4.5
MRI 69.2 12.8 7.1 30.1 6.5 -1.4 -2.4 5.1 10.9 10.8
Scintigraphic apparatus -23.5 134.0 -12.8 16.8 8.0 0.0 -1.0 6.6 12.4 12.4
Other electrodiagnostic apparatus -9.3 17.5 9.8 -0.2 1.0 -6.4 -7.3 -0.1 5.3 5.3

RADIATION APPARATUS 7.3 15.2 4.3 42.1 1.3 -6.1 -7.0 0.2 5.7 5.8
CT scanners 38.1 33.1 47.3 45.4 3.9 -3.7 -4.7 2.6 8.2 8.2
Other medical x-ray apparatus 6.9 7.7 -14.5 35.0 -0.5 -7.8 -8.7 -1.7 3.6 3.6
A, B, C ray apparatus -81.5 94.8 15.1 166.8 -2.1 -9.3 -10.1 -3.2 2.1 2.1

IMAGING PARTS &
ACCESSORIES -5.1 17.3 14.4 3.0 -0.7 -8.0 -8.8 -1.8 3.6 3.6
Contrast media -5.9 23.2 3.3 5.5 -1.7 -9.0 -9.9 -2.9 2.3 2.3
Medical x-ray film (flat) 4.7 6.4 9.1 -7.8 -4.7 -11.7 -12.6 -5.9 -0.7 -0.7
Medical x-ray film (rolled) -28.8 -18.1 29.3 95.0 2.1 -5.4 -6.2 1.0 6.5 6.5
X-ray tubes 10.1 7.3 8.3 15.2 2.2 -5.3 -6.2 1.0 6.5 6.5
Other imaging parts & accessories -11.2 21.6 22.0 2.2 -0.1 -7.4 -8.3 -1.3 4.1 4.1
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 40
Diagnostic Imaging Market, 2008-2018
US$mn
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 41
Diagnostic Imaging Market, 2009-2018
US$mn CAGR
Source: BMI Espicom
Dental Products Market Forecast
The Australian dental market is estimated at US$247.1mn in 2013, equal to US$10.6 per capita and 5.1% of
the total market. The market for instruments & supplies accounts for the majority of the dental market and is
estimated at US$217.1mn in 2013. The capital equipment market, including drills, chairs and X-ray
apparatus is estimated at US$30.1mn.
The dental market has outperformed the market as a whole in recent years as the government has been keen
to boost dental provision across the country, and has taken steps to boost the numbers of dentists trained and
recruited each year. After a CAGR of 7.5% over the 2008-13 period, Espicom projects a fall in the CAGR
to 1.6% for the 2013-18 period, with capital equipment outperforming this (at a CAGR of 2.8%) as the
number of dentists increases. This will take the dental market to US$268.1mn by 2018, equal to US$10.9
per capita.
The USA and Germany are the major suppliers of dental equipment, with Switzerland and Ireland also
significant suppliers of dental instruments and fittings.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 42
Table: Dental Products Market, 2008-2018 (US$mn)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

DENTAL
PRODUCTS 172.2 187 205.1 226 240 247.1 236.2 224 229.2 247.7 268.1 7.5 1.6

CAPITAL
EQUIPMENT 20.3 26 35.7 28.4 28.8 30.1 29.1 27.9 28.9 31.5 34.4 8.2 2.8
Dental drills 1.7 3 3.5 2.4 2.1 2 1.8 1.6 1.6 1.6 1.6 2.8 -4.1
Dental chairs 8.6 9 12.7 10.2 9.2 9.3 8.6 7.9 7.9 8.2 8.6 1.4 -1.5
Dental x-ray 10 14 19.5 15.8 17.5 18.8 18.7 18.3 19.4 21.7 24.2 13.7 5.2

INSTRUMENTS
& SUPPLIES 151.9 161 169.4 197.7 211.2 217.1 207.1 196 200.3 216.1 233.7 7.4 1.5
Dental cements 32 34 37 53.6 59.8 64.3 64.2 63.5 67.7 76 85.4 14.8 5.8
Dental
instruments 74 82 78 87.1 92.5 90.7 82.4 74.2 71.9 73.5 75.1 4.2 -3.7
Teeth & other
fittings 45.7 45 54.4 57 59 62 60.4 58.3 60.7 66.6 73.1 6.3 3.4
Artificial teeth 5 6 11.4 12.5 13.5 13.6 12.6 11.6 11.5 12.1 12.6 20.7 -1.5
Other dental
fittings 40 39.8 43 44.5 45.4 48.4 47.8 46.7 49.1 54.5 60.5 3.7 4.6
Source: BMI Espicom
Table: Dental Products Market, 2008-2018 (US$ Per Capita)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

DENTAL
PRODUCTS 8 9 9.2 10 10.5 10.6 10 9.4 9.5 10.2 10.9 7.5 1.6

CAPITAL
EQUIPMENT 0.9 1 1.6 1.3 1.3 1.3 1.2 1.2 1.2 1.3 1.4 8.2 2.8
Dental drills 0.1 0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.8 -4.1
Dental chairs 0 0 0.6 0.5 0.4 0.4 0.4 0.3 0.3 0.3 0.3 1.4 -1.5
Dental x-ray 0.5 1 0.9 0.7 0.8 0.8 0.8 0.8 0.8 0.9 1 13.7 5.2

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 43
Dental Products Market, 2008-2018 (US$ Per Capita) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18
INSTRUMENTS
& SUPPLIES 7 7 7.6 8.7 9.2 9.4 8.8 8.2 8.3 8.9 9.5 7.4 1.5
Dental cements 1.5 2 1.7 2.4 2.6 2.8 2.7 2.7 2.8 3.1 3.5 14.8 5.8
Dental
instruments 3.4 4 3.5 3.9 4 3.9 3.5 3.1 3 3 3 4.2 -3.7
Teeth & other
fittings 2 2 2.4 2.5 2.6 2.7 2.6 2.5 2.5 2.7 3 6.3 3.4
Artificial teeth 0 0.3 0.5 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.5 20.7 -1.5
Other dental
fittings 2 1.8 1.9 2 2 2.1 2 2 2 2.2 2.5 3.7 4.6
Source: BMI Espicom
Table: Dental Products Market, 2009-2018 (US$mn % Change)

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

DENTAL PRODUCTS 8.5 9.8 10.2 6.2 2.9 -4.4 -5.2 2.3 8.1 8.3

CAPITAL EQUIPMENT 26.5 39.3 -20.5 1.6 4.3 -3.2 -4.1 3.4 9.2 9.3
Dental drills 77.7 13.8 -32.4 -14.0 -2.3 -9.5 -10.3 -3.4 1.8 1.8
Dental chairs -1.2 48.3 -19.4 -9.4 0.4 -7.0 -7.9 -0.8 4.6 4.6
Dental x-ray 41.6 39.5 -19.1 11.0 7.2 -0.7 -1.7 5.9 11.6 11.6

INSTRUMENTS &
SUPPLIES 6.1 5.1 16.7 6.9 2.8 -4.6 -5.3 2.2 7.9 8.1
Dental cements 6.3 8.0 44.8 11.6 7.7 -0.2 -1.1 6.5 12.3 12.3
Dental instruments 10.3 -4.5 11.7 6.2 -1.9 -9.1 -10.0 -3.1 2.2 2.2
Teeth & other fittings -0.8 20.0 4.8 3.4 5.1 -2.5 -3.5 4.0 9.7 9.8
Artificial teeth 4.5 105.6 10.0 8.1 0.4 -7.0 -7.9 -0.8 4.6 4.5
Other dental fittings -1.5 8.1 3.4 2.1 6.5 -1.3 -2.3 5.2 11.0 10.9
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 44
Dental Products Market, 2008-2018
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 45
Dental Products Market, 2009-2018
US$mn CAGR
Source: BMI Espicom
Orthopaedics & Prosthetics Market Forecast
The Australian orthopaedic & prosthetic market is estimated at US$864.7mn in 2013, equal to US$37.2 per
capita and 18.0% of the total market.
Australia has a sizeable domestic orthopaedic & prosthetic production sector, but this concentrates on
exports. Products used locally, especially at the advanced end of the technology scale, tend to be imported,
principally from the USA, Ireland and Switzerland.
The orthopaedic & prosthetic market grew at a CAGR of 9.9% between 2008 and 2013. Driven by the
ageing population and increasing availability of newer more expensive products, Espicom projects that this
will be one of the better performing market segments in the coming years, albeit at a low CAGR of 1.7%
over the 2013-18. This is expected to take the overall market to US$939.5mn by 2018, equal to US$38.1 per
capita.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 46
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$mn)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

ORTHOPAEDICS
& PROSTHETICS 539.8 557.2 656.7 850.6 835.0 864.7 829.8 788.3 806.7 870.5 939.5 9.9 1.7

FIXATION
DEVICES 141.2 110.4 134.4 219.9 201.5 204.2 191.8 178.3 178.5 188.5 198.9 7.7 -0.5
ARTIFICIAL
JOINTS 171.0 156.6 194.2 245.0 280.2 294.4 286.6 276.2 286.6 313.5 343.0 11.5 3.1
OTHER
ARTIFICIAL BODY
PARTS 227.6 290.2 328.0 385.7 353.3 366.0 351.3 333.8 341.6 368.5 397.6 10.0 1.7
Source: BMI Espicom
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$ Per Capita)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

ORTHOPAEDICS
& PROSTHETICS 25.1 25.4 29.5 37.6 36.4 37.2 35.3 33.1 33.5 35.7 38.1 8.2 0.4

FIXATION
DEVICES 6.6 5.0 6.0 9.7 8.8 8.8 8.2 7.5 7.4 7.7 8.1 6.0 -1.7
ARTIFICIAL
JOINTS 7.9 7.1 8.7 10.8 12.2 12.7 12.2 11.6 11.9 12.9 13.9 9.8 1.9
OTHER
ARTIFICIAL BODY
PARTS 10.6 13.3 14.7 17.1 15.4 15.8 14.9 14.0 14.2 15.1 16.1 8.3 0.4
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 47
Table: Orthopaedics & Prosthetics Market, 2009-2018 (USmn % Change)

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

ORTHOPAEDICS &
PROSTHETICS 3.2 17.9 29.5 -1.8 3.6 -4.0 -5.0 2.3 7.9 7.9

FIXATION DEVICES -21.8 21.8 63.6 -8.4 1.4 -6.1 -7.0 0.1 5.6 5.6
ARTIFICIAL JOINTS -8.4 24.1 26.1 14.4 5.1 -2.6 -3.6 3.8 9.4 9.4
OTHER ARTIFICIAL BODY
PARTS 27.5 13.0 17.6 -8.4 3.6 -4.0 -5.0 2.3 7.9 7.9
Source: BMI Espicom
Orthopaedics & Prosthetics Market, 2008-2018
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 48
Orthopaedics & Prosthetics Market, 2009-2018
US$mn CAGR
Source: BMI Espicom
Patient Aids Market Forecast
The market for patient aids is estimated at US$792.1mn in 2013, equal to US$34.1 per capita and 18.0% of
the total market. Within this, portable aids account for US$562.5mn and therapeutic appliances for US
$229.7mn.
Australia has considerable production expertise in a number of these areas. Cochlear is one of the world's
leading developers of digital hearing aids, while ResMed is a major manufacturer of therapeutic respiration
products. Both companies make most of their sales in markets outside Australia, however. The Australian
market is therefore largely reliant on imports, primarily from the USA, China, Switzerland and Ireland.
The market grew at a CAGR of 4.8% between 2008 and 2013, but is projected to decline at a CAGR of
1.0% to US$755.0mn by 2018. In recent years, the strongest growth has been seen in the therapeutic
appliances segment, and this is the only area of the market expected to continue to show any growth over
the next five years.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 49
Table: Patient Aids Market, 2008-2018 (US$mn)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

PATIENT AIDS 626.8 551.6 682.5 810.0 787.8 792.1 738.8 683.6 681.7 717.2 755.0 4.8 -1.0

PORTABLE AIDS 475.3 408.5 470.3 576.4 563.1 562.5 521.1 478.7 473.9 494.8 516.8 3.4 -1.7
Hearing aids 111.8 96.4 116.8 143.4 138.1 139.0 129.8 120.6 120.7 127.4 134.4 4.4 -0.7
Pacemakers 121.5 116.6 130.9 147.2 177.8 181.5 171.6 160.6 161.9 172.0 182.8 8.4 0.1
Other portable
aids 242.1 195.5 222.6 285.8 247.1 242.0 219.6 197.5 191.3 195.4 199.6 0.0 -3.8

THERAPEUTIC
APPLIANCES 151.4 143.1 212.2 233.6 224.7 229.7 217.8 204.9 207.8 222.4 238.2 8.7 0.7
Mechano-
therapy
apparatus 63.8 54.0 61.3 70.2 81.2 80.0 73.0 65.9 64.1 65.7 67.4 4.6 -3.4
Therapeutic
respiration
apparatus 87.7 89.1 150.9 163.4 143.5 149.7 144.8 139.0 143.7 156.6 170.7 11.3 2.7
Source: BMI Espicom
Table: Patient Aids Market, 2008-2018 (US$ Per Capita)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

PATIENT AIDS 29.1 25.2 30.6 35.8 34.4 34.1 31.4 28.7 28.3 29.4 30.6 3.2 -2.2

PORTABLE AIDS 22.1 18.7 21.1 25.5 24.6 24.2 22.2 20.1 19.7 20.3 20.9 1.9 -2.9
Hearing aids 5.2 4.4 5.2 6.3 6.0 6.0 5.5 5.1 5.0 5.2 5.4 2.9 -1.9
Pacemakers 5.6 5.3 5.9 6.5 7.8 7.8 7.3 6.8 6.7 7.1 7.4 6.7 -1.1
Other portable
aids 11.3 8.9 10.0 12.6 10.8 10.4 9.3 8.3 7.9 8.0 8.1 -1.5 -4.9

THERAPEUTIC
APPLIANCES 7.0 6.5 9.5 10.3 9.8 9.9 9.3 8.6 8.6 9.1 9.7 7.0 -0.5
Mechano-
therapy
apparatus 3.0 2.5 2.8 3.1 3.5 3.4 3.1 2.8 2.7 2.7 2.7 3.1 -4.5
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 50
Patient Aids Market, 2008-2018 (US$ Per Capita) - Continued

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18
Therapeutic
respiration
apparatus 4.1 4.1 6.8 7.2 6.3 6.4 6.2 5.8 6.0 6.4 6.9 9.6 1.4
Source: BMI Espicom
Table: Patient Aids Market, 2009-2018 (US$mn % Change)

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

PATIENT AIDS -12.0 23.7 18.7 -2.7 0.5 -6.7 -7.5 -0.3 5.2 5.3

PORTABLE AIDS -14.1 15.1 22.6 -2.3 -0.1 -7.4 -8.1 -1.0 4.4 4.4
Hearing aids -13.7 21.1 22.8 -3.7 0.6 -6.6 -7.1 0.1 5.5 5.5
Pacemakers -4.0 12.3 12.4 20.8 2.1 -5.5 -6.4 0.8 6.3 6.3
Other portable aids -19.2 13.9 28.4 -13.5 -2.1 -9.2 -10.1 -3.1 2.1 2.1

THERAPEUTIC APPLIANCES -5.5 48.3 10.1 -3.8 2.2 -5.2 -5.9 1.4 7.0 7.1
Mechano-therapy apparatus -15.4 13.6 14.5 15.8 -1.5 -8.8 -9.7 -2.7 2.6 2.6
Therapeutic respiration
apparatus 1.6 69.4 8.3 -12.2 4.3 -3.3 -4.0 3.4 9.0 9.0
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 51
Patient Aids Market, 2008-2018
US$mn
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 52
Patient Aids Market, 2009-2018
US$mn CAGR
Source: BMI Espicom
Other Medical Devices Market Forecast
The market for all other devices is estimated at US$1,528.3mn in 2013, equal to US$65.8 per capita and
31.7% of the total device market. Leading categories include endoscopy apparatus, ophthalmic instruments,
dialysis apparatus and hospital furniture.
This segment of the market grew at a CAGR of 8.6% between 2008 and 2013, but is projected to fall back
to a CAGR of just 0.5% over the next five years, to reach US$1,564.9mn in 2018.
Fresenius has a local plant in New South Wales which makes dialysis products, but beyond this, most
requirements are imported, largely from the USA and Germany.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 53
Table: Other Medical Devices Market, 2008-2018 (US$mn)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

OTHERS 1,012 1,054 1,195 1,381 1,494 1,528 1,449 1,361 1,376 1,468 1,565 8.6 0.5

WHEELCHAIRS 26.5 24.4 28.0 31.2 32.2 32.7 30.7 28.7 28.8 30.5 32.4 4.3 -0.2
Wheelchairs, not
mechanically propelled 11.2 10.0 10.7 12.9 13.4 14.1 13.6 13.1 13.5 14.7 16.1 4.7 2.7
Wheelchairs,
mechanically propelled 15.3 14.4 17.3 18.3 18.8 18.6 17.1 15.6 15.3 15.8 16.3 4.0 -2.6

OPHTHALMIC
INSTRUMENTS 65.1 65.8 68.5 85.3 96.5 98.8 93.7 88.0 89.0 95.0 101.3 8.7 0.5

HOSPITAL FURNITURE 41.0 35.0 41.6 50.1 58.6 59.5 55.9 52.0 52.1 55.0 58.1 7.7 -0.4

MEDICAL, SURGICAL
STERILISERS 16.5 17.3 18.9 20.3 22.4 22.5 20.9 19.2 19.0 19.8 20.7 6.4 -1.7

ULTRA-VIOLET OR
INFRA-RED RAY
APPARATUS 1.8 1.5 2.4 2.3 4.0 4.2 4.0 3.8 3.9 4.3 4.6 18.2 2.2

OTHER INSTRUMENTS
& APPLIANCES 860.9 910.0 1,036 1,192 1,280 1,311 1,244 1,169 1,183 1,263 1,348 8.8 0.6
Anaesthetic apparatus
and instruments 86.5 91.4 98.4 96.2 120.7 121.7 113.7 105.1 104.7 109.9 115.3 7.1 -1.1
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 54
Table: Other Medical Devices Market, 2008-2018 (US$ Per Capita)

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR
2008-13
CAGR
2013-18

OTHERS 47 48 53.7 61.1 65.2 65.8 61.6 57.2 57.1 60.2 63.4 8.6 0.5

WHEELCHAIRS 1.2 1 1.3 1.4 1.4 1.4 1.3 1.2 1.2 1.3 1.3 4.3 -0.2
Wheelchairs, not
mechanically
propelled 0.5 1 0.5 0.6 0.6 0.6 0.6 0.5 0.6 0.6 0.7 4.7 2.7
Wheelchairs,
mechanically
propelled 1 1 0.8 0.8 0.8 0.8 0.7 0.7 0.6 0.6 0.7 4 -2.6

OPHTHALMIC
INSTRUMENTS 3 3 3.1 3.8 4.2 4.3 4 3.7 3.7 3.9 4.1 8.7 0.5

HOSPITAL
FURNITURE 1.9 2 1.9 2.2 2.6 2.6 2.4 2.2 2.2 2.3 2.4 7.7 -0.4

MEDICAL,
SURGICAL
STERILISERS 1 1 0.8 0.9 1 1 0.9 0.8 0.8 0.8 0.8 6.4 -1.7

ULTRA-VIOLET
OR INFRA-RED
RAY APPARATUS 0 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 18.2 2.2

OTHER
INSTRUMENTS &
APPLIANCES 40 41.5 46.5 52.7 55.9 56.5 52.9 49.1 49.1 51.8 54.6 8.8 0.6
Anaesthetic
apparatus and
instruments 4 4.2 4.4 4.3 5.3 5.2 4.8 4.4 4.3 4.5 4.7 7.1 -1.1
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 55
Table: Other Medical Devices Market, 2009-2018 (US$mn % Change)

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

OTHERS 4.2 13.4 15.5 8.2 2.3 -5.2 -6.1 1.1 6.6 6.6

WHEELCHAIRS -7.9 14.8 11.5 3.2 1.5 -5.9 -6.8 0.5 6.0 6.1
Wheelchairs, not mechanically
propelled -11.1 7.3 21.0 3.9 4.7 -3.0 -4.0 3.4 9.0 9.0
Wheelchairs, mechanically propelled -5.6 19.9 5.6 2.7 -0.8 -8.1 -9.0 -2.0 3.4 3.4

OPHTHALMIC INSTRUMENTS 1.1 4.0 24.6 13.2 2.3 -5.2 -6.1 1.2 6.7 6.7

HOSPITAL FURNITURE -14.8 19.1 20.4 17.0 1.4 -6.0 -7.0 0.2 5.7 5.6

MEDICAL, SURGICAL STERILISERS 5.0 9.1 7.6 10.5 0.2 -7.2 -8.1 -1.0 4.4 4.4

ULTRA-VIOLET OR INFRA-RED RAY
APPARATUS -14.5 56.5 -5.7 75.3 4.1 -3.6 -4.5 2.8 8.4 8.4

OTHER INSTRUMENTS &
APPLIANCES 5.7 13.8 15.0 7.4 2.4 -5.1 -6.0 1.2 6.7 6.7
Anaesthetic apparatus and instruments 5.7 7.7 -2.3 25.6 0.8 -6.6 -7.5 -0.4 5.0 5.0
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 56
Other Medical Devices Market, 2008-2018
US$mn
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 57
Other Medical Devices Market, 2008-2019
US$mn CAGR
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 58
Annual Medical Device Imports
Since 2001, Australian medical device imports have seen a period of sustained rapid growth. In 2012,
imports reached a new high of US$4,523.6mn, rising by 3.9% over 2011. In CAGR terms, growth was
10.8% between 2007 and 2012.
Medical Device Imports, 2002-2012
US$mn
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 59
Change In Medical Device Imports, 2003-2012
%
Source: BMI Espicom
Consumables
After two years of double-digit growth, imports of consumables fell by 0.1% to US$637.1mn in 2012. The
decrease was due to a sudden drop in imports of bandages & dressings which fell by 20.1% in 2012, while
all other segments of the consumables import sector achieved growth. Consumables account for over 14.0%
of total medical device imports and expanded at a CAGR of 10.8% during the 2007-2012 period. Just over
half of consumables imports in 2012 were in the form of syringes, needles & catheters which increased by
6.5% to total US$320.2mn.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 60
Diagnostic Imaging
Imports of diagnostic imaging apparatus grew by 13.6% to reach US$710.3mn in 2012. The sector had a
CAGR of 9.8% over the 2007-2012 period. Electrodiagnostic apparatus imports form the majority of the
sector, and were valued at US$317.7mn in 2012, accounting for 44.7% of total diagnostic imaging imports.
The fastest growing segment in 2012 was X-ray/radiation apparatus which increased by 41.5% to a value of
US$217.7mn.
Dental Products
Dental product imports grew by 6.1% to reach US$228.7mn in 2012. The bulk of dental imports consist of
instruments & supplies and it was this segment which underpinned the growth recorded in 2012, rising by
6.7% to US$200.2mn. Dental imports increased at a CAGR of 10.1% during the period.
Orthopaedics & Prosthetics
After a 29.6% rise in imports of orthopaedics & prosthetics in 2011, demand fell back by 1.8% to total US
$830.2mn in 2012. Despite the decline, growth was seen in imports of artificial joints which increased by
14.4% to US$279.9mn. Imports classed under the fixation devices and other artificial body parts categories
both fell by 8.4% during 2012, to US$ 201.1mn and US$349.2mn, respectively.
CAGR growth over the 2007-12 period was 12.9% for orthopaedic & prosthetic products, with only limited
variance from this figure within the three segments.
Patient Aids
Imports of patient aids totalled US$692.5mn in 2012, a decrease of 3.0% from the previous year. Against
this trend, a 20.8% increase was recorded in imports of pacemakers, which climbed to US$177.4mn.
Despite the fall in demand in 2012, imports of patient aids rose at a CAGR of 6.7% between 2008 and 2012,
with pacemakers driving growth with a CAGR of 8.3% over the period.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 61
Table: Medical Device Imports By Product Area, 2008-2012 (US$000s)

2008 2009 2010 2011 2012

CONSUMABLES 449,953 459,804 520,038 637,885 637,081
BANDAGES & DRESSINGS 113,412 111,442 137,261 187,099 149,530
SUTURING MATERIALS 61,158 59,873 61,776 76,309 92,225
SYRINGES, NEEDLES & CATHETERS 251,618 251,132 257,615 300,683 320,161
OTHER CONSUMABLES 23,765 37,357 63,386 73,794 75,165

DIAGNOSTIC IMAGING 485,171 498,508 573,551 625,215 710,258
ELECTRODIAGNOSTIC APPARATUS 233,212 244,243 278,101 302,136 317,717
RADIATION APPARATUS 118,564 127,651 147,009 153,395 217,698
IMAGING PARTS & ACCESSORIES 133,395 126,614 148,441 169,684 174,843

DENTAL PRODUCTS 164,828 178,962 196,840 215,630 228,729
CAPITAL EQUIPMENT 20,011 25,340 35,290 28,038 28,500
INSTRUMENTS & SUPPLIES 144,817 153,622 161,550 187,592 200,229

ORTHOPAEDICS & PROSTHETICS 536,706 553,455 652,432 845,462 830,236

PATIENT AIDS 557,582 490,274 601,442 713,719 692,528
PORTABLE AIDS 422,793 364,011 417,392 510,670 494,795
THERAPEUTIC APPLIANCES 134,789 126,263 184,050 203,049 197,733

OTHERS 965,105 1,005,186 1,140,024 1,317,076 1,424,780

TOTAL 3,159,345 3,186,189 3,684,327 4,354,987 4,523,612
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 62
Table: Medical Device Imports By Product Area 2008-2012 (US$000s, % Change)

2008 2009 2010 2011 2012

CONSUMABLES 17.8 2.2 13.1 22.7 -0.1
BANDAGES & DRESSINGS 20.2 -1.7 23.2 36.3 -20.1
SUTURING MATERIALS 16.1 -2.1 3.2 23.5 20.9
SYRINGES, NEEDLES & CATHETERS 18.5 -0.2 2.6 16.7 6.5
OTHER CONSUMABLES 4.9 57.2 69.7 16.4 1.9

DIAGNOSTIC IMAGING 9.2 2.7 15.1 9.0 13.6
ELECTRODIAGNOSTIC APPARATUS 0.4 4.7 13.9 8.6 5.2
RADIATION APPARATUS 34.6 7.7 15.2 4.3 41.9
IMAGING PARTS & ACCESSORIES 7.8 -5.1 17.2 14.3 3.0

DENTAL PRODUCTS 16.8 8.6 10.0 9.5 6.1
CAPITAL EQUIPMENT 25.7 26.6 39.3 -20.5 1.6
INSTRUMENTS & SUPPLIES 15.7 6.1 5.2 16.1 6.7

ORTHOPAEDICS & PROSTHETICS 18.3 3.1 17.9 29.6 -1.8

PATIENT AIDS 11.6 -12.1 22.7 18.7 -3.0
PORTABLE AIDS 10.7 -13.9 14.7 22.3 -3.1
THERAPEUTIC APPLIANCES 14.5 -6.3 45.8 10.3 -2.6

OTHERS 22.9 4.2 13.4 15.5 8.2

TOTAL 16.8 0.8 15.6 18.2 3.9
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 63
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s)

2008 2009 2010 2011 2012

CONSUMABLES 538,111 588,680 566,468 617,979 615,184
BANDAGES & DRESSINGS 135,632 142,678 149,516 181,260 144,391
SUTURING MATERIALS 73,140 76,655 67,292 73,928 89,055
SYRINGES, NEEDLES & CATHETERS 300,917 321,521 280,616 291,300 309,157
OTHER CONSUMABLES 28,421 47,828 69,045 71,491 72,582

DIAGNOSTIC IMAGING 580,229 638,232 624,759 605,704 685,846
ELECTRODIAGNOSTIC APPARATUS 278,904 312,701 302,931 292,707 306,797
RADIATION APPARATUS 141,794 163,430 160,134 148,608 210,216
IMAGING PARTS & ACCESSORIES 159,531 162,102 161,694 164,389 168,834

DENTAL PRODUCTS 197,122 229,122 214,414 208,901 220,867
CAPITAL EQUIPMENT 23,932 32,442 38,441 27,163 27,520
INSTRUMENTS & SUPPLIES 173,190 196,680 175,974 181,738 193,347

ORTHOPAEDICS & PROSTHETICS 641,861 708,580 710,683 819,078 801,700

PATIENT AIDS 666,827 627,690 655,140 691,446 668,725
PORTABLE AIDS 505,629 466,038 454,658 494,734 477,789
THERAPEUTIC APPLIANCES 161,198 161,653 200,483 196,713 190,937

OTHERS 1,154,194 1,286,925 1,241,809 1,275,975 1,375,809

TOTAL 3,778,343 4,079,230 4,013,274 4,219,083 4,368,132
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 64
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s, % Change)

2008 2009 2010 2011 2012

CONSUMABLES 17.9 9.4 -3.8 9.1 -0.5
BANDAGES & DRESSINGS 20.3 5.2 4.8 21.2 -20.3
SUTURING MATERIALS 16.2 4.8 -12.2 9.9 20.5
SYRINGES, NEEDLES & CATHETERS 18.6 6.8 -12.7 3.8 6.1
OTHER CONSUMABLES 5.0 68.3 44.4 3.5 1.5

DIAGNOSTIC IMAGING 9.3 10.0 -2.1 -3.0 13.2
ELECTRODIAGNOSTIC APPARATUS 0.5 12.1 -3.1 -3.4 4.8
RADIATION APPARATUS 34.7 15.3 -2.0 -7.2 41.5
IMAGING PARTS & ACCESSORIES 7.9 1.6 -0.3 1.7 2.7

DENTAL PRODUCTS 16.9 16.2 -6.4 -2.6 5.7
CAPITAL EQUIPMENT 25.8 35.6 18.5 -29.3 1.3
INSTRUMENTS & SUPPLIES 15.8 13.6 -10.5 3.3 6.4

ORTHOPAEDICS & PROSTHETICS 18.4 10.4 0.3 15.3 -2.1

PATIENT AIDS 11.7 -5.9 4.4 5.5 -3.3
PORTABLE AIDS 10.8 -7.8 -2.4 8.8 -3.4
THERAPEUTIC APPLIANCES 14.6 0.3 24.0 -1.9 -2.9

OTHERS 23.0 11.5 -3.5 2.8 7.8

TOTAL 16.9 8.0 -1.6 5.1 3.5
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 65
Table: Medical Device Imports By Product Area, 2008-2012 (% Distribution)

2008 2009 2010 2011 2012

CONSUMABLES 14.2 14.4 14.1 14.6 14.1
BANDAGES & DRESSINGS 3.6 3.5 3.7 4.3 3.3
SUTURING MATERIALS 1.9 1.9 1.7 1.8 2.0
SYRINGES, NEEDLES & CATHETERS 8.0 7.9 7.0 6.9 7.1
OTHER CONSUMABLES 0.8 1.2 1.7 1.7 1.7

DIAGNOSTIC IMAGING 15.4 15.6 15.6 14.4 15.7
ELECTRODIAGNOSTIC APPARATUS 7.4 7.7 7.5 6.9 7.0
RADIATION APPARATUS 3.8 4.0 4.0 3.5 4.8
IMAGING PARTS & ACCESSORIES 4.2 4.0 4.0 3.9 3.9

DENTAL PRODUCTS 5.2 5.6 5.3 5.0 5.1
CAPITAL EQUIPMENT 0.6 0.8 1.0 0.6 0.6
INSTRUMENTS & SUPPLIES 4.6 4.8 4.4 4.3 4.4

ORTHOPAEDICS & PROSTHETICS 17.0 17.4 17.7 19.4 18.4

PATIENT AIDS 17.6 15.4 16.3 16.4 15.3
PORTABLE AIDS 13.4 11.4 11.3 11.7 10.9
THERAPEUTIC APPLIANCES 4.3 4.0 5.0 4.7 4.4

OTHERS 30.5 31.5 30.9 30.2 31.5

TOTAL 100.0 100.0 100.0 100.0 100.0
Source: BMI Espicom
The USA remains the dominant supplier. Total shipments from the USA amounted to US$1,701.1mn, equal
to 37.6% in 2012. Germany (US$386.4mn), Ireland (US$367.6mn), China (US$306.7mn) and Switzerland
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 66
(US$291.6mn) were the other leading suppliers with shares of 8.5%, 8.1%, 6.8% and 6.4% respectively.
Total shipments from the European Union amounted to US$1,406.4mn in 2012.
Table: Leading Medical Device Suppliers By Product Area (US$000s)

USA Germany Ireland China Switzerland EU-27

CONSUMABLES 251,379 19,050 24,802 49,871 16,311 172,728
BANDAGES & DRESSINGS 91,182 9,109 711 34,704 4,783 79,281
SUTURING MATERIALS

SYRINGES, NEEDLES & CATHETERS 145,122 9,740 23,706 8,461 9,084 69,388
OTHER CONSUMABLES 15,075 201 385 6,706 2,444 24,059

DIAGNOSTIC IMAGING 282,002 129,606 2,066 59,318 2,739 231,411
ELECTRODIAGNOSTIC APPARATUS 153,168 35,615 1,075 26,277 2,188 76,878
RADIATION APPARATUS 87,034 51,814 229 19,381 5 84,172
IMAGING PARTS & ACCESSORIES 41,800 42,177 762 13,660 546 70,361

DENTAL PRODUCTS 48,708 45,727 14,255 4,144 19,201 93,365
CAPITAL EQUIPMENT 7,592 5,789 0 1,125 65 15,331
INSTRUMENTS & SUPPLIES 41,116 39,938 14,255 3,019 19,136 78,034

ORTHOPAEDICS & PROSTHETICS 373,773 53,973 128,925 12,432 106,660 300,112

PATIENT AIDS 137,829 23,852 93,590 120,449 111,229 182,935
PORTABLE AIDS 106,234 16,838 89,485 34,274 109,803 159,292
THERAPEUTIC APPLIANCES 31,595 7,014 4,105 86,175 1,426 23,643

OTHERS 607,369 114,175 103,948 60,511 35,431 425,827

TOTAL 1,701,060 386,383 367,586 306,725 291,571 1,406,378
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 67
Table: Leading Medical Device Suppliers By Product Area (% Distribution)

USA Germany Ireland China Switzerland EU-27

CONSUMABLES 39.5 3.0 3.9 7.8 2.6 27.1
BANDAGES & DRESSINGS 13.1 4.2 0.5 23.2 0.7 42.5
SUTURING MATERIALS 77.6 3.1 0.0 0.0 4.1 17.0
SYRINGES, NEEDLES & CATHETERS 45.3 3.0 7.4 2.6 2.8 21.7
OTHER CONSUMABLES 20.1 0.3 0.5 8.9 3.3 32.0

DIAGNOSTIC IMAGING 39.7 18.2 0.3 8.4 0.4 32.6
ELECTRODIAGNOSTIC APPARATUS 48.2 11.2 0.3 8.3 0.7 24.2
RADIATION APPARATUS 40.0 23.8 0.1 8.9 0.0 38.7
IMAGING PARTS & ACCESSORIES 23.9 24.1 0.4 7.8 0.3 40.2

DENTAL PRODUCTS 21.3 20.0 6.2 1.8 8.4 40.8
CAPITAL EQUIPMENT 26.6 20.3 0.0 3.9 0.2 53.8
INSTRUMENTS & SUPPLIES 20.5 19.9 7.1 1.5 9.6 39.0

ORTHOPAEDICS & PROSTHETICS 45.0 6.5 15.5 1.5 12.8 36.1

PATIENT AIDS 19.9 3.4 13.5 17.4 16.1 26.4
PORTABLE AIDS 21.5 3.4 18.1 6.9 22.2 32.2
THERAPEUTIC APPLIANCES 16.0 3.5 2.1 43.6 0.7 12.0

OTHERS 42.6 8.0 7.3 4.2 2.5 29.9

TOTAL 37.6 8.5 8.1 6.8 6.4 31.1
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 68
Table: Top 20 Medical Device Suppliers (US$000s)

Country 2012 % of Total

1 USA 1,701,060 37.6
2 Germany 386,383 8.5
3 Ireland 367,586 8.1
4 China 306,725 6.8
5 Switzerland 291,571 6.4
6 Japan 184,306 4.1
7 United Kingdom 163,147 3.6
8 Singapore 135,334 3.0
9 Mexico 111,859 2.5
10 France 84,872 1.9
11 Netherlands 83,440 1.8
12 Denmark 67,114 1.5
13 Italy 65,097 1.4
14 Malaysia 50,575 1.1
15 Finland 47,701 1.1
16 Sweden 42,964 0.9
17 Taiwan 42,402 0.9
18 Costa Rica 36,754 0.8
19 New Zealand 34,992 0.8
20 Canada 26,827 0.6

Subtotal 4,230,709 93.5


Others 292,903 6.5


Total 4,523,612 100.0
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 69
Table: Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s)

2008 2009 2010 2011 2012

CONSUMABLES 449,953 459,804 520,038 637,885 637,081

BANDAGES & DRESSINGS 113,412 111,442 137,261 187,099 149,530
Medical dressings (adhesive) 50,161 48,049 56,174 70,564 69,520
Medical dressings (non-adhesive) 63,251 63,393 81,087 116,535 80,010

SUTURING MATERIALS 61,158 59,873 61,776 76,309 92,225

SYRINGES, NEEDLES & CATHETERS 251,618 251,132 257,615 300,683 320,161
Syringes (with/without needles) 35,513 44,342 46,311 50,715 50,595
Tubular metal needles/needles for sutures 26,466 30,015 28,501 33,574 35,650
Other needles, catheters, cannulae etc 189,639 176,775 182,803 216,394 233,916

OTHER CONSUMABLES 23,765 37,357 63,386 73,794 75,165
Blood-grouping reagents 6,040 4,059 4,602 6,357 5,135
First-aid boxes & kits 2,797 2,383 3,598 4,483 6,748
Ostomy products 914 17,582 35,519 35,483 39,872
Surgical gloves 14,014 13,333 19,667 27,471 23,410

DIAGNOSTIC IMAGING 485,171 498,508 573,551 625,215 710,258

ELECTRODIAGNOSTIC APPARATUS 233,212 244,243 278,101 302,136 317,717
Electrocardiographs 9,765 9,785 13,075 15,211 14,838
Ultrasound 74,334 78,222 81,610 87,865 86,742
MRI 27,144 45,924 51,807 55,510 72,217
Scintigraphic apparatus 2,217 1,696 3,968 3,459 4,040
Other electrodiagnostic apparatus 119,752 108,616 127,641 140,091 139,880

RADIATION APPARATUS 118,564 127,651 147,009 153,395 217,698
CT scanners 23,716 32,748 43,599 64,238 93,374
Other medical x-ray apparatus 87,532 93,551 100,776 86,124 116,232
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 70
Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s) - Continued

2008 2009 2010 2011 2012
A, B, C ray apparatus 7,316 1,352 2,634 3,033 8,092

IMAGING PARTS & ACCESSORIES 133,395 126,614 148,441 169,684 174,843
Contrast media 26,744 25,172 31,022 32,052 33,830
Medical x-ray film (flat) 20,741 21,707 23,104 25,202 23,235
Medical x-ray film (rolled) 240 171 140 181 353
X-ray tubes 16,493 18,166 19,497 21,106 24,315
Other imaging parts & accessories 69,177 61,398 74,678 91,143 93,110

DENTAL PRODUCTS 164,828 178,962 196,840 215,630 228,729

CAPITAL EQUIPMENT 20,011 25,340 35,290 28,038 28,500
Dental drills 1,730 3,075 3,499 2,367 2,036
Dental chairs 8,466 8,364 12,401 9,992 9,055
Dental x-ray 9,815 13,901 19,390 15,679 17,409

INSTRUMENTS & SUPPLIES 144,817 153,622 161,550 187,592 200,229
Dental cements 28,544 30,347 32,782 47,472 52,964
Dental instruments 71,208 78,563 75,056 83,815 89,012
Teeth & other fittings 45,065 44,712 53,712 56,305 58,253
Artificial teeth 5,296 5,534 11,380 12,516 13,524
Other dental fittings 39,769 39,178 42,332 43,789 44,729

ORTHOPAEDICS & PROSTHETICS 536,706 553,455 652,432 845,462 830,236

FIXATION DEVICES 141,003 110,224 134,204 219,541 201,138
ARTIFICIAL JOINTS 170,803 156,388 194,009 244,735 279,894
OTHER ARTIFICIAL BODY PARTS 224,900 286,843 324,219 381,186 349,204

PATIENT AIDS 557,582 490,274 601,442 713,719 692,528

PORTABLE AIDS 422,793 364,011 417,392 510,670 494,795
Hearing aids 75,454 65,090 78,838 96,785 86,481
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 71
Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s) - Continued

2008 2009 2010 2011 2012
Pacemakers 121,172 116,281 130,614 146,838 177,406
Other portable aids 226,167 182,640 207,940 267,047 230,908

THERAPEUTIC APPLIANCES 134,789 126,263 184,050 203,049 197,733
Mechano-therapy apparatus 63,141 53,446 60,690 69,469 80,433
Therapeutic respiration apparatus 71,648 72,817 123,360 133,580 117,300

OTHERS 965,105 1,005,186 1,140,024 1,317,076 1,424,780

WHEELCHAIRS 25,773 23,724 27,203 30,355 31,320
Wheelchairs, not mechanically propelled 11,103 9,873 10,597 12,822 13,319
Wheelchairs, mechanically propelled 14,670 13,851 16,606 17,533 18,001

OPHTHALMIC INSTRUMENTS 60,986 61,683 64,173 79,971 90,491

HOSPITAL FURNITURE 39,883 33,979 40,470 48,719 56,998

MEDICAL, SURGICAL STERILISERS 16,051 16,848 18,379 19,769 21,846

ULTRA-VIOLET OR INFRA-RED RAY APPARATUS 1,764 1,509 2,362 2,228 3,906

OTHER INSTRUMENTS & APPLIANCES 820,648 867,443 987,437 1,136,034 1,220,219
Anaesthetic apparatus and instruments 86,450 91,379 98,407 96,152 120,742

TOTAL 3,159,345 3,186,189 3,684,327 4,354,987 4,523,612
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 72
Table: Detailed Medical Device Import Trends By Product Area

2012 %
of Total
Latest Year %
Change, US$
Latest Year % Change
(Local Currency)
5 Year %
CAGR, US$
5 Year % CAGR
(Local Currency)

CONSUMABLES 14.1 -0.1 -0.5 10.8 6.2

BANDAGES &
DRESSINGS 3.3 -20.1 -20.3 9.6 5.1
Medical dressings
(adhesive) 1.5 -1.5 -1.8 10.6 6.0
Medical dressings (non-
adhesive) 1.8 -31.3 -31.6 8.8 4.3

SUTURING MATERIALS 2.0 20.9 20.5 11.8 7.2

SYRINGES, NEEDLES &
CATHETERS 7.1 6.5 6.1 8.6 4.0
Syringes (with/without
needles) 1.1 -0.2 -0.6 8.0 3.5
Tubular metal needles/
needles for sutures 0.8 6.2 5.8 14.5 9.8
Other needles,
catheters, cannulae etc 5.2 8.1 7.7 7.9 3.4

OTHER
CONSUMABLES 1.7 1.9 1.5 27.1 21.8
Blood-grouping
reagents 0.1 -19.2 -19.5 1.0 -3.2
First-aid boxes & kits 0.1 50.5 50.0 34.3 28.7
Ostomy products 0.9 12.4 12.0 463.8 440.3
Surgical gloves 0.5 -14.8 -15.1 7.6 3.1

DIAGNOSTIC IMAGING 15.7 13.6 13.2 9.8 5.3

ELECTRODIAGNOSTIC
APPARATUS 7.0 5.2 4.8 6.5 2.0
Electrocardiographs 0.3 -2.5 -2.8 6.3 1.9
Ultrasound 1.9 -1.3 -1.6 7.0 2.5
MRI 1.6 30.1 29.7 14.7 9.9
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 73
Detailed Medical Device Import Trends By Product Area - Continued

2012 %
of Total
Latest Year %
Change, US$
Latest Year % Change
(Local Currency)
5 Year %
CAGR, US$
5 Year % CAGR
(Local Currency)
Scintigraphic apparatus 0.1 16.8 16.4 12.8 8.1
Other electrodiagnostic
apparatus 3.1 -0.2 -0.5 2.9 -1.3

RADIATION
APPARATUS 4.8 41.9 41.5 19.8 14.8
CT scanners 2.1 45.4 44.9 34.9 29.3
Other medical x-ray
apparatus 2.6 35.0 34.5 12.8 8.1
A, B, C ray apparatus 0.2 166.8 165.9 17.7 12.8

IMAGING PARTS &
ACCESSORIES 3.9 3.0 2.7 7.2 2.7
Contrast media 0.7 5.5 5.2 14.0 9.3
Medical x-ray film (flat) 0.5 -7.8 -8.1 -0.9 -5.0
Medical x-ray film
(rolled) 0.0 95.0 94.4 19.3 14.3
X-ray tubes 0.5 15.2 14.8 7.8 3.3
Other imaging parts &
accessories 2.1 2.2 1.8 7.5 3.0

DENTAL PRODUCTS 5.1 6.1 5.7 10.1 5.6

CAPITAL EQUIPMENT 0.6 1.6 1.3 12.4 7.7
Dental drills 0.0 -14.0 -14.3 11.3 6.7
Dental chairs 0.2 -9.4 -9.7 4.4 0.1
Dental x-ray 0.4 11.0 10.7 18.5 13.6

INSTRUMENTS &
SUPPLIES 4.4 6.7 6.4 9.8 5.3
Dental cements 1.2 11.6 11.2 18.7 13.8
Dental instruments 2.0 6.2 5.9 6.0 1.6
Teeth & other fittings 1.3 3.5 3.1 9.9 5.3
Artificial teeth 0.3 8.1 7.7 24.9 19.7
Other dental fittings 1.0 2.1 1.8 7.0 2.5

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 74
Detailed Medical Device Import Trends By Product Area - Continued

2012 %
of Total
Latest Year %
Change, US$
Latest Year % Change
(Local Currency)
5 Year %
CAGR, US$
5 Year % CAGR
(Local Currency)
ORTHOPAEDICS &
PROSTHETICS 18.4 -1.8 -2.1 12.9 8.1

FIXATION DEVICES 4.4 -8.4 -8.7 11.1 6.4
ARTIFICIAL JOINTS 6.2 14.4 14.0 12.0 7.4
OTHER ARTIFICIAL
BODY PARTS 7.7 -8.4 -8.7 14.7 9.9

PATIENT AIDS 15.3 -3.0 -3.3 6.7 2.3

PORTABLE AIDS 10.9 -3.1 -3.4 5.3 0.9
Hearing aids 1.9 -10.6 -10.9 5.6 1.2
Pacemakers 3.9 20.8 20.4 8.3 3.8
Other portable aids 5.1 -13.5 -13.8 3.2 -1.1

THERAPEUTIC
APPLIANCES 4.4 -2.6 -2.9 10.9 6.3
Mechano-therapy
apparatus 1.8 15.8 15.4 5.5 1.1
Therapeutic respiration
apparatus 2.6 -12.2 -12.5 15.9 11.1

OTHERS 31.5 8.2 7.8 12.7 8.0

WHEELCHAIRS 0.7 3.2 2.8 8.0 3.5
Wheelchairs, not
mechanically propelled 0.3 3.9 3.5 11.5 6.9
Wheelchairs,
mechanically propelled 0.4 2.7 2.3 5.8 1.4

OPHTHALMIC
INSTRUMENTS 2.0 13.2 12.8 12.4 7.7

HOSPITAL FURNITURE 1.3 17.0 16.6 12.7 8.0

MEDICAL, SURGICAL
STERILISERS 0.5 10.5 10.1 12.0 7.4
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 75
Detailed Medical Device Import Trends By Product Area - Continued

2012 %
of Total
Latest Year %
Change, US$
Latest Year % Change
(Local Currency)
5 Year %
CAGR, US$
5 Year % CAGR
(Local Currency)

ULTRA-VIOLET OR
INFRA-RED RAY
APPARATUS 0.1 75.3 74.7 11.0 6.3

OTHER INSTRUMENTS
& APPLIANCES 27.0 7.4 7.1 12.8 8.1
Anaesthetic apparatus
and instruments 2.7 25.6 25.2 10.1 5.5

TOTAL 100.0 3.9 3.5 10.8 6.2
Source: BMI Espicom
Table: Detailed Leading Medical Device Suppliers By Product Area (US$000s)

USA Germany Ireland China Switzerland EU-27

CONSUMABLES 251,379 19,050 24,802 49,871 16,311 172,728

BANDAGES & DRESSINGS 19,642 6,250 711 34,665 1,034 63,594
Medical dressings (adhesive) 9,596 3,064 709 7,061 227 37,270
Medical dressings (non-adhesive) 10,046 3,186 2 27,604 807 26,324

SUTURING MATERIALS 71,540 2,859 0 39 3,749 15,687

SYRINGES, NEEDLES & CATHETERS 145,122 9,740 23,706 8,461 9,084 69,388
Syringes (with/without needles) 18,690 864 1,595 2,862 532 10,132
Tubular metal needles/needles for
sutures 7,798 1,104 3,813 656 98 9,517
Other needles, catheters, cannulae
etc 118,634 7,772 18,298 4,943 8,454 49,739

OTHER CONSUMABLES 15,075 201 385 6,706 2,444 24,059
Blood-grouping reagents 2,371 64 0 0 2,261 472
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 76
Detailed Leading Medical Device Suppliers By Product Area (US$000s) - Continued

USA Germany Ireland China Switzerland EU-27
First-aid boxes & kits 114 4 2 6,190 10 243
Ostomy products 12,228 133 383 159 173 23,310
Surgical gloves 362 0 0 357 0 34

DIAGNOSTIC IMAGING 282,002 129,606 2,066 59,318 2,739 231,411

ELECTRODIAGNOSTIC APPARATUS 153,168 35,615 1,075 26,277 2,188 76,878
Electrocardiographs 5,220 1,801 9 689 810 3,175
Ultrasound 54,998 634 0 4,630 104 4,634
MRI 23,056 14,670 0 13,142 0 34,369
Scintigraphic apparatus 3,155 51 0 12 0 100
Other electrodiagnostic apparatus 66,739 18,459 1,066 7,804 1,274 34,600

RADIATION APPARATUS 87,034 51,814 229 19,381 5 84,172
CT scanners 41,036 18,284 229 16,682 0 19,835
Other medical x-ray apparatus 42,174 33,398 0 2,699 5 63,867
A, B, C ray apparatus 3,824 132 0 0 0 470

IMAGING PARTS & ACCESSORIES 41,800 42,177 762 13,660 546 70,361
Contrast media 3,723 9,265 605 6,533 0 19,506
Medical x-ray film (flat) 8,103 626 0 1 0 1,512
Medical x-ray film (rolled) 67 0 0 0 0 250
X-ray tubes 9,485 10,381 0 284 102 11,747
Other imaging parts & accessories 20,422 21,905 157 6,842 444 37,346

DENTAL PRODUCTS 48,708 45,727 14,255 4,144 19,201 93,365

CAPITAL EQUIPMENT 7,592 5,789 0 1,125 65 15,331
Dental drills 66 264 0 3 48 1,251
Dental chairs 4,238 734 0 1,122 15 2,368
Dental x-ray 3,288 4,791 0 0 2 11,712

INSTRUMENTS & SUPPLIES 41,116 39,938 14,255 3,019 19,136 78,034
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 77
Detailed Leading Medical Device Suppliers By Product Area (US$000s) - Continued

USA Germany Ireland China Switzerland EU-27
Dental cements 6,007 9,935 13,916 2 2,874 26,421
Dental instruments 22,175 28,073 234 2,801 9,374 42,253
Teeth & other fittings 12,934 1,930 105 216 6,888 9,360
Artificial teeth 358 0 0 195 39 1,009
Other dental fittings 12,576 1,930 105 21 6,849 8,351

ORTHOPAEDICS & PROSTHETICS 373,773 53,973 128,925 12,432 106,660 300,112

FIXATION DEVICES 108,395 17,686 394 7,395 48,113 26,474
ARTIFICIAL JOINTS 124,724 13,329 51,030 3,461 27,482 122,584
OTHER ARTIFICIAL BODY PARTS 140,654 22,958 77,501 1,576 31,065 151,054

PATIENT AIDS 137,829 23,852 93,590 120,449 111,229 182,935

PORTABLE AIDS 106,234 16,838 89,485 34,274 109,803 159,292
Hearing aids 1,905 388 0 22,239 6,734 15,817
Pacemakers 36,268 7,692 25,480 0 88,786 36,575
Other portable aids 68,061 8,758 64,005 12,035 14,283 106,900

THERAPEUTIC APPLIANCES 31,595 7,014 4,105 86,175 1,426 23,643
Mechano-therapy apparatus 11,615 1,214 1,443 46,282 681 8,385
Therapeutic respiration apparatus 19,980 5,800 2,662 39,893 745 15,258

OTHERS 607,369 114,175 103,948 60,511 35,431 425,827

WHEELCHAIRS 7,563 1,410 11 8,158 186 2,947
Wheelchairs, not mechanically
propelled 3,444 568 11 4,009 186 1,695
Wheelchairs, mechanically propelled 4,119 842 0 4,149 0 1,252

OPHTHALMIC INSTRUMENTS 48,461 8,264 13 670 6,201 21,036

HOSPITAL FURNITURE 13,115 7,438 7 15,604 138 16,410
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 78
Detailed Leading Medical Device Suppliers By Product Area (US$000s) - Continued

USA Germany Ireland China Switzerland EU-27

MEDICAL, SURGICAL STERILISERS 3,345 3,993 0 292 960 12,737

ULTRA-VIOLET OR INFRA-RED RAY
APPARATUS 2,512 209 0 91 17 1,004

OTHER INSTRUMENTS &
APPLIANCES 532,373 92,861 103,917 35,696 27,929 371,693
Anaesthetic apparatus and
instruments 24,126 5,655 2,509 6,961 372 27,118

TOTAL 1,701,060 386,383 367,586 306,725 291,571 1,406,378
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 79
Monthly Medical Device Imports
The latest Australian monthly trade data reveals that medical device imports increased by 2.2% in US dollar
terms in the 12 months to October 2013, taking the running annual total to US$4,571.6mn. The highest
growth was recorded in the patient aids sector, which increased by 9.0% over the 12 month period to US
$749.0mn. Imports of orthopaedics & prosthetics and consumables also increased - by 6.1% and 3.3%
respectively. The largest market segment, other medical devices, showed a marginal 0.5% increase to US
$1,407.4mn.
Medical device imports grew by 1.2% to US$1,188.4mn over the three months to October 2013, compared
with the corresponding period in 2012. Growth was achieved in the patient aids and orthopaedics &
prosthetics sectors which increased by 15.1% and 4.1% respectively. All other sectors experienced a drop in
imports over the quarter. The sharpest decline was in the demand for diagnostic imaging products which fell
by 7.9%, followed by dental products which decreased by 6.9%.
Table: Monthly Medical Device Imports By Product Area, September 2010-October 2013 (US$mn)

Consumables Diagnostic Dental Orthopaedics Patient Aids Others Total

Sep-10 47.7 50.5 17.2 59.4 51.7 99.7 326.2
Oct-10 45.5 49.9 15.1 53.7 55.3 99.0 318.5
Nov-10 48.7 56.7 17.4 64.5 54.9 109.0 351.3
Dec-10 50.0 60.2 14.9 46.7 56.0 106.6 334.4
Jan-11 48.7 43.1 12.5 52.3 51.0 88.0 295.6
Feb-11 45.2 44.7 15.6 80.7 58.3 93.4 337.9
Mar-11 56.4 51.2 19.0 80.5 67.2 137.8 412.0
Apr-11 50.0 56.4 17.6 75.3 54.7 118.6 372.7
May-11 57.2 55.4 19.1 76.9 60.0 113.7 382.3
Jun-11 53.9 61.6 18.9 67.9 55.1 111.4 368.8
Jul-11 51.4 52.9 17.3 82.8 66.1 110.5 380.9
Aug-11 56.6 57.7 20.2 84.2 58.7 117.8 395.2
Sep-11 52.7 49.9 18.1 64.6 53.1 109.3 347.8
Oct-11 53.8 57.0 18.7 60.1 66.1 107.3 363.0
Nov-11 60.1 48.7 20.5 71.6 68.9 109.2 378.9
Dec-11 47.4 50.4 19.1 50.4 54.4 102.6 324.3
Jan-12 52.4 41.5 15.6 57.4 50.7 96.9 314.5
Feb-12 49.2 51.3 18.2 75.3 52.9 127.0 373.9
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 80
Monthly Medical Device Imports By Product Area, September 2010-October 2013 (US$mn) - Continued

Consumables Diagnostic Dental Orthopaedics Patient Aids Others Total
Mar-12 54.0 59.0 20.2 77.6 55.8 120.6 387.3
Apr-12 49.8 58.4 17.5 67.2 48.0 120.3 361.2
May-12 51.3 65.2 19.8 70.1 55.6 117.2 379.2
Jun-12 49.5 88.4 19.3 70.5 56.7 115.2 399.5
Jul-12 49.2 57.5 20.0 69.7 59.2 122.5 378.2
Aug-12 60.1 62.8 19.5 79.4 60.1 122.3 404.3
Sep-12 47.4 56.1 19.0 68.8 53.9 115.2 360.4
Oct-12 64.2 54.4 18.7 69.7 71.1 131.5 409.6
Nov-12 55.4 64.5 20.8 67.5 68.6 118.6 395.5
Dec-12 54.5 51.3 20.1 56.9 59.9 117.5 360.1
Jan-13 50.1 47.8 15.3 63.9 55.4 103.9 336.5
Feb-13 51.6 43.8 17.7 78.5 64.6 97.7 353.9
Mar-13 58.4 59.4 20.8 79.4 55.5 114.4 387.9
Apr-13 54.8 53.2 17.1 77.6 56.1 118.4 377.2
May-13 58.1 67.4 19.7 75.2 61.4 115.4 397.2
Jun-13 51.7 63.4 19.5 69.7 58.5 125.0 387.9
Jul-13 52.6 47.5 19.2 82.6 55.8 129.3 387.0
Aug-13 56.0 60.7 16.9 71.5 77.6 121.4 404.1
Sep-13 52.2 47.1 18.4 79.8 74.5 118.7 390.7
Oct-13 60.2 51.7 18.0 75.6 60.9 127.2 393.6

Quarter to

Oct-12 171.8 173.2 57.2 217.9 185.1 369.0 1,174.3
Oct-13 168.5 159.5 53.3 226.8 213.1 367.3 1,188.4

Qtr % +/- -1.9 -7.9 -6.9 4.1 15.1 -0.5 1.2

Year to

Oct-12 634.7 693.5 227.3 827.8 687.4 1,400.5 4,471.2
Oct-13 655.6 657.8 223.7 878.2 749.0 1,407.4 4,571.6

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 81
Monthly Medical Device Imports By Product Area, September 2010-October 2013 (US$mn) - Continued

Consumables Diagnostic Dental Orthopaedics Patient Aids Others Total
12 months % +/- 3.3 -5.2 -1.6 6.1 9.0 0.5 2.2
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 82
Annual Medical Device Exports
Australian medical device exports bounced back strongly from the dip in 2009, recording strong growth
over the 2010-2012 period. In 2012, exports rose by 10.5% to reach US$1,696.0mn.
The CAGR for medical device exports in US dollar terms, over the 2007-2012 period was 6.1%. Segments
which outperformed the overall sector included orthopaedic & prosthetic products (19.5%) and dental
products (11.8%).
The leading destination for Australian exports is the USA, which accounted for 32.4% of the total in 2012,
importing goods to the value of US$549.4mn. Strong export markets also included New Zealand and the
United Kingdom, which took 14.4% and 12.6% of the total, respectively.
Medical Device Exports, 2002-2012
US$mn
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 83
Change In Medical Device Exports, 2003-2012
%
Source: BMI Espicom
Consumables
Australian exports of consumables reached US$59.0mn in 2012, making up just 3.5% of the total, and
expanding at a CAGR of 4.0% over the 2007-2012. period. The largest segment within the consumables
sector is syringes, needles & catheters with shipments totalling US$37.3mn in 2012.
Diagnostic Imaging
Diagnostic imaging exports totalled US$83.5mn in 2012, equal to 4.9% of total device exports. Much of
this category's value lies in electrodiagnostic apparatus which totalled US$57.1mn in 2012. Exports fell by
17.5% in 2012 as a direct result of a 27.7% decline in shipments of electrodiagnostic apparatus.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 84
Dental Products
Dental product exports represented 3.5% of total exports in 2012 at a value of US$59.1mn. Exports rose by
21.5% over the previous year and increased at a CAGR of 11.8% during the 2007-2012 period. Instruments
& supplies account for almost the entire category, amounting to US$57.5mn in 2012.
Orthopaedics & Prosthetics
Orthopaedic & prosthetics exports fell by 11.7% to total US$86.4mn in 2012. The category made up just
5.1% of total Australian device exports in 2012. Most exports in this category are classed under artificial
body parts, exports of which totalled US$78.2mn in 2012.
Patient Aids
Patient aids is by far the largest segment of Australia's medical device export sector. In 2012, it represented
61.7% of total exports, with a total value of US$1,047.2mn. The category is split fairly evenly between
therapeutic appliances and portable aids.
The category rose by 9.8% in 2012, well ahead of the CAGR for the 2007-2012 period of 4.8%. The growth
in 2012 was all due to a 21.8% rise in exports of portable aids to US$545.0mn. Exports of therapeutic
appliances showed a slight decline in 2012.
The USA is the leading destination for Australian exports of patient aids. In 2012, these amounted to US
$460.8mn, equal to 44.0% of the total. The UK is another important market, receiving exports valued at US
$194.2mn in 2012. Exports to the Netherlands totalled US$104.1mn.
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s)

2008 2009 2010 2011 2012

CONSUMABLES 50,250 41,394 49,995 50,359 58,954
BANDAGES & DRESSINGS 12,024 10,238 13,057 11,771 7,522
SUTURING MATERIALS 7,702 2,570 4,601 3,597 2,655
SYRINGES, NEEDLES & CATHETERS 25,590 23,804 25,607 29,269 37,267
OTHER CONSUMABLES 4,934 4,782 6,730 5,722 11,510
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 85
Medical Device Exports By Product Area, 2008-2012 (US$000s) - Continued

2008 2009 2010 2011 2012

DIAGNOSTIC IMAGING 69,356 69,464 90,988 101,265 83,510
ELECTRODIAGNOSTIC APPARATUS 45,821 48,063 70,037 78,906 57,053
RADIATION APPARATUS 5,992 6,588 7,566 4,085 6,496
IMAGING PARTS & ACCESSORIES 17,543 14,813 13,385 18,274 19,961

DENTAL PRODUCTS 43,559 39,645 42,285 48,621 59,082
CAPITAL EQUIPMENT 1,707 1,450 1,457 4,639 1,619
INSTRUMENTS & SUPPLIES 41,852 38,195 40,828 43,982 57,463

ORTHOPAEDICS & PROSTHETICS 58,613 37,412 68,476 97,906 86,423

PATIENT AIDS 817,055 717,512 905,745 953,316 1,047,179
PORTABLE AIDS 347,622 296,097 399,755 447,578 544,980
THERAPEUTIC APPLIANCES 469,433 421,415 505,990 505,738 502,199

OTHERS 301,228 284,658 300,075 283,494 360,835

TOTAL 1,340,061 1,190,085 1,457,564 1,534,961 1,695,983
Source: BMI Espicom
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change)

2008 2009 2010 2011 2012

CONSUMABLES 3.9 -17.6 20.8 0.7 17.1
BANDAGES & DRESSINGS -8.4 -14.9 27.5 -9.8 -36.1
SUTURING MATERIALS -13.7 -66.6 79.0 -21.8 -26.2
SYRINGES, NEEDLES & CATHETERS 23.6 -7.0 7.6 14.3 27.3
OTHER CONSUMABLES -12.2 -3.1 40.7 -15.0 101.2

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 86
Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change) - Continued

2008 2009 2010 2011 2012
DIAGNOSTIC IMAGING 11.9 0.2 31.0 11.3 -17.5
ELECTRODIAGNOSTIC APPARATUS 25.2 4.9 45.7 12.7 -27.7
RADIATION APPARATUS 20.6 9.9 14.8 -46.0 59.0
IMAGING PARTS & ACCESSORIES -14.0 -15.6 -9.6 36.5 9.2

DENTAL PRODUCTS 29.0 -9.0 6.7 15.0 21.5
CAPITAL EQUIPMENT -29.3 -15.1 0.5 218.4 -65.1
INSTRUMENTS & SUPPLIES 33.5 -8.7 6.9 7.7 30.7

ORTHOPAEDICS & PROSTHETICS 65.5 -36.2 83.0 43.0 -11.7

PATIENT AIDS -1.4 -12.2 26.2 5.3 9.8
PORTABLE AIDS 4.7 -14.8 35.0 12.0 21.8
THERAPEUTIC APPLIANCES -5.4 -10.2 20.1 0.0 -0.7

OTHERS 19.9 -5.5 5.4 -5.5 27.3

TOTAL 6.4 -11.2 22.5 5.3 10.5
Source: BMI Espicom
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s)

2008 2009 2010 2011 2012

CONSUMABLES 60,095 52,996 54,459 48,787 56,928
BANDAGES & DRESSINGS 14,380 13,108 14,223 11,404 7,263
SUTURING MATERIALS 9,211 3,290 5,012 3,485 2,564
SYRINGES, NEEDLES & CATHETERS 30,604 30,476 27,893 28,356 35,986
OTHER CONSUMABLES 5,901 6,122 7,331 5,543 11,114

DIAGNOSTIC IMAGING 82,945 88,934 99,112 98,105 80,640
ELECTRODIAGNOSTIC APPARATUS 54,799 61,534 76,290 76,444 55,092
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 87
Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s) - Continued

2008 2009 2010 2011 2012
RADIATION APPARATUS 7,166 8,435 8,242 3,958 6,273
IMAGING PARTS & ACCESSORIES 20,980 18,965 14,580 17,704 19,275

DENTAL PRODUCTS 52,093 50,757 46,060 47,104 57,051
CAPITAL EQUIPMENT 2,041 1,856 1,587 4,494 1,563
INSTRUMENTS & SUPPLIES 50,052 48,900 44,473 42,609 55,488

ORTHOPAEDICS & PROSTHETICS 70,097 47,898 74,590 94,851 83,453

PATIENT AIDS 977,137 918,620 986,613 923,566 1,011,187
PORTABLE AIDS 415,730 379,089 435,446 433,611 526,249
THERAPEUTIC APPLIANCES 561,407 539,531 551,166 489,956 484,938

OTHERS 360,246 364,443 326,867 274,647 348,433

TOTAL 1,602,614 1,523,648 1,587,700 1,487,060 1,637,691
Source: BMI Espicom
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change)

2008 2009 2010 2011 2012

CONSUMABLES 4.0 -11.8 2.8 -10.4 16.7
BANDAGES & DRESSINGS -8.3 -8.8 8.5 -19.8 -36.3
SUTURING MATERIALS -13.6 -64.3 52.3 -30.5 -26.4
SYRINGES, NEEDLES & CATHETERS 23.7 -0.4 -8.5 1.7 26.9
OTHER CONSUMABLES -12.1 3.8 19.7 -24.4 100.5

DIAGNOSTIC IMAGING 12.0 7.2 11.4 -1.0 -17.8
ELECTRODIAGNOSTIC APPARATUS 25.3 12.3 24.0 0.2 -27.9
RADIATION APPARATUS 20.7 17.7 -2.3 -52.0 58.5
IMAGING PARTS & ACCESSORIES -13.9 -9.6 -23.1 21.4 8.9
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 88
Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change) - Continued

2008 2009 2010 2011 2012

DENTAL PRODUCTS 29.2 -2.6 -9.3 2.3 21.1
CAPITAL EQUIPMENT -29.3 -9.1 -14.5 183.2 -65.2
INSTRUMENTS & SUPPLIES 33.7 -2.3 -9.1 -4.2 30.2

ORTHOPAEDICS & PROSTHETICS 65.7 -31.7 55.7 27.2 -12.0

PATIENT AIDS -1.3 -6.0 7.4 -6.4 9.5
PORTABLE AIDS 4.8 -8.8 14.9 -0.4 21.4
THERAPEUTIC APPLIANCES -5.4 -3.9 2.2 -11.1 -1.0

OTHERS 20.1 1.2 -10.3 -16.0 26.9

TOTAL 6.5 -4.9 4.2 -6.3 10.1
Source: BMI Espicom
Table: Medical Device Exports By Product Area, 2008-2012 (% Distribution)

2008 2009 2010 2011 2012

CONSUMABLES 3.7 3.5 3.4 3.3 3.5
BANDAGES & DRESSINGS 0.9 0.9 0.9 0.8 0.4
SUTURING MATERIALS 0.6 0.2 0.3 0.2 0.2
SYRINGES, NEEDLES & CATHETERS 1.9 2.0 1.8 1.9 2.2
OTHER CONSUMABLES 0.4 0.4 0.5 0.4 0.7

DIAGNOSTIC IMAGING 5.2 5.8 6.2 6.6 4.9
ELECTRODIAGNOSTIC APPARATUS 3.4 4.0 4.8 5.1 3.4
RADIATION APPARATUS 0.4 0.6 0.5 0.3 0.4
IMAGING PARTS & ACCESSORIES 1.3 1.2 0.9 1.2 1.2

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 89
Medical Device Exports By Product Area, 2008-2012 (% Distribution) - Continued

2008 2009 2010 2011 2012
DENTAL PRODUCTS 3.3 3.3 2.9 3.2 3.5
CAPITAL EQUIPMENT 0.1 0.1 0.1 0.3 0.1
INSTRUMENTS & SUPPLIES 3.1 3.2 2.8 2.9 3.4

ORTHOPAEDICS & PROSTHETICS 4.4 3.1 4.7 6.4 5.1

PATIENT AIDS 61.0 60.3 62.1 62.1 61.7
PORTABLE AIDS 25.9 24.9 27.4 29.2 32.1
THERAPEUTIC APPLIANCES 35.0 35.4 34.7 32.9 29.6

OTHERS 22.5 23.9 20.6 18.5 21.3

TOTAL 100.0 100.0 100.0 100.0 100.0
Source: BMI Espicom
Table: Leading Medical Device Destinations By Product Area (US$000s)

USA New Zealand UK Netherlands Japan EU-27

CONSUMABLES 3,942 21,972 1,756 1,128 3,568 11,075
BANDAGES & DRESSINGS 283 4,567 1,105 0 0 1,178
SUTURING MATERIALS

SYRINGES, NEEDLES & CATHETERS 3,481 13,366 221 1,123 3,556 9,206
OTHER CONSUMABLES 178 4,039 430 5 12 691

DIAGNOSTIC IMAGING 15,904 19,393 1,469 3,760 3,102 14,439
ELECTRODIAGNOSTIC APPARATUS 10,387 16,229 884 2,185 1,079 10,225
RADIATION APPARATUS 1,553 818 34 48 14 1,094
IMAGING PARTS & ACCESSORIES 3,964 2,346 551 1,527 2,009 3,120

DENTAL PRODUCTS 6,890 17,411 383 532 611 12,844
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 90
Leading Medical Device Destinations By Product Area (US$000s) - Continued

USA New Zealand UK Netherlands Japan EU-27
CAPITAL EQUIPMENT 152 903 262 0 4 388
INSTRUMENTS & SUPPLIES 6,738 16,508 121 532 607 12,456

ORTHOPAEDICS & PROSTHETICS 12,055 15,883 4,743 1,499 2,557 41,705

PATIENT AIDS 460,837 28,678 194,234 104,122 55,943 318,454
PORTABLE AIDS 180,620 22,177 193,883 2,119 13,147 204,154
THERAPEUTIC APPLIANCES 280,217 6,501 351 102,003 42,796 114,300

OTHERS 49,734 140,659 10,486 4,378 27,836 68,900

TOTAL 549,362 243,996 213,071 115,419 93,617 467,417
Source: BMI Espicom
Table: Leading Medical Device Destinations By Product Area (% Distribution)

USA New Zealand UK Netherlands Japan EU-27

CONSUMABLES 6.7 37.3 3.0 1.9 6.1 18.8
BANDAGES & DRESSINGS 3.8 60.7 14.7 0.0 0.0 15.7
SUTURING MATERIALS 0.0 0.0 0.0 0.0 0.0 0.0
SYRINGES, NEEDLES & CATHETERS 9.3 35.9 0.6 3.0 9.5 24.7
OTHER CONSUMABLES 1.5 35.1 3.7 0.0 0.1 6.0

DIAGNOSTIC IMAGING 19.0 23.2 1.8 4.5 3.7 17.3
ELECTRODIAGNOSTIC APPARATUS 18.2 28.4 1.5 3.8 1.9 17.9
RADIATION APPARATUS 23.9 12.6 0.5 0.7 0.2 16.8
IMAGING PARTS & ACCESSORIES 19.9 11.8 2.8 7.6 10.1 15.6

DENTAL PRODUCTS 11.7 29.5 0.6 0.9 1.0 21.7
CAPITAL EQUIPMENT 9.4 55.8 16.2 0.0 0.2 24.0
INSTRUMENTS & SUPPLIES 11.7 28.7 0.2 0.9 1.1 21.7
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 91
Leading Medical Device Destinations By Product Area (% Distribution) - Continued

USA New Zealand UK Netherlands Japan EU-27

ORTHOPAEDICS & PROSTHETICS 13.9 18.4 5.5 1.7 3.0 48.3

PATIENT AIDS 44.0 2.7 18.5 9.9 5.3 30.4
PORTABLE AIDS 33.1 4.1 35.6 0.4 2.4 37.5
THERAPEUTIC APPLIANCES 55.8 1.3 0.1 20.3 8.5 22.8

OTHERS 13.8 39.0 2.9 1.2 7.7 19.1

TOTAL 32.4 14.4 12.6 6.8 5.5 27.6
Source: BMI Espicom
Table: Top 20 Medical Device Destinations (US$000s)

Country 2012 % of Total

1 United States of America 549,362 32.4
2 New Zealand 243,996 14.4
3 United Kingdom 213,071 12.6
4 Netherlands 115,419 6.8
5 Japan 93,617 5.5
6 China 91,789 5.4
7 Germany 75,067 4.4
8 Singapore 62,477 3.7
9 Denmark 29,968 1.8
10 South Korea 23,257 1.4
11 Panama 19,927 1.2
12 India 19,760 1.2
13 Papua New Guinea 12,327 0.7
14 Hong Kong 10,151 0.6
15 Ireland 9,667 0.6
16 Taiwan 9,664 0.6
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 92
Top 20 Medical Device Destinations (US$000s) - Continued

Country 2012 % of Total
17 France 8,917 0.5
18 Malaysia 8,192 0.5
19 Philippines 8,040 0.5
20 Brazil 7,344 0.4

Subtotal 1,612,012 95.0


Others 83,971 5.0


Total 1,695,983 100.0
Source: BMI Espicom
Table: Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s)

2008 2009 2010 2011 2012

CONSUMABLES 50,250 41,394 49,995 50,359 58,954

BANDAGES & DRESSINGS 12,024 10,238 13,057 11,771 7,522
Medical dressings (adhesive) 3,678 3,896 2,771 2,221 2,853
Medical dressings (non-adhesive) 8,346 6,342 10,286 9,550 4,669

SUTURING MATERIALS 7,702 2,570 4,601 3,597 2,655

SYRINGES, NEEDLES & CATHETERS 25,590 23,804 25,607 29,269 37,267
Syringes (with/without needles) 3,919 2,293 3,937 4,416 6,678
Tubular metal needles/needles for sutures 11,484 5,443 735 6,641 14,581
Other needles, catheters, cannulae etc 10,187 16,068 20,935 18,212 16,008

OTHER CONSUMABLES 4,934 4,782 6,730 5,722 11,510
Blood-grouping reagents 2,496 2,593 1,525 1,529 1,910
First-aid boxes & kits 896 820 1,434 594 952
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 93
Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s) - Continued

2008 2009 2010 2011 2012
Ostomy products 1,011 681 3,316 2,942 7,920
Surgical gloves 531 688 455 657 728

DIAGNOSTIC IMAGING 69,356 69,464 90,988 101,265 83,510

ELECTRODIAGNOSTIC APPARATUS 45,821 48,063 70,037 78,906 57,053
Electrocardiographs 1,504 1,304 1,026 1,994 1,454
Ultrasound 7,458 11,249 6,004 10,236 14,209
MRI 1,055 1,926 3,256 4,150 3,219
Scintigraphic apparatus 234 346 792 299 155
Other electrodiagnostic apparatus 35,570 33,238 58,959 62,227 38,016

RADIATION APPARATUS 5,992 6,588 7,566 4,085 6,496
CT scanners 1,275 946 2,632 571 307
Other medical x-ray apparatus 3,637 3,269 3,738 2,149 3,531
A, B, C ray apparatus 1,080 2,373 1,196 1,365 2,658

IMAGING PARTS & ACCESSORIES 17,543 14,813 13,385 18,274 19,961
Contrast media 1,007 738 334 835 484
Medical x-ray film (flat) 843 751 782 1,322 1,447
Medical x-ray film (rolled) 150 239 53 174 162
X-ray tubes 3,083 3,501 3,376 2,510 2,330
Other imaging parts & accessories 12,460 9,584 8,840 13,433 15,538

DENTAL PRODUCTS 43,559 39,645 42,285 48,621 59,082

CAPITAL EQUIPMENT 1,707 1,450 1,457 4,639 1,619
Dental drills 167 71 70 40 76
Dental chairs 1,028 996 1,076 2,443 1,009
Dental x-ray 512 383 311 2,156 534

INSTRUMENTS & SUPPLIES 41,852 38,195 40,828 43,982 57,463
Dental cements 23,744 22,076 23,035 26,784 35,539
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 94
Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s) - Continued

2008 2009 2010 2011 2012
Dental instruments 12,428 12,404 15,335 15,235 18,214
Teeth & other fittings 5,680 3,715 2,458 1,963 3,710
Artificial teeth 167 124 182 310 100
Other dental fittings 5,513 3,591 2,276 1,653 3,610

ORTHOPAEDICS & PROSTHETICS 58,613 37,412 68,476 97,906 86,423

FIXATION DEVICES 6,373 3,361 6,819 10,537 6,614
ARTIFICIAL JOINTS 2,157 796 1,321 1,367 1,581
OTHER ARTIFICIAL BODY PARTS 50,083 33,255 60,336 86,002 78,228

PATIENT AIDS 817,055 717,512 905,745 953,316 1,047,179

PORTABLE AIDS 347,622 296,097 399,755 447,578 544,980
Hearing aids 61,232 57,549 154,057 170,361 234,399
Pacemakers 2,398 829 1,473 1,610 2,305
Other portable aids 283,992 237,719 244,225 275,607 308,276

THERAPEUTIC APPLIANCES 469,433 421,415 505,990 505,738 502,199
Mechano-therapy apparatus 7,753 4,389 4,164 3,608 4,187
Therapeutic respiration apparatus 461,680 417,026 501,826 502,130 498,012

OTHERS 301,228 284,658 300,075 283,494 360,835

WHEELCHAIRS 2,397 1,986 2,127 1,829 4,575
Wheelchairs, not mechanically propelled 464 599 564 685 567
Wheelchairs, mechanically propelled 1,933 1,387 1,563 1,144 4,008

OPHTHALMIC INSTRUMENTS 36,561 30,676 30,695 27,963 31,488

HOSPITAL FURNITURE 10,634 7,513 7,989 7,793 8,528

MEDICAL, SURGICAL STERILISERS 1,607 1,505 1,453 3,175 3,078
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 95
Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s) - Continued

2008 2009 2010 2011 2012

ULTRA-VIOLET OR INFRA-RED RAY APPARATUS 293 213 125 1,109 457

OTHER INSTRUMENTS & APPLIANCES 249,736 242,765 257,686 241,625 312,709

TOTAL 1,340,061 1,190,085 1,457,564 1,534,961 1,695,983
Source: BMI Espicom
Table: Detailed Medical Device Export Trends By Product Area

2012 %
of Total
Latest Year %
Change, US$
Latest Year % Change
(Local Currency)
5 Year %
CAGR, US$
5 Year % CAGR
(Local Currency)

CONSUMABLES 3.5 17.1 16.7 4.0 -0.3

BANDAGES &
DRESSINGS 0.4 -36.1 -36.3 -10.5 -14.3
Medical dressings
(adhesive) 0.2 28.5 28.0 -6.2 -10.1
Medical dressings (non-
adhesive) 0.3 -51.1 -51.3 -12.7 -16.3

SUTURING MATERIALS 0.2 -26.2 -26.4 -21.5 -24.8

SYRINGES, NEEDLES &
CATHETERS 2.2 27.3 26.9 12.5 7.8
Syringes (with/without
needles) 0.4 51.2 50.7 21.0 16.0
Tubular metal needles/
needles for sutures 0.9 119.6 118.8 10.4 5.8
Other needles,
catheters, cannulae etc 0.9 -12.1 -12.4 11.6 6.9

OTHER
CONSUMABLES 0.7 101.2 100.5 15.4 10.6
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 96
Detailed Medical Device Export Trends By Product Area - Continued

2012 %
of Total
Latest Year %
Change, US$
Latest Year % Change
(Local Currency)
5 Year %
CAGR, US$
5 Year % CAGR
(Local Currency)
Blood-grouping
reagents 0.1 24.9 24.5 -4.6 -8.6
First-aid boxes & kits 0.1 60.3 59.7 14.8 10.0
Ostomy products 0.5 169.2 168.3 40.8 34.9
Surgical gloves 0.0 10.8 10.4 -10.7 -14.4

DIAGNOSTIC IMAGING 4.9 -17.5 -17.8 6.1 1.7

ELECTRODIAGNOSTIC
APPARATUS 3.4 -27.7 -27.9 9.3 4.7
Electrocardiographs 0.1 -27.1 -27.3 -16.1 -19.6
Ultrasound 0.8 38.8 38.4 25.5 20.3
MRI 0.2 -22.4 -22.7 22.4 17.3
Scintigraphic apparatus 0.0 -48.2 -48.3 -19.8 -23.1
Other electrodiagnostic
apparatus 2.2 -38.9 -39.1 7.2 2.7

RADIATION
APPARATUS 0.4 59.0 58.5 5.5 1.1
CT scanners 0.0 -46.2 -46.4 -26.7 -29.7
Other medical x-ray
apparatus 0.2 64.3 63.8 6.5 2.1
A, B, C ray apparatus 0.2 94.7 94.1 23.0 17.9

IMAGING PARTS &
ACCESSORIES 1.2 9.2 8.9 -0.4 -4.6
Contrast media 0.0 -42.0 -42.2 -28.3 -31.3
Medical x-ray film (flat) 0.1 9.5 9.1 -2.3 -6.4
Medical x-ray film
(rolled) 0.0 -6.9 -7.2 -0.7 -4.9
X-ray tubes 0.1 -7.2 -7.5 -4.5 -8.5
Other imaging parts &
accessories 0.9 15.7 15.3 3.5 -0.9

DENTAL PRODUCTS 3.5 21.5 21.1 11.8 7.2

CAPITAL EQUIPMENT 0.1 -65.1 -65.2 -7.7 -11.5
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 97
Detailed Medical Device Export Trends By Product Area - Continued

2012 %
of Total
Latest Year %
Change, US$
Latest Year % Change
(Local Currency)
5 Year %
CAGR, US$
5 Year % CAGR
(Local Currency)
Dental drills 0.0 90.0 89.4 -20.3 -23.6
Dental chairs 0.1 -58.7 -58.8 -12.7 -16.3
Dental x-ray 0.0 -75.2 -75.3 22.6 17.5

INSTRUMENTS &
SUPPLIES 3.4 30.7 30.2 12.9 8.2
Dental cements 2.1 32.7 32.3 14.9 10.1
Dental instruments 1.1 19.6 19.2 10.8 6.2
Teeth & other fittings 0.2 89.0 88.4 6.8 2.3
Artificial teeth 0.0 -67.7 -67.8 -10.9 -14.6
Other dental fittings 0.2 118.4 117.7 7.6 3.2

ORTHOPAEDICS &
PROSTHETICS 5.1 -11.7 -12.0 19.5 14.6

FIXATION DEVICES 0.4 -37.2 -37.4 4.0 -0.3
ARTIFICIAL JOINTS 0.1 15.7 15.3 1.0 -3.2
OTHER ARTIFICIAL
BODY PARTS 4.6 -9.0 -9.3 22.4 17.3

PATIENT AIDS 61.7 9.8 9.5 4.8 0.4

PORTABLE AIDS 32.1 21.8 21.4 10.4 5.8
Hearing aids 13.8 37.6 37.1 41.0 35.1
Pacemakers 0.1 43.2 42.7 5.5 1.1
Other portable aids 18.2 11.9 11.5 1.4 -2.9

THERAPEUTIC
APPLIANCES 29.6 -0.7 -1.0 0.2 -3.9
Mechano-therapy
apparatus 0.2 16.0 15.7 -11.7 -15.4
Therapeutic respiration
apparatus 29.4 -0.8 -1.1 0.4 -3.8

OTHERS 21.3 27.3 26.9 7.5 3.0

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 98
Detailed Medical Device Export Trends By Product Area - Continued

2012 %
of Total
Latest Year %
Change, US$
Latest Year % Change
(Local Currency)
5 Year %
CAGR, US$
5 Year % CAGR
(Local Currency)
WHEELCHAIRS 0.3 150.1 149.3 16.8 11.9
Wheelchairs, not
mechanically propelled 0.0 -17.2 -17.5 7.2 2.7
Wheelchairs,
mechanically propelled 0.2 250.3 249.2 18.7 13.7

OPHTHALMIC
INSTRUMENTS 1.9 12.6 12.2 -0.8 -4.9

HOSPITAL FURNITURE 0.5 9.4 9.1 0.0 -4.2

MEDICAL, SURGICAL
STERILISERS 0.2 -3.1 -3.4 7.3 2.8

ULTRA-VIOLET OR
INFRA-RED RAY
APPARATUS 0.0 -58.8 -58.9 31.1 25.6

OTHER INSTRUMENTS
& APPLIANCES 18.4 29.4 29.0 8.8 4.2

TOTAL 100.0 10.5 10.1 6.1 1.7
Source: BMI Espicom
The leading destination for Australian exports is the USA, which accounted for 32.4% of the total in 2012,
importing goods to the value of US$549.4mn. Strong export markets also included New Zealand and the
United Kingdom, which took 14.4% and 12.6% of the total, respectively.
The USA is the leading market as a result of its imports of patient aids which can be traced back to ResMed.
In 2012, exports of patient aids to the USA totalled US$460.8mn, equating to 44.0% of the category total.
Although, second to the US overall, New Zealand is the leading importer of consumables, diagnostic
imaging products, dental products, orthopaedic & prosthetic products and other medical devices from
Australia.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 99
Table: Detailed Leading Medical Device Destinations By Product Area (US$000s)

USA New Zealand UK Netherlands Japan EU-27

CONSUMABLES 3,942 21,972 1,756 1,128 3,568 11,075

BANDAGES & DRESSINGS 283 4,567 1,105 0 0 1,178
Medical dressings (adhesive) 52 2,187 12 0 0 57
Medical dressings (non-adhesive) 231 2,380 1,093 0 0 1,121

SUTURING MATERIALS 0 0 0 0 0 0

SYRINGES, NEEDLES & CATHETERS 3,481 13,366 221 1,123 3,556 9,206
Syringes (with/without needles) 170 3,613 0 986 130 1,300
Tubular metal needles/needles for
sutures 2,850 936 0 4 1,077 5,727
Other needles, catheters, cannulae etc 461 8,817 221 133 2,349 2,179

OTHER CONSUMABLES 178 4,039 430 5 12 691
Blood-grouping reagents 6 112 0 0 0 21
First-aid boxes & kits 3 172 189 5 0 194
Ostomy products 169 3,348 241 0 12 476
Surgical gloves 0 407 0 0 0 0

DIAGNOSTIC IMAGING 15,904 19,393 1,469 3,760 3,102 14,439

ELECTRODIAGNOSTIC APPARATUS 10,387 16,229 884 2,185 1,079 10,225
Electrocardiographs 842 160 73 11 0 312
Ultrasound 2,723 2,585 94 491 157 2,346
MRI 175 281 3 89 203 282
Scintigraphic apparatus 32 0 0 0 0 0
Other electrodiagnostic apparatus 6,615 13,203 714 1,594 719 7,285

RADIATION APPARATUS 1,553 818 34 48 14 1,094
CT scanners 74 2 0 6 0 6
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 100
Detailed Leading Medical Device Destinations By Product Area (US$000s) - Continued

USA New Zealand UK Netherlands Japan EU-27
Other medical x-ray apparatus 897 461 34 42 14 536
A, B, C ray apparatus 582 355 0 0 0 552

IMAGING PARTS & ACCESSORIES 3,964 2,346 551 1,527 2,009 3,120
Contrast media 131 93 0 0 0 35
Medical x-ray film (flat) 0 1,235 0 0 0 30
Medical x-ray film (rolled) 0 9 0 0 0 0
X-ray tubes 823 181 49 0 453 82
Other imaging parts & accessories 3,010 828 502 1,527 1,556 2,973

DENTAL PRODUCTS 6,890 17,411 383 532 611 12,844

CAPITAL EQUIPMENT 152 903 262 0 4 388
Dental drills 0 12 0 0 4 0
Dental chairs 152 560 262 0 0 262
Dental x-ray 0 331 0 0 0 126

INSTRUMENTS & SUPPLIES 6,738 16,508 121 532 607 12,456
Dental cements 5,604 3,070 0 482 154 8,463
Dental instruments 956 11,325 121 0 12 3,906
Teeth & other fittings 178 2,113 0 50 441 87
Artificial teeth 0 68 0 0 3 0
Other dental fittings 178 2,045 0 50 438 87

ORTHOPAEDICS & PROSTHETICS 12,055 15,883 4,743 1,499 2,557 41,705

FIXATION DEVICES 2,579 2,654 436 0 0 1,068
ARTIFICIAL JOINTS 419 421 6 0 0 282
OTHER ARTIFICIAL BODY PARTS 9,057 12,808 4,301 1,499 2,557 40,355

PATIENT AIDS 460,837 28,678 194,234 104,122 55,943 318,454

PORTABLE AIDS 180,620 22,177 193,883 2,119 13,147 204,154
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 101
Detailed Leading Medical Device Destinations By Product Area (US$000s) - Continued

USA New Zealand UK Netherlands Japan EU-27
Hearing aids 156,128 2,993 0 0 3,639 538
Pacemakers 1,264 748 5 0 0 192
Other portable aids 23,228 18,436 193,878 2,119 9,508 203,424

THERAPEUTIC APPLIANCES 280,217 6,501 351 102,003 42,796 114,300
Mechano-therapy apparatus 196 3,166 110 0 16 290
Therapeutic respiration apparatus 280,021 3,335 241 102,003 42,780 114,010

OTHERS 49,734 140,659 10,486 4,378 27,836 68,900

WHEELCHAIRS 2,215 665 244 0 19 1,304
Wheelchairs, not mechanically
propelled 0 233 69 0 0 74
Wheelchairs, mechanically propelled 2,215 432 175 0 19 1,230

OPHTHALMIC INSTRUMENTS 7,460 1,446 1,088 409 6,882 6,204

HOSPITAL FURNITURE 522 2,477 544 281 239 1,199

MEDICAL, SURGICAL STERILISERS 37 1,510 181 0 0 576

ULTRA-VIOLET OR INFRA-RED RAY
APPARATUS 50 96 0 0 0 5

OTHER INSTRUMENTS &
APPLIANCES 39,450 134,465 8,429 3,688 20,696 59,612

TOTAL 549,362 243,996 213,071 115,419 93,617 467,417
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 102
Table: Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s)

2008 2009 2010 2011 2012

CONSUMABLES -399,703 -418,410 -470,043 -587,526 -578,127

BANDAGES & DRESSINGS -101,388 -101,204 -124,204 -175,328 -142,008
Medical dressings (adhesive) -46,483 -44,153 -53,403 -68,343 -66,667
Medical dressings (non-adhesive) -54,905 -57,051 -70,801 -106,985 -75,341

SUTURING MATERIALS -53,456 -57,303 -57,175 -72,712 -89,570

SYRINGES, NEEDLES & CATHETERS -226,028 -227,328 -232,008 -271,414 -282,894
Syringes (with/without needles) -31,594 -42,049 -42,374 -46,299 -43,917
Tubular metal needles/needles for sutures -14,982 -24,572 -27,766 -26,933 -21,069
Other needles, catheters, cannulae etc -179,452 -160,707 -161,868 -198,182 -217,908

OTHER CONSUMABLES -18,831 -32,575 -56,656 -68,072 -63,655
Blood-grouping reagents -3,544 -1,466 -3,077 -4,828 -3,225
First-aid boxes & kits -1,901 -1,563 -2,164 -3,889 -5,796
Ostomy products 97 -16,901 -32,203 -32,541 -31,952
Surgical gloves -13,483 -12,645 -19,212 -26,814 -22,682

DIAGNOSTIC IMAGING -415,815 -429,044 -482,563 -523,950 -626,748

ELECTRODIAGNOSTIC APPARATUS -187,391 -196,180 -208,064 -223,230 -260,664
Electrocardiographs -8,261 -8,481 -12,049 -13,217 -13,384
Ultrasound -66,876 -66,973 -75,606 -77,629 -72,533
MRI -26,089 -43,998 -48,551 -51,360 -68,998
Scintigraphic apparatus -1,983 -1,350 -3,176 -3,160 -3,885
Other electrodiagnostic apparatus -84,182 -75,378 -68,682 -77,864 -101,864

RADIATION APPARATUS -112,572 -121,063 -139,443 -149,310 -211,202
CT scanners -22,441 -31,802 -40,967 -63,667 -93,067
Other medical x-ray apparatus -83,895 -90,282 -97,038 -83,975 -112,701
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 103
Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s) - Continued

2008 2009 2010 2011 2012
A, B, C ray apparatus -6,236 1,021 -1,438 -1,668 -5,434

IMAGING PARTS & ACCESSORIES -115,852 -111,801 -135,056 -151,410 -154,882
Contrast media -25,737 -24,434 -30,688 -31,217 -33,346
Medical x-ray film (flat) -19,898 -20,956 -22,322 -23,880 -21,788
Medical x-ray film (rolled) -90 68 -87 -7 -191
X-ray tubes -13,410 -14,665 -16,121 -18,596 -21,985
Other imaging parts & accessories -56,717 -51,814 -65,838 -77,710 -77,572

DENTAL PRODUCTS -121,269 -139,317 -154,555 -167,009 -169,647

CAPITAL EQUIPMENT -18,304 -23,890 -33,833 -23,399 -26,881
Dental drills -1,563 -3,004 -3,429 -2,327 -1,960
Dental chairs -7,438 -7,368 -11,325 -7,549 -8,046
Dental x-ray -9,303 -13,518 -19,079 -13,523 -16,875

INSTRUMENTS & SUPPLIES -102,965 -115,427 -120,722 -143,610 -142,766
Dental cements -4,800 -8,271 -9,747 -20,688 -17,425
Dental instruments -58,780 -66,159 -59,721 -68,580 -70,798
Teeth & other fittings -39,385 -40,997 -51,254 -54,342 -54,543
Artificial teeth -5,129 -5,410 -11,198 -12,206 -13,424
Other dental fittings -34,256 -35,587 -40,056 -42,136 -41,119

ORTHOPAEDICS & PROSTHETICS -478,093 -516,043 -583,956 -747,556 -743,813

FIXATION DEVICES -134,630 -106,863 -127,385 -209,004 -194,524
ARTIFICIAL JOINTS -168,646 -155,592 -192,688 -243,368 -278,313
OTHER ARTIFICIAL BODY PARTS -174,817 -253,588 -263,883 -295,184 -270,976

PATIENT AIDS 259,473 227,238 304,303 239,597 354,651

PORTABLE AIDS -75,171 -67,914 -17,637 -63,092 50,185
Hearing aids -14,222 -7,541 75,219 73,576 147,918
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 104
Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s) - Continued

2008 2009 2010 2011 2012
Pacemakers -118,774 -115,452 -129,141 -145,228 -175,101
Other portable aids 57,825 55,079 36,285 8,560 77,368

THERAPEUTIC APPLIANCES 334,644 295,152 321,940 302,689 304,466
Mechano-therapy apparatus -55,388 -49,057 -56,526 -65,861 -76,246
Therapeutic respiration apparatus 390,032 344,209 378,466 368,550 380,712

OTHERS -663,877 -720,528 -839,949 -1,033,582 -1,063,945

WHEELCHAIRS -23,376 -21,738 -25,076 -28,526 -26,745
Wheelchairs, not mechanically propelled -10,639 -9,274 -10,033 -12,137 -12,752
Wheelchairs, mechanically propelled -12,737 -12,464 -15,043 -16,389 -13,993

OPHTHALMIC INSTRUMENTS -24,425 -31,007 -33,478 -52,008 -59,003

HOSPITAL FURNITURE -29,249 -26,466 -32,481 -40,926 -48,470

MEDICAL, SURGICAL STERILISERS -14,444 -15,343 -16,926 -16,594 -18,768

ULTRA-VIOLET OR INFRA-RED RAY APPARATUS -1,471 -1,296 -2,237 -1,119 -3,449

OTHER INSTRUMENTS & APPLIANCES -570,912 -624,678 -729,751 -894,409 -907,510
Anaesthetic apparatus and instruments -86,450 -91,379 -98,407 -96,152 -120,742

TOTAL -1,819,284 -1,996,104 -2,226,763 -2,820,026 -2,827,629
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 105
Monthly Medical Device Exports
The latest Australian monthly trade data reveals that medical device exports showed a modest 1.7% increase
to US$1,715.6mn in the 12 months to October 2013, when compared with the corresponding period to
October 2012. The greatest movement occurred in the other medical devices segment, which increased by
17.2% to total US$406.2mn. The largest segment, patient aids, declined by 1.1% to US$1,025.5mn.
Medical device exports exhibited a slight improvement during the three months to October 2013, rising by
1.5% to US$476.9mn over the same quarter in 2012. Double digit growth was achieved in the diagnostic
imaging and other medical devices segments, but exports decreased in all other areas. The largest segment,
patient aids, fell by 0.1% to US$292.3mn. The heaviest fall was reported in the dental products segment
which declined by 23.0% to US$14.4mn.
Table: Monthly Medical Device Exports By Product Area, September 2010-October 2013 (US$mn)

Consumables Diagnostic Dental Orthopaedics Patient Aids Others Total

Sep-10 4.4 9.1 3.7 7.0 76.5 26.0 126.8
Oct-10 5.8 8.7 4.2 7.1 86.7 29.1 141.5
Nov-10 5.0 8.8 3.9 7.4 84.6 27.9 137.6
Dec-10 4.2 7.3 5.6 7.8 95.1 31.4 151.4
Jan-11 4.6 4.9 2.8 4.7 59.1 19.5 95.7
Feb-11 4.5 8.4 3.3 9.8 75.9 21.3 123.1
Mar-11 4.2 10.1 4.7 9.2 91.2 28.7 148.1
Apr-11 4.2 9.8 4.3 9.2 84.0 25.8 137.4
May-11 4.0 11.5 7.2 9.0 86.8 24.3 142.9
Jun-11 4.4 9.3 5.1 9.8 86.6 26.9 142.1
Jul-11 5.2 9.6 4.3 9.3 91.1 29.2 148.9
Aug-11 4.6 9.0 4.1 10.1 101.8 27.0 156.6
Sep-11 4.7 9.4 4.3 8.5 105.8 34.4 167.2
Oct-11 5.1 9.3 4.4 8.2 88.7 23.7 139.4
Nov-11 5.1 10.3 4.3 11.3 87.7 24.6 143.3
Dec-11 5.1 11.3 6.6 9.8 83.5 27.5 143.7
Jan-12 4.1 6.1 3.7 5.1 61.9 18.5 99.5
Feb-12 5.6 8.0 5.1 6.1 86.4 27.9 139.1
Mar-12 6.5 7.9 4.8 8.0 83.6 30.4 141.2
Apr-12 3.9 5.3 4.6 5.0 76.4 28.1 123.2
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 106
Monthly Medical Device Exports By Product Area, September 2010-October 2013 (US$mn) - Continued

Consumables Diagnostic Dental Orthopaedics Patient Aids Others Total
May-12 5.3 5.6 3.8 7.0 89.4 31.0 142.2
Jun-12 4.0 11.2 4.2 5.7 89.7 28.3 143.1
Jul-12 5.3 6.3 5.4 6.8 85.4 33.2 142.5
Aug-12 5.5 6.4 5.5 7.6 94.6 29.6 149.3
Sep-12 5.2 7.0 6.8 9.2 107.6 30.0 165.8
Oct-12 4.7 7.2 6.4 8.4 90.3 37.6 154.7
Nov-12 4.4 6.4 3.9 9.3 95.7 33.4 153.2
Dec-12 4.5 6.0 4.7 8.2 86.0 32.8 142.2
Jan-13 4.0 3.8 3.2 5.4 48.2 27.9 92.5
Feb-13 4.4 4.9 4.2 6.4 69.5 33.4 122.8
Mar-13 4.9 5.8 5.0 8.6 84.6 38.5 147.4
Apr-13 4.6 7.4 4.1 9.8 88.9 32.8 147.7
May-13 4.8 6.8 5.4 8.6 76.9 33.1 135.7
Jun-13 5.1 6.2 4.2 8.4 97.4 34.6 155.9
Jul-13 4.7 5.8 5.2 8.0 85.9 31.8 141.4
Aug-13 5.3 8.4 5.0 8.3 108.0 35.8 171.0
Sep-13 3.8 7.5 4.7 7.2 81.3 34.7 139.2
Oct-13 5.1 7.8 4.7 8.6 103.0 37.4 166.7

Quarter to

Oct-12 15.4 20.7 18.7 25.3 292.5 97.2 469.9
Oct-13 14.3 23.8 14.4 24.2 292.3 107.9 476.9

Qtr % +/- -7.4 14.9 -23.0 -4.3 -0.1 11.0 1.5

Year to

Oct-12 60.3 92.7 61.3 90.0 1,036.7 346.7 1,687.7
Oct-13 55.6 77.1 54.4 96.9 1,025.5 406.2 1,715.6

12 months % +/- -7.7 -16.9 -11.4 7.7 -1.1 17.2 1.7
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 107
Macroeconomic Forecasts
BMI View: Several domestic and external factors have served to boost the level of economic activity in
Australia. While we revised up our GDP growth forecasts for 2014 to 2.0% from 1.8% previously, this
change masks our concerns for the ever-growing risks within the Australian economy. Given that an
increasing proportion of capital is being invested in the housing sector despite the weak performance of
business spending, (a turnaround in which is required to generate wage growth), this misallocation of
capital increases the economy's vulnerability to external shocks, on top of the ongoing weakness in the
mining sector.
Since the September elections, the Australia economy has recorded an uptick in activity levels and business
sentiment from the lows recorded earlier in 2013, supported by both domestic and external factors.
Domestically, prospects of lower regulatory burden, ranging from taxes to various regulatory procedures,
have helped lift the outlook for certain industries, such as oil and gas. Moreover, September's readings of
the performance indices showed that deterioration in the services and construction sectors were moderating,
while activity in the manufacturing sector posted expansion in both September and October. The expansion
recorded in the new order sub-indices for the manufacturing and construction sectors further suggests that
this recent up-tick in activity could persist in the near term.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 108
Signs Of Life
Australia - Performance Of Manufacturing, Services And Construction Sector Indices
Source: BMI; Australian Industry Group
Externally, efforts by the Chinese authorities to stimulate their economy and the decision of the US Federal
Reserve to postpone any reduction to its ongoing unconventional monetary stimulus have helped lift key
commodity prices and import volumes, such as iron ore, from their earlier lows in June. Together with
domestic factors, these trends suggest that economic growth could hold up until Q214, and as such, we have
raised our 2014 forecast, expecting real GDP growth to come in at 2.0% versus our previous estimates of
1.8%. This upgrade, however, masks our downbeat medium-term outlook for the economy as risks of a
sharp deflationary shock to the Australian economy continue to grow larger.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 109
Households Driving Debt Demand
Australia - Total Private Sector Credit Growth (% chg y-o-y) & Growth Contribution From
Components (pp)
Source: BMI; Reserve Bank of Australia
Ongoing Misallocation Of Capital Increases Risks
As we have highlighted before, Australia's high level of external portfolio debt makes its currency very
vulnerable to external shocks. With much of this debt extended to the financial sector, the risks that a re-
pricing of the creditworthiness of banks or a similar liquidity squeeze as seen in 2008-09 could have a
significant impact on the Australian economy. Moreover, via the banks, much of this liquidity has continued
to flow into the housing sector, even as households owe roughly two-thirds of the total private sector debt in
the country that currently towers at 140.4% of GDP. In comparison, businesses have reined in their use of
credit despite the Reserve Bank of Australia's (RBA) easing its cash rate, cutting 50 basis points (bps) to
bring the cash rate to 2.50% as of end-October.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 110
Divergent Performance Unlikely To Persist
Australia - House Price Indices For Queensland, Sydney, Australia
Source: BMI; RP Data
Indeed, attribution analysis of the drivers of credit growth clearly shows the ongoing misallocation of
capital within the Australia, where ever more liquidity is headed to the housing sector, driving up property
prices. Although some observers have accredited the uneven house price growth in the different states to
differing underlying supply and demand dynamics in each area, we believe that these factors are unlikely to
hold up in the face of a weaker job market. We believe that demand for goods and services remain uncertain
at best, and see room for input prices such as wages to head lower. Growth from the mining sector is likely
to slow further as demand for resources tapers. As such, until businesses restart spending and hiring, we
believe the current uptick in activity will be limited, and hence, we maintain that the current trajectory of
house prices is built on shaky fundamentals and could correct should renewed worries of the economy come
to the fore and/or the financial sector find itself in another funding squeeze.
Increasing Pressures For Greater Macro-Prudential Rules
Given the disproportionate flows into the housing sector, we believe that there the RBA, in conjunction with
the banking regulator, the Australian Prudential Regulatory Authority (APRA), will find it increasingly
attractive to put in place macro-prudential rules and other limits to rein lending to the household sector.
Indeed, as banks were announcing their quarterly earnings result at the end of October, the APRA warned
the sector of handing out excessive dividends to shareholders, and further cautioned that it was looking at
implementing a higher capital charge on domestic systematically important banks (DSIB).
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 111
Private Consumption: The mining sector slowdown is expected to weigh on overall economic growth in
the country, which is likely to affect wage growth as well. Given that many businesses have adopted the
wait and see approach to hiring and spending, we believe that softness in the job market is likely to persist,
and weigh on household consumption. As such, we maintain our outlook for private consumption growth to
slow from 3.7% in 2012 to 1.5% and 1.3% in 2013 and 2014 respectively.
Private Investment: We have long implied a slow growth in investment as business credit has remained
slow, despite the aggressive rate cuts by the central bank this year, and cost cuts within industries like the
auto manufacturers suggest that investment could remain weak. The tapering off of iron ore and coal
investments will similarly weigh on fixed capital investment growth. That said, we have upgraded our
forecast 2014 slightly to better reflect the accelerating pace of construction for several gas terminals,
expecting fixed-capital formation to grow at 2.0% in 2014 versus 1.2% previously.
Public Consumption And Investment: The new coalition government remains keen on pushing through
its infrastructure and spending plans even though this is likely to raise the amount of public debt. While we
maintain our outlook for the government expenditure on goods and services (not infrastructure) to growth
by 2.0% in 2013 and 2014, we highlight that upside risks could increase in 2014 should the economy falter
once again.
Net Exports: While the stimulus in China helped lift its domestic steel industry and, correspondingly,
Australian iron ore exports from contractionary territory in the near term, we believe that the ongoing
rebalancing within the Chinese economy will lead to a gradual decline in demand for certain Australian
commodity exports. Moreover, ongoing construction of gas terminals in Australia is likely to put upward
pressure on import growth over 2014-2017. As such, we believe that the country's trade balance will see a
much more gradual improvement in 2014, and we forecast real export and import growth to rise to 4.5%
and 2.7% respectively, compared to estimates of 2.3% and 1.4% in 2013.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 112
Table: Australia - Economic Activity

2008 2009 2010 2011e 2012e 2013f 2014f 2015f 2016f 2017f
Nominal GDP,
AUDbn 1,3
1,233.40 1,254.60 1,356.00 1,444.60 1,488.30 1,559.50 1,623.70 1,703.80 1,798.50 1,902.40
Nominal GDP,
US$bn 1,3
1,031.30 979.9 1,244.80 1,491.10 1,541.30 1,535.60 1,420.70 1,363.00 1,375.80 1,426.80
Real GDP
growth, %
change y-o-y
2,3
2.8 1.1 2.9 2.2 3.7 2.4 2 2.5 2.8 3
GDP per capita,
US$ 1,3
48,120 44,870 56,895 66,785 68,351 67,434 61,782 58,702 58,686 60,267
Population, mn
4
21.6 22 22.4 22.7 23.1 23.3 23.6 23.9 24.2 24.5
Industrial
production
index, % y-o-y,
ave 3
2.3 -0.1 3.9 -0.6 3.6 2.5 1.2 1.6 2.1 2
Unemployment,
% of labour
force, eop 3
4.6 5.5 4.9 5.2 5.4 6 6.6 6.1 5.7 5.5
Notes:
e
BMI estimates.
f
BMI forecasts.
1
Calendar Years;
2
Calendar Years, Base Year = FY2008/09 (July-June).
Sources:
3
ABS/BMI calculation;
4
World Bank/UN/BMI.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 113
Industry Risk Reward Ratings
Australia is the most attractive market in the Asia Pacific region for commercialising a medical device,
according to BMI Espicom's Medical Device Risk/Reward Ratings (RRRs). The country's overall score for
Q214 is 75.8 out of 100, which is marginally ahead of Japan (75.7).
REWARDS
Industry Rewards: The Australian market ranks amongst the largest in the world, with per capita spending
on a par with several developed West European markets. Manufacturing tends to be focused on niche areas,
so demand is largely met by imports. Australia's score of 69.8 out of 100 for this component of the RRRs is
only surpassed by China (79.3) and South Korea (74.1) in the context of the Asia Pacific region).
Country Rewards: Although the new government is looking to cut public spending, the existing
commitment to the National Health Reform Plan will see significant investment in the hospital sector up to
2019-2020. This, coupled with a rising population and an aging demographic, presents Australia as a
potentially rewarding market. Australia's score of 79.0 out of 100 for Country Rewards is the fourth highest
in the region, behind Japan (81.0), Hong Kong (80.5) and Singapore (80.0).
RISKS
Industry Risks: The incoming conservative Liberal-National coalition is intent on cutting public
expenditure and this is currently the main threat to the country's medical device industry. Australia's score
of 80.0 out of 100 is one of the highest in the Asia Pacific region, on a par with Singapore and Taiwan, but
less than Japan (86.7) and New Zealand (83.3).
Country Risks: Australia's medical device market is vulnerable on two fronts: the installation of a
government committed to cutting public spending and a weakening economy. Although one of the world's
larger markets, growth is forecast to be negligible over the next five years. Australia's score of 83.7 out of
100 for Country Risks is the second highest in the Asia Pacific region, behind New Zealand (88.2).
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 114
Table: Asia Pacific Medical Device Risk/Reward Ratings, Q214

Industry
Rewards
Country
Rewards
REWARDS Industry
Risks
Country
Risks
RISKS MEDICAL DEVICE RISK/
REWARD RATING
Australia 69.8 79.0 72.8 80.0 83.7 81.5 75.8
Japan 67.7 81.0 72.0 86.7 76.5 82.6 75.7
South Korea 74.1 70.5 72.9 73.3 70.6 72.2 72.7
New Zealand 57.3 75.2 63.1 83.3 88.2 85.3 70.9
Singapore 57.7 80.0 64.9 80.0 80.5 80.2 70.3
Taiwan 65.5 66.7 65.8 80.0 64.3 73.7 68.6
China 79.3 53.8 71.1 60.0 59.6 59.8 67.1
Malaysia 67.5 58.6 64.6 70.0 70.8 70.3 66.6
Hong Kong 47.3 80.5 58.0 76.7 80.4 78.2 65.1
Thailand 62.7 43.8 56.6 66.7 63.6 65.5 59.7
India 63.6 41.0 56.3 50.0 50.8 50.3 54.2
Indonesia 55.0 48.6 52.9 50.0 46.2 48.5 51.4
Vietnam 52.5 42.4 49.2 40.0 47.4 43.0 47.0
Philippines 36.1 43.3 38.5 56.7 48.0 53.2 43.6
Pakistan 36.6 43.3 38.8 33.3 42.7 37.1 38.2
Bangladesh 25.2 37.1 29.1 33.3 36.9 34.8 31.1
Regional
average
57.4 59.0 57.9 63.8 63.1 63.5 59.9
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 115
Market Overview
Medical Device Market Overview
Medical Market Analysis
Overview

Among top 15 largest medical markets in the world, behind only China, Japan and South Korea in the
Asia-Pacific region

A strong steady economy with per capita GDP among top five highest worldwide

Health expenditure is strong, both as a percentage of GDP and in per capita terms

Much of spending is in the public sector; private spending equal to one third of the total

Domestic manufacturers tend to be small and focused on a few specialty areas

Therefore market is heavily reliant on imports, with the USA the major supplier
Australia represents a large and highly advanced medical device market. The country has a large number of
medical device manufacturers, although these tend to be relatively small and concentrate on niche markets.
Australia has a range of modern and sophisticated health facilities, and despite its geographical remoteness,
represents a healthy market for imported medical equipment and supplies; over 90% of medical products are
imported, principally from the USA. The position of the USA in the market was further strengthened with
the free trade agreement approved in 2005.
Australia has a well-developed public hospital sector and a historically-strong private hospital sector. Issues
of funding remain a key political concern but, in general, Australian hospitals are among the best in the
Asia/Pacific region. These factors mean that the market should continue to be receptive to new technologies
in the future.
The majority of public hospital purchasing is conducted along state lines, with purchasing procedures
varying from state to state. In New South Wales and Queensland, purchasing is generally conducted
centrally, while in other states, hospitals are allowed more freedom, purchasing medical equipment within a
given budget.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 116
Table: Medical Device Market, Key Ratios

2013
Market size, US$mn 4,814.3

As % of total health expenditure 3.6
As % of GDP 0.3
As % of world market 1.5

Supplied by imports (%) 95.6
Projected CAGR (%) 0.1

Per capita (US$) 207.4
Source: BMI Espicom
The Market In 2013
The Australian market for medical equipment and supplies was estimated at US$4,814.3mn in 2013, equal
to US$193.3 per capita. Australia accounts for around 1.5% of the total world market.
The market is over 90% dependent on imports, although there is a highly skilled domestic industry which
supplies many basic hospital requirements. Advanced technologies, however, are almost always imported.
The MTAA (Medical Technology Association of Australia) has estimated that the public sector accounts for
around 55% of the total market.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 117
Table: Medical Device Market By Product Area

2013 2013 2013 2013 2013

US$mn As % of Total
Market
Per Capita (US$) Local Currency
(mn)
Per Capita
(Local Currency)
Consumables 646.8 13.4 27.9 647 27.9
Diagnostic Imaging 735.2 15.3 31.7 735.4 31.7
Dental products 247.1 5.1 10.6 247.2 10.6
Orthopaedics & prosthetics 864.7 18 37.2 865 37.3
Patient aids 792.1 16.5 34.1 792.4 34.1
Others 1,528.30 31.7 65.8 1,528.80 65.9

Total 4,814.30 100 207.4 4,815.70 207.5
Source: BMI Espicom
Medical Device Market By Product Area
% Distribution
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 118
Healthcare Overview
Health Status
The Australian population has increased over the last decade to reach an estimated 23.3mn in 2013. The
birth rate of 13.1 per 1,000 population is more than double the death rate.
In 2013, 14.3% of the population were aged 65 and over, a figure which is increasing steadily year on year.
Life expectancy is amongst the highest in the world, at an estimated 80.0 years for males and 84.5 years for
females in 2013.
The infant mortality rate fell by a CAGR of 2.8% between 2008 and 2013, reaching 3.6 per 1,000 live births
in 2013.
Healthcare System
Organisation
The Australian healthcare system is complex, operating at three levels; Commonwealth (national) level,
State/Territory level and local government level.
Commonwealth Level
The Commonwealth government is responsible for the overall co-ordination of the public health sector,
principally through the Medicare system. It provides the funding for an estimated 67% of all health
spending, through grants to States and Territories, for the running of public hospitals. Funding is also
provided for specific programmes, such as mental health, aerial medical, aboriginal health and blood
transfusion services. The Pharmaceutical Benefits Scheme is also run at Commonwealth level.
State/Territory & Local Governments
The main responsibility for the running of healthcare services rests with the State and Territory
governments, either directly or via local authorities or semi-governmental bodies. Included within their
remit are:

Management and supervision of public hospitals and nursing homes,

Community care, of children, the elderly and the mentally ill,
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 119

Dental health,

Health and safety in the workplace.
The federal nature of the system allows regional flexibility, but makes the co-ordination of any national
policy or reform difficult. A major example is the failure at local level to implement Aboriginal health
programmes. There are also concerns over cost-shifting from one sector to another.
National Policies
In August 2011, after months of negotiation, the Commonwealth Government signed an agreement with all
States and Territories to formalise the National Health Reform plan. Designed to improve funding to
hospitals and to reduce patient waiting times, the plan will see the Commonwealth Government invest at
least A$16.4bn (US$16.0bn) in additional funding for public hospitals over the period 2014-15 to 2019-20.
The Commonwealth Government will match 45% of efficient growth funding from July 2014, and 50% of
efficient growth from July 2017.
As part of the reform, a new Independent Hospital Pricing Authority will set the "national efficient price"
for public hospital services and will develop a national activity based funding system.
A single National Health Funding Pool will be established to improve the transparency of public hospital
funding. The administrator of the Pool will report on Commonwealth, State and Territory funding flowing
through the pool and the services delivered by this funding. This will ensure that all hospitals are funded
under the same arrangements, allowing all Australians to clearly see how their taxes are being spent.
Local Hospital Networks are being established by State and Territory governments, and will ensure
decisions about hospital management are devolved to the local level. In addition, local clinicians will be
engaged to advise about patient pathways which best meet the needs of the local community.
The National Health Performance Authority will deliver further transparency on the performance of health
and hospital services, by developing and publishing Hospital Performance Reports and Healthy
Communities Reports. These reports will help to identify high-performing organisations, and will highlight
on areas for further development and investment in the future.
The Commonwealth Government will also invest A$1.8bn to establish new targets for emergency
departments and elective surgery, with funding dedicated to help states and Territories reach these targets
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 120
and reward them when they do. An additional investment of A$1.6bn is being provided to fully fund the
capital and recurrent costs of 1,316 new sub-acute beds or equivalent services.
The targets to be implemented are: a four-hour target for emergency departments with the aim that 90% of
patients across all age categories are seen, treated, admitted or discharged within four hours; and a 100%
elective surgery target aimed at ensuring all patients waiting for elective surgery are treated within clinically
recommended times. The emergency department target will be implemented over four years from 2012, and
the elective surgery target will be implemented over five years from 2012.
Healthcare Funding
Social Security
Medicare
Medicare was introduced in 1984, and is the principal source of funding for hospital treatment. It is a
special health fund administered by the Commonwealth government. The scheme sets out a schedule (the
Medicare Benefits Schedule) which lists fees for different medical services. This schedule is under constant
review and is updated twice yearly. Inpatients in public hospitals can receive Medicare benefits at 85% of
the relevant Schedule fee. For low income groups, benefits are paid at 100%. Private patients choosing
treatment in public hospitals receive benefits at 75%. Medicare was originally funded by a 1% levy on
taxable income, but this amount has been raised several times since.
Health Expenditure
In 2013, Espicom estimates Australian healthcare expenditure at US$138.1bn, equal to US$5,917 per
capita. Australia has long had a relatively high level of health spending and in 2013 it stood at 9.1% of
GDP, having grown at a CAGR of 0.6% over the 2008-2013 period. Spending in US$ per capita terms has
doubled since 2003.
Almost one third of spending is private, which is funded through a combination of private insurance and
out-of-pocket payments.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 121
Healthcare Resources
Infrastructure
Australia had 1,363 hospitals in 2013, which were fairly evenly split between the public sector (753) and the
private sector (610). The number of beds totalled 88,163 in 2013, equal to 3.8 beds per thousand
population. This bed-to-population ratio is above the average for the Asia Pacific region, although
significantly lower than the rates in prevalent in Japan, New Zealand and South Korea for example.
Medical Device Technology
In 2012, Australia made some notable investments in medical technology, more than doubling the number
of MRI units installed and increasing the number of CT scanners by 16% and the number of PET scanners
by 31%.
In 2012, there were 341 MRI units in operation, equating to 15.0 per mn population. This rate stands at one
of the world's highest, ahead of the USA and most West European nations. The increase in the number of
CT scanners in 2012 cemented Australia's position as having the second highest concentration in the world
at 50.6 per mn, behind Japan.
The addition of 10 PET scanners in 2012 took Australia's installed base to 42, a rate of 1.9 per million
which is similar to Australia and Ireland, but well below the USA, Switzerland and South Korea.
While the number of most types of imaging equipment has been increasing, the number of mammography
units has fallen in each year since 2009. In 2012, there were 517 mammography units in Australia, a rate of
22.8 per mn population, a rate that compares well with most European countries.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 122
Table: Diagnostic Imaging Technology By Type, 2006-2012

2006 2007 2008 2009 2010 2011 2012 CAGR
DIAGNOSTIC IMAGING


ELECTRODIAGNOSTIC APPARATUS


MRI units 100 108 120 124 125 127 341 22.69%
Gamma cameras n/a n/a 419 441 455 452 456 2.14%
PET scanners n/a n/a 15 24 31 32 42 29.36%

RADIATION APPARATUS


CT scanners 1160 n/a n/a 849 949 990 1,148 -0.17%
DSA units n/a n/a 311 324 355 362 376 4.86%
Mammographs 506 508 500 534 533 520 517 0.36%
Radiation therapy equipment 127 n/a 168 193 205 205 221 9.67%
Source: BMI Espicom using OECD data
Table: Diagnostic Imaging Technology Per Million Population By Type, 2006-2012

2006 2007 2008 2009 2010 2011 2012
DIAGNOSTIC IMAGING


ELECTRODIAGNOSTIC APPARATUS


MRI units 4.8 5.1 5.6 5.7 5.7 5.7 15.0
Gamma cameras n/a n/a 19.6 20.3 20.6 20.3 20.1
PET scanners n/a n/a 0.7 1.1 1.4 1.4 1.9

RADIATION APPARATUS


Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 123
Diagnostic Imaging Technology Per Million Population By Type, 2006-2012 - Continued

2006 2007 2008 2009 2010 2011 2012
CT scanners 56.0 n/a n/a 39.0 43.0 44.4 50.6
DSA units n/a n/a 14.5 14.9 16.1 16.2 16.6
Mammographs 24.5 24.2 23.4 24.5 24.2 23.3 22.8
Radiation therapy equipment 6.1 n/a 7.9 8.7 9.3 9.2 9.7
Source: BMI Espicom using OECD data
Healthcare Activity
Inpatient admissions have grown at a CAGR of 2.9% since 2008, reaching almost 4.0mn in 2013, equal to
169.9 admissions per thousand population, which is one of the highest rates in Asia, though well behind
Thailand, Hong Kong, South Korea and New Zealand. The number of surgical procedures has grown at a
slightly higher CAGR of 3.3%, reaching an estimated 2.5mn in 2013.
Australia's total of 54.8mn outpatient visits in 2013 equates to 2,348 per thousand population, which is
below the average for the Asia-Pacific region.
Healthcare Personnel
The number of physicians in Australia is estimated to exceed 79,000, equal to a rate of 3.4 per thousand
population in 2013. This is the highest rate in the Asia Pacific region.
The situation is the same for nurses, with Australia's rate of 12.6 per thousand population in 2013 being the
highest in the Asia Pacific region, as well as being as one of the highest in the world, just behind Germany.
Key Data
Table: Key Data, 2008-2013
Economic Data 2008 2009 2010 2011 2012 2013 CAGR

GDP (US$ bn) 1,031.3 980.0 1,244.8 1,491.1 1,541.3 1,509.6 7.9
Real growth (%) 2.8 1.1 2.9 2.2 3.7 2.4 n/a
Per capita (US$) 48,121.2 44,871.6 56,895.2 66,786.2 66,073.9 62,054.6 5.2
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 124
Key Data, 2008-2013 - Continued
Economic Data 2008 2009 2010 2011 2012 2013 CAGR

Health Expenditure (US$ bn) 91.8 91.3 116.2 134.3 140.5 138.1 8.5
Per capita (US$) 4,240.4 4,141.9 5,187.3 5,907.6 6,096.9 5,917.1 6.9
Health expenditure % of GDP 8.9 9.3 9.3 9.0 9.1 9.1 0.6

Public % of health expenditure 67.9 68.5 68.5 68.5 68.1 67.8 n/a
Social security % of public n/a n/a n/a n/a n/a n/a n/a

Private % of health expenditure 32.1 31.5 31.5 31.5 31.9 32.2 n/a
Out of pocket % of private 56.4 59.0 59.4 63.0 n/a n/a n/a
Private insurance % of private 25.1 24.9 24.9 24.9 n/a n/a n/a

Exchange rate, national currency per US$ 1.2 1.3 1.1 1.0 1.0 1.0 -2.9

Population Data 2008 2009 2010 2011 2012 2013 CAGR

Population (mn) 21.6 22.0 22.4 22.7 23.1 23.3 1.5
Population growth (%) 1.9 1.8 1.7 1.5 1.4 1.3 n/a
% of population aged 65+ 13.1 13.3 13.4 13.7 14.0 14.3 1.7

Demographic Data 2008 2009 2010 2011 2012 2013 CAGR

Live Births (000s) 296.6 295.7 297.9 301.6 303.3 305.0 0.6
Per 000 population 13.7 13.4 13.3 13.3 13.2 13.1 -0.9

Deaths (000s) 143.9 140.8 143.5 146.9 148.8 150.6 0.9
Per 000 population 6.7 6.4 6.4 6.5 6.5 6.5 -0.6
Infant mortality/000 live births 4.1 4.3 4.1 3.8 3.7 3.6 -2.8
Male life expectancy at birth 79.2 79.3 79.5 79.7 79.9 80.0 0.2
Female life expectancy at birth 83.7 83.9 84.0 84.2 84.3 84.5 0.2

Healthcare Data 2008 2009 2010 2011 2012 2013 CAGR

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 125
Key Data, 2008-2013 - Continued
Economic Data 2008 2009 2010 2011 2012 2013 CAGR
Hospitals 1,314 1,320 1,334 1,345 1,354 1,363 0.7
Public 762 756 753 752 753 753 -0.2
Private 552 564 581 593 601 610 2.0
Beds 83,396 83,702 84,648 86,123 87,205 88,163 1.1
Per 000 population 3.9 3.8 3.8 3.8 3.8 3.8 -0.4

Inpatient admissions (000s) 3,445.2 3,503.9 3,613.4 3,732.1 3,877.3 3,965.4 2.9
Per 000 population 159.2 159.0 161.3 164.1 168.2 169.9 1.3
Average length of stay (days) 6.2 6.0 5.9 5.8 5.8 5.7 -1.5
Surgical procedures (hosp.-000s) 2,151.7 2,221.4 2,304.9 2,358.8 2,443.9 2,525.3 3.3

Outpatient visits (hosp.-000s) 49,986.5 50,681.0 51,548.0 52,379.0 53,574.5 54,800.5 1.9
Per 000 population 2,309.4 2,299.8 2,300.8 2,303.3 2,324.2 2,347.7 0.3

Physicians (employed) 68,689 72,739 74,342 75,980 77,654 79,366 2.9
Per 000 population 3.2 3.3 3.3 3.3 3.4 3.4 1.4

Nurses (employed) 272,741 276,751 280,820 284,949 289,138 293,389 1.5
Per 000 population 12.6 12.6 12.5 12.5 12.5 12.6 -0.1

Dentists 10,923 11,192 11,467 11,750 12,039 12,336 2.5
Per 000 population 0.5 0.5 0.5 0.5 0.5 0.5 0.9

Pharmacists 16,041 16,332 16,604 16,853 17,083 17,299 1.5
Per 000 population 0.7 0.7 0.7 0.7 0.7 0.7 0.0
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 126
Industry Trends & Developments
Industry Trends & Developments
Imports Grow By Just Over 1% In Last Quarter
The latest Australian monthly trade data reveals that medical device imports grew by 1.2% to US
$1,188.4mn over the three months to October 2013, compared with the corresponding period in 2012.
Growth was achieved in the patient aids and orthopaedics & prosthetics sectors which increased by 15.1%
and 4.1% respectively. All other sectors experienced a drop in imports over the quarter. The sharpest
decline was in the demand for diagnostic imaging products which fell by 7.9%, followed by dental products
which decreased by 6.9%.
Medical device imports increased by 2.2% in US dollar terms in the 12 months to October 2013, taking the
running annual total to US$4,571.6mn. The highest growth was recorded in the patient aids sector, which
increased by 9.0% over the 12 month period to US$749.0mn. Imports of orthopaedics & prosthetics and
consumables also increased - by 6.1% and 3.3% respectively. The largest market segment, other medical
devices, showed a marginal 0.5% increase to US$1,407.4mn.
Limited Growth In Exports Over Last Quarter
The latest Australian monthly trade data reveals that medical device exports exhibited a slight improvement
during the three months to October 2013, rising by 1.5% to US$476.9mn over the same quarter in 2012.
Double digit growth was achieved in the diagnostic imaging and other medical devices segments, but
exports decreased in all other areas. The largest segment, patient aids, fell by 0.1% to US$292.3mn. The
heaviest fall was reported in the dental products segment which declined by 23.0% to US$14.4mn.
Medical device exports showed a modest 1.7% increase to US$1,715.6mn in the 12 months to October
2013, when compared with the corresponding period to October 2012. The greatest movement occurred in
the other medical devices segment, which increased by 17.2% to total US$406.2mn. The largest segment,
patient aids, declined by 1.1% to US$1,025.5mn.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 127
Medical Device Market Growth Set For Sluggish Growth
The Australian market for medical equipment and supplies is estimated at US$4,814.3mn in 2013, equal to
US$193.3 per capita. After a phase of strong growth since 2008, a CAGR for 2013-2018 of 0.1% is
projected to edge the market to US$4,836.5mn by 2018, equal to US$196 per capita. Australia is expected
to be amongst the top 20 largest medical device markets in the world by 2018.
Government Allocates A$559mn For Medical Research
In October 2013, the Prime Minister, Tony Abbott, announced funding of A$559.1mn to Australian health
and medical researchers to generate new health discoveries across Australia.
The new funding will support 963 grants across three National Health and Medical Research Council
(NHMRC) research support schemes and five fellowship schemes. The importance of tackling national
health priorities to researchers is reflected in the funding support to research in these areas. As an example,
A$21.7mn has been committed to dementia research, while A$31.8mn continues the NHMRC's
commitment to research to improve Aboriginal and Torres Strait Islander health.
Victoria will receive the highest amount of funding, with A$236.4mn allocated for 414 grants. The
University of Melbourne is the research institution receiving the greatest amount of funding, with A
$80.1mn earmarked for 145 grants.
NSW Medical Devices Fund Announces Grants
In July 2013, the New South Wales Minister for Health and Minister for Medical Research presented grants
totalling over A$10.3mn to five organisations in the inaugural round of the NSW Government's Medical
Devices Fund.
The five grant recipients were chosen from a shortlist of 13, which was drawn from 147 applications. The
five recipients are:

Elastagen: for pioneering elastatherapy (using human protein elastin to naturally repair the skin,
particularly for severe burns).

Endoluminal: for developing a breakthrough technology for the treatment of failing heart valves.

HearWorks: for HearLab, the world's first fully-automated test for hearing. It attaches to a laptop and can
be used in any clinic to conduct complex electrophysiology for the assessment of hearing.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 128

MobiLife: for MobiDRIP, an innovative, portable intravenous (IV) pump to allow patients to be treated at
home.

Saluda Medical: for developing world-first technology for an implantable device, which supplies constant
pain relief to people suffering chronic neuropathic pain.
The New South Wales Medical Devices Fund has been established to help encourage and support
investment in the development and commercialisation of medical devices and related technologies in New
South Wales.
Central Government Budget Reveals Increased Investment
The Australian Government announced its 2013-2014 budget on 14
th
May 2013 which confirmed its
ongoing commitment to investment in healthcare. Funding for public hospitals is set to reach record levels,
with a budget of A$14.9bn (US$14.9bn), an increase of A$871mn over the previous year.
Cancer care received a boost with an extra A$226.4mn to be provided over four years under its World
Cancer Care Package. Within this figure, A$55.7mn will go towards an expanded BreastScreen Australia
programme, A$18.5mn will be spent on a new Prostate Cancer Research Institute and A$29.6mn over two
years will go to help with the dispensing of chemotherapy medicines.
Australia, Brazil, Canada And The USA Plan Shared Medical Device Audit Programme
The medical device regulatory agencies of Australia, Brazil, Canada and the US have signed a statement of
co-operation to develop a single audit programme for medical devices.
The US Food and Drug Administration (FDA), Australian Therapeutic Foods Administration (TGA),
ANVISA of Brazil and Health Canada plan to make their respective quality management system auditing
processes more efficient and less burdensome by establishing the Medical Device Single Audit Program
(MDSAP). Upon implementation of the MDSAP programme, the audit of a medical device manufacturer's
quality system in any one of the four participating countries will meet the regulatory requirements of each
of the four countries
Among the MSDAP's stated objectives are promoting work-sharing arrangements and mutual acceptance
among participating regulators to allow more efficient and flexible use of resources among the FDA, Health
Canada, ANVISA and TGA regarding medical device quality system audits; standardising participants'
market oversight practices regarding third-party auditing entities; and leveraging existing conformity
assessment structures when appropriate.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 129
New Royal Adelaide Hospital
Heralded as the future centrepiece of South Australia's A$2.2bn (US$2.3bn) Health Care Plan 2007-2016,
the construction of the new Royal Adelaide Hospital started in September 2011 with completion scheduled
in 2016. The new hospital is expected to receive more than 80,000 patient admissions per year. It will have
a capacity of 800 beds (700 multi-day beds and 100 same-day beds). All overnight stay beds will be single-
room. Specialty care services at the proposed hospital will include trauma, renal transplantation, major
burns and spinal injury care, in addition to an ambulatory care centre, operating theatre suite and all
necessary clinical and non-clinical support services.
New Perth Children's Hospital
Work started in January 2012 on the construction of a new children's hospital in Perth which will replace
the original Princess Margaret Hospital for Children (PMHM), at a total cost of A$1.2bn (US$1.3bn).
Facilities will include a bed capacity of 274 beds and one of Western Australia's only paediatric trauma
centres. The hospital will also offer double the number of surgical theatres, with inpatient and outpatient
care, as well as ambulatory services. Construction is due to be completed in 2015.
Sydney Teaching Hospital Redevelopment
The Royal North Shore Hospital, one of Sydney's leading teaching hospitals, has been undergoing a A
$1.1bn (US$1.1bn) redevelopment programme. Under the programme, a range of outdated buildings on the
site are being transformed into new purpose-built facilities. The new developments include 18 new
operating theatres and a 58-bed intensive care unit.
The redevelopment scheme will finish with the completion of a new A$153mn (US$153mn) Clinical
Services Building, scheduled to open in late 2014, which will contain a new burns unit, women's and
children's health and mental health units.
Other developments under the programme have included a new Acute Services Building which was opened
to patients in December 2012.
Sydney Children's Hospital Wing Opened
A new A$27.8mn (US$27.8mn) clinical services wing was opened at Sydney Children's Hospital in July
2013. The new five-level Ainsworth Building contains:
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 130

A 28-bed short-stay surgical unit;

An eight-bed purpose-built child and adolescent mental health unit;

A comprehensive rehabilitation centre;

A world-class respiratory laboratory, which includes the only infant lung function laboratory in Sydney.

Ronald McDonald House Charities Family Centre for parents and carers;

A child protection unit;

New clinical office space for health care professionals from a range of disciplines.
The NSW Government contributed almost A$12.3mn (US$12.3mn) to construct the new wing. The Sydney
Children's Hospital Foundation pledged A$15mn (US$15mn), with A$500,000 (US$500,000) from the
Motor Accidents Authority for the rehabilitation centre.
Sydney Children's Hospital cares for more than 39,000 children each year. It provides comprehensive a
range of services in paediatric and adolescent medicine and surgery, treating children with conditions
including cancer, trauma, HIV/AIDS, congenital abnormalities, disabilities, heart disease and respiratory
disorders.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 131
Regulatory Development
Medical Device Regulations
Competent Authority
Medical products are regulated in Australia by the Therapeutic Goods Administration (TGA). The TGA is
part of the Department of Health & Ageing. Medical devices are the responsibility of the Office of Devices,
Blood and Tissues (ODBT), within the TGA.
Regulations
Australia introduced a new set of medical device regulations in October 2002. The system used prior to this
dated to the Therapeutic Goods Act, 1989, and differed markedly from the international norm. It did not
divide devices into Classes, but instead divided all devices into one of two categories; Registerable or
Listable. Registerable devices were deemed to be high-risk. They only comprised around 5% of all devices
on the market. All devices had to be placed on the Australian Therapeutic Goods Register (ARTG), but only
Registerable devices generally had to undergo a detailed product evaluation.
Reform of the 1989 Therapeutic Goods Act was first proposed in 1996 report by the Australian Industry
Commission. The report highlighted the following problems:
The existing legislation was poor at dealing with technological change, since it dealt with devices product to
product, according to specified groupings. This was considered a major shortcoming in such a rapidly
evolving industry.
Many low risk products were unnecessarily included within the TGA's remit due to the nature of the
legislation. Such goods are already covered adequately under the Trade Practices Act.
Certain standards were mandated by the current legislation, but a range of standards offering different
routes to compliance was not. This was inflexible and increased industry costs.
The detailed requirements for devices in Australia 'differ markedly from those of its major trading partners',
making trade more costly and onerous than it needed to be.
Conformance assessment of medical devices was not open for any form of competition; there was therefore
little pressure on the TGA to improve both the speed and cost-effectiveness of the review process.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 132
The government approved the new regulatory system in 1999. It is very much based on the EU MDDs,
following the 1998 mutual recognition agreement. For the first time, a Class I, II, III risk based system will
be introduced. Originally the new system was due to be operating in September 2000. However, it was
delayed by a year, and came into effect on 4th October 2002. Since October 2002, all new devices have
been regulated under the new system. Products already on the register were given until October 2007 to
move to the new system.
Many devices classified 'exempt' from inclusion in the ARTG (such as non-powered hospital furniture &
simple non-powered surgical instruments) are now classified in Class I, while some devices classified as
'listable' under the current system (such as thermometers & dressings) are also Class I devices. Other
'listable' devices (such as hearing aids & dental filling materials) become Class IIa devices. Higher-risk
devices, including some classified 'listable' and most of those classified 'registerable' under the current
system are now registered as Class IIb and III devices.
Changes introduced under the new system include:

Minimum requirements for exempt Class I devices. These may require inclusion on the ARTG, unlike
prior to October 2002.

A more comprehensive pre-market assessment of new technologies, high-risk active devices and
implantables. The 1989 system required only registerable devices to undergo extensive testing. The new
system introduces some form of conformity assessment for all medical device classes. TGA testing may
well be required in the case of the highest-risk products, but in practice the new regulations allow for EU-
approved Notified Bodies to be used when submitting evidence of conformity assessment.

An extension of quality systems requirements to more devices.

A greater reliance on international standards, such as EN 46000 or ISO 13485/88. Similarly to the USA
system, compliance with these standards will be mandatory.

Better reporting by sponsors of device-related problems. A mandatory adverse event reporting system for
all device classes ('Vigilance System') will be introduced. Adverse events must be reported by the
manufacturer within 10 days, and within 30 days for a near adverse event. These are defined as under the
EU directives.
The introduction of a tracking system for high risk implantables, for which there was previously no
provision. Manufacturers will be responsible for tracking devices such as active implantable cardiac
devices, prosthetic heart valves, intravascular stents, annuloplasty rings, silicone gel prostheses, hip/knee
prostheses, and implantable devices of biological origin.
The TGA keeps a number of detailed guidance documents relating to the new regulations on its web site, at:
http://www.tga.gov.au/devices/devices.htm
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 133
Australia New Zealand Therapeutic Products Authority
Overview
In December 2003, the Australian and New Zealand governments signed a treaty to form a single
therapeutic agency for the regulation of therapeutic products, including medical devices, OTC, prescription
and complementary medicines. This was to be named the Australia New Zealand Therapeutic Products
Authority (ANZTPA).
The bi-national agency was to replace the Australian Therapeutic Goods Administration (TGA) and the
New Zealand Medicines and Medical Devices Safety Authority (Medsafe). While the basic principles were
easy to establish, the details of the proposed merger have proved complex, leading to more than one slip on
the legislative timetable. Progress appeared to be made, however, with legislation being presented in New
Zealand in December 2006, and in Australia in April 2007.
In June 2011, the Prime Ministers of Australia and New Zealand reaffirmed their commitment to the
establishment of the Australia New Zealand Therapeutic Products Agency (ANZTPA) to administer a
joint regulatory scheme for therapeutic products. This reaffirmation acknowledged that the New Zealand
Government will introduce a separate scheme to regulate certain natural health products in the New Zealand
market.
The Prime Ministers have agreed that a three stage approach over a period of up to five years will be
adopted to progressively achieve this goal by mid-2016. The three stages involve the two countries'
regulators, the TGA and Medsafe.
In December 2013, the TGA and Medsafe announced they completed a series of joint projects that promises
to deliver improved access to information about therapeutic products in both countries, as well as enhanced
cooperation between the regulators ahead of the proposed Australia New Zealand Therapeutic Products
Agency (ANZTPA).
The TGA and Medsafe have now commenced a further programme of harmonisation work that will be
undertaken over the next two and a half years, which includes 14 activities across six regulatory areas. This
new phase of joint work will progressively increase aspects of regulatory alignment between TGA and
Medsafe that will facilitate business planning and align aspects of regulatory practice for the transition to
ANZTPA. It will involve consultation with stakeholders as these activities are progressed.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 134
For medical devices, the targets would be:

The publication of guidance on the requirements for the submission and assessment of manufacturers'
evidence on the TGA, Medsafe and ANZTPA websites, by December 2014.

To identify the extent of product overlap in the Australian & New Zealand markets for medical devices in
Class III and Active Implantable Medical Devices and the impacts for transition, by February 2015.
Early Warning System For Product Safety Issues
In June 2013, the TGA and Medsafe developed an early warning system to communicate potential safety
concerns with therapeutic products. This scheme will operate in parallel in Australia and New Zealand.
The TGA and Medsafe will apply the agreed communication process independently to potential safety
concerns identified with therapeutic products through their existing therapeutic product vigilance processes.
These communications will be country specific and may differ reflecting different legislative requirements,
and different availability and/or usage of certain therapeutic products between Australia and New Zealand.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 135
Competitive Landscape
Domestic Medical Device Production
Australia has a large number of small manufacturers, mostly making hospital consumables and supplies..
Production is generally high quality, but low tech; advanced products are almost always imported. The
majority of production is consumed locally, although there are some exceptions; Cochlear and Resmed for
example, export most of their output.
According to the MTAA (Medical Technology Association of Australia), the Australian industry includes
over 500 medical technology companies with products listed on the Australian Register of Therapeutic
Goods (ARTG). It employs around 19,000 people with turnover of around A$10.8bn in 2010-11, although
this includes distribution activity.
MTAA
The Medical Technology Association of Australia (MTAA, formerly the Medical Industry Association of
Australia, MIAA) is the country's leading medical device industry association. It was formed 25 years ago,
as the Australian Medical Device and Diagnostics Association, taking its current name in March 2008. It
has over 80 members, comprising local companies and multinational subsidiaries. Many do not manufacture
locally, but concentrate on importing and distribution. The MTAA claims that its members account for over
90% of the value of non-pharmaceutical healthcare products distributed in Australia.
National Medical Device Manufacturers
Advanced Surgical Design & Manufacture
Advanced Surgical Design & Manufacture (ASDM) manufactures a range of orthopaedic and spinal
implants, as well as undertaking contract manufacturing of medical devices. The company reported an 18%
increase in revenues to A$8.7mn (US$9.1mn) in fiscal 2012 (year ended June 2012). ASDM is based in St.
Leonards, New South Wales.
In August 2013, ASDM announced the execution of a 12 month Transitional Services Agreement (TSA)
with Orthofix Australia. Under the TSA, ASDM will provide distribution services as Orthofix Australia
develops a direct sales force. As a result of the new arrangements, the existing spinal business held by
ASDM has been acquired by Orthofix Australia.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 136
Ansell
Ansell is a global manufacturer of protection wear including gloves and personal protection products such
as condoms. Ansell's healthcare activities include the manufacture of examination gloves, surgical gloves
and a range of surgical room safety devices. Ansell's Medical business unit achieved revenues of A
$349.5mn (US$315.5mn) in fiscal 2013, a decrease of 1.9% on the 2012 figure. This represented 25.5% of
group revenues. During fiscal 2013, Ansell continued to exit from the natural rubber latex (NRL)
examination gloves sector. Synthetic surgical gloves sales volume rose by 16%, while surgical safety
products grew by 11% in volume terms.
Ansell has been active in acquiring companies as part of an evident expansion programme.
In December 2012 it acquired companies in the US and Brazil:

Hércules Equipamentos de Protecao, a privately held Brazilian company located in São Paulo, with
annual sales of approximately US$30mn. Hércules is a leading manufacturer of Personal Protective
Equipment (PPE) in Brazil with approximately 350 employees. It has a plant located outside São Paulo
and wide distribution network across Brazil.

Preferred Surgical Products, a privately held US product and technology company producing infection
prevention products. The PSP range aims to improve infection control, protect the patient's skin and
optimise room turnover time, while reducing total cost per procedure.
In September 2012, Ansell announced the settlement of its purchase of Comasec and its subsidiaries for
EUR 101.5mn. Comasec is a privately owned French group with annual sales of around EUR 100mn,
manufacturing operations in Portugal and Malaysia and over 1,200 employees globally. It is a leading
player in the European Personal Protective Equipment (PPE) Glove Market, has a presence in North
America and specialises in gloves for chemical protection, food handling, cut protection, mechanical
protection, dry box and thermal protection. Major brands are Comasec, Marigold, and Marigold Industrial.
In May 2012, Ansell concluded the acquisition of Trelleborg's Protective Products (TPP) business for EUR
23.7mn. Ansell will operate the former Trelleborg business under the name Ansell Protective Solutions
(APS), and as part of its Specialty Markets Global Business Unit.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 137
Cochlear
Based in Lane Cove, New South Wales, Cochlear manufacturers cochlear implants. The company has
manufacturing/R&D facilities in Australia and Belgium. The company's latest product is the Nucleus
Freedom, launched in major markets in 2005. The company has around 1,655 employees.
The Nucleus Freedom cochlear implant system features both an internal component and an external speech
processor. The Nucleus Freedom is designed to mimic functions of the human ear. The implant features the
Contour Advance electrode, a self-curling electrode array that allows the electrodes to be placed close to the
hearing nerve for targeted stimulation and increased power efficiency, while applying minimal pressure on
the cochlear structures. According to Cochlear, the Contour Advance is the only electrode array designed to
protect cochlear structures during surgery.
In July 2009, Cochlear began construction of a new A$128mn Global Headquarters and manufacturing and
research facility on the Macquarie University Campus, North Ryde, Sydney. The first part was completed in
October 2010. It forms part of a world-first hearing research, treatment and development precinct which
will link over 2,000 professionals involved in the hearing industry across academia, government as well as
rehabilitation and research.
In March 2005, Cochlear acquired Entific Medical systems for A$195.3mn. This represented the company's
first major acquisition. Entific is a Swedish developer of the Baha system, an implant which allows hearing
through bone conduction. In May 2006, Cochlear signed a major A$270mn six year contract to supply
implants to children in Taiwan and China. The company anticipates that the majority of sales will take place
towards the end of the contract term.
For fiscal year 2013 (ended June 2013), Cochlear reported sales of A$752.7mn (US$679.5mn), a reduction
of 3.4% from the A$779.0mn recorded in 2012. After the sharp fall in net profit from A$180.1mn in 2011 to
A$56.8mn in 2012, Cochlear was able to report a 133% rise to A$132.6mn in fiscal 2013. The company
achieved record cochlear implant unit sales of 26,674 in 2013, a rise of 16%.
Sales in the Americas amounted to A$284.4mn, a fall of 4% compared with 2012. Sales in EMEA (Europe,
Middle East and Africa) also fell, by 1% to A$283.0mn. For the second consecutive year, the Asia-Pacific
region bucked the negative trend, with revenues rising by 20% to reach A$147.6mn. This result was
supported by a Chinese tender sale of approximately 2,800 units.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 138
Dynamic Hearing
Dynamic Hearing is based in Richmond, Victoria. It is a spin-off company from the Cooperative Research
Centre (CRC) for Cochlear Implant and Hearing Aid Innovation, a body linked to the University of
Melbourne. Dynamic Hearing has developed the ADRO software system for digital hearing aids, which
aims to improve sound output quality. Companies using the technology include Intertron (Germany) and
Gennum (Canada). In August 2006, Dynamic Hearing announced a new product in the US, the Freedom
AD, in collaboration with America Hears.
In October 2005, Dynamic Hearing signed an exclusive multi-year licence agreement with the US-based
House Ear Institute (HEI) to develop and commercialise its patented feedback cancellation technology for
use in hearing aids and auditory implants.
Dynamic Hearing was acquired by Wolfson Microelectronics of the UK in 2011.
Elastagen
Elastagen is a Sydney based pioneer in technologies to repair and augment skin using Elastin, a naturally
occurring protein that is responsible for the skin's elasticity and supple properties. In July 2013, Elastagen
received funding from the New South Wales Medical Devices Fund for its pioneering elastatherapy (using
human protein elastin to naturally repair the skin, particularly for severe burns).
Endoluminal
In July 2013, Endoluminal received funding from the New South Wales Medical Devices Fund for
developing a breakthrough technology for the treatment of failing heart valves. Endoluminal was
established in 2007 and is based in Eveleigh, NSW.
HearWorks
HEARworks Pty Ltd. manages the intellectual property and commercial activity of the HEARing
Cooperative Research Centre (CRC), an international consortium of research, clinical and industry
organisations, constituting five core and 21 support members. The CRC was funded in 2007 through
Australia's Commonwealth Government Cooperative Research Centre programme. The HEARing CRC is
investing AU$115mn over seven years into hearing healthcare research and utilisation.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 139
In July 2013, HearWorks received funding from the New South Wales Medical Devices Fund for its
development of the world's first fully-automated test for hearing. It attaches to a laptop and can be used in
any clinic to conduct complex electrophysiology for the assessment of hearing.
mobiLIFE
Based in the Hunter Valley, NSW, Australia, mobiLIFE was started in 2002 as a joint venture to take ideas
and concepts from the University of Newcastle into the medical device industry. The company draws upon
a 50+ strong team of design and engineering project staff - based in Sydney, Chicago and in China (with
associated manufacturing facilities).
In July 2013, mobiLIFE received funding from the New South Wales Medical Devices Fund for
MobiDRIP, its innovative, portable intravenous (IV) pump to allow patients to be treated at home.
Saluda Medical
Saluda Medical has developed a versatile implant that both stimulates and senses nerve responses. The
Implanted Neural Sensing & Stimulation product (INS2) is the platform for neurostimulation therapies. The
initial target market for this product is Spinal Cord Stimulation (SCS) for the control of chronic back and
lower limb pain. The implant is designed to nestle alongside the dorsal processes of the spine.
In July 2013, Saluda Medical received A$5mn in funding from the New South Wales Medical Devices
Fund for developing world-first technology for an implantable device, which supplies constant pain relief to
people suffering chronic neuropathic pain.
Multinational Medical Device Manufacturers
Multinational Manufacturers
Baxter
Baxter manufactures renal and medication delivery products at its facility in Toongabbie, New South
Wales.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 140
CareFusion
CareFusion manufactures critical care technology products at its facility in Seven Hills, New South Wales.
Danaher
Danaher's Invetech subsidiary undertakes contract manufacturing of diagnostic instruments and medical
devices at its facility in Mt. Waverley, Victoria.
Fresenius
Fresenius has a 5,350 square-metre manufacturing plant and warehouse for haemodialysis concentrate in
Smithfield, New South Wales. FMS Australia Pty Ltd. had 364 employees at the end of 2012 and achieved
revenues of €143.2mn.
Paul Hartmann
Hartmann acquired Unomedical's custom procedure packs business in 2010 and continues to manufacture
these products at the former Unomedical facility in Mona Vale, New South Wales.
ResMed
ResMed is a respiratory medical device manufacturer, specialising in products for the diagnosis and
treatment of sleep disordered breathing (SDB). The company was formed in 1989, primarily to
commercialise a device for treating obstructive sleep apnoea (OSA), a major subset of SDB. Developed in
1981 by Professor Colin Sullivan and colleagues at the University of Sydney, nasal continuous positive
airway pressure (CPAP) provided the first successful non-invasive treatment of OSA.
Resmed has its headquarters in the USA, although the company's production base is in Australia.
Manufacturing is also undertaken in Singapore and the USA. In 2011, the company employed around 3,450
people worldwide.
In 2004, the company moved to a new manufacturing site in Australia. The new ResMed campus, set on 30
acres of land to the north-west of Sydney, is a purpose-built site, designed to meet long term manufacturing
needs. It triples the size of the company's production area. The campus is being built in two stages, with
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 141
stage one housing production and stage two housing administration. Stage one was completed in April 2004
and was immediately set up for production. New research and development and office facilities were
completed in May 2006.
In May 2005, ResMed acquired Saime, a developer and distributor of ventilation products in France and
Germany. The transaction was valued at around 86mn euros. Saime has annual revenues of around 28mn
euros. ResMed and Saime have had a relationship since 1996, when ResMed bought its original French
sleep therapy distribution assets from Saime.
ResMed sales in fiscal 2013 (year ended 30
th
June 2013) amounted to US$1.5bn, a rise of 11% over 2011.
Net income in fiscal 2013 was US$307.1mn, an increase of 21%.
In August 2012, ResMed announced that it had acquired a data services technology provider, Umbian,
which is headquartered in Halifax, Canada. Umbian offers a comprehensive patient compliance
management solution called U-Sleep, which monitors continuous positive airway pressure (CPAP) devices
and provides a suite of interactive follow-up services for healthcare providers.
Multinational Market Activity
The top ten leading multinational companies all have at least a local representative office in Australia in
charge of marketing, distribution and service for their respective products. In terms of manufacturing, only
Fresenius has activities in Australia.
Table: Multinational Market Activity, 2014
Company Operations

Baxter International Baxter's Australian operations commenced in 1963 and now comprise a
manufacturing plant in Western Sydney; distribution and warehousing depots in New
South Wales, Queensland, Victoria, South Australia, Western Australia and Tasmania;
and aseptic compounding facilities in New South Wales, Queensland, Victoria, South
Australia and Western Australia.
B.Braun B.Braun Australia Pty, based in Bella Vista, NSW, is a fully-owned subsidiary with 124
employees. In 2012, the company achieved sales of €64.6mn.
Boston Scientific Boston Scientific has no manufacturing plant in the country. There is a representative
office serving both Australia and New Zealand, Boston Scientific ANZ, in New South
Wales.
Covidien Covidien Australia Pty Ltd is the country head office based in Sydney, New South
Wales. The company does not manufacture medical devices locally.
Fresenius Fresenius has a 5,350 square-metre manufacturing plant and warehouse for
haemodialysis concentrate in Smithfield, New South Wales. The head office is based
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 142
Multinational Market Activity, 2014 - Continued
Company Operations
in Sydney. The company's 71.6%-owned subsidiary, FMS Australia Pty Ltd., had 364
employees at the end of 2012 and achieved revenues of €143.2mn.
General Electric GE Healthcare, which comes under GE Technology Infrastructure in Australia and
New Zealand, has representative offices in Melbourne, Sydney, Perth and Brisbane.
Johnson & Johnson J&J has a local presence in Australia through Johnson & Johnson Medical Pty. Ltd.
and Synthes Australia. Synthes Australia employs 140 staff and has its head office in
Sydney.
Medtronic The company's Australasian headquarters is located in North Ryde, Sydney, New
South Wales. There are other offices in Melbourne, Brisbane, Adelaide, Perth and
Auckland (New Zealand). There is no manufacturing activity.
Philips Philips Healthcare has an office in North Ryde, New South Wales, which serves both
Australia and New Zealand. There is no local manufacturing.
Siemens The company has several subsidiaries in Australia; from a medical devices
perspective it has two companies, Siemens Healthcare Diagnostics Ltd and Siemens
Hearing Instruments Pty. Ltd, in Bayswater, Australia. There is no local manufacturing.
Smith & Nephew The company does not have a manufacturing facility for medical devices in Australia
but has representative offices in New South Wales, Queensland, Victoria, South
Australia and Western Australia.
Stryker The company has a representative office, Stryker South Pacific, in St Leonards, New
South Wales. There is no manufacturing activity.
Source: BMI Espicom
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 143
Methodology
Medical Device Market Methodology
The medical device market reports use a wide definition of medical equipment, similar to that used by the
US FDA or EU EMA. In short, it is defined as any piece of equipment or apparatus used to treat or diagnose
an illness that comes into direct contact with the patient. Pharmaceuticals, IV diagnostics and laboratory
equipment are not within the scope of these reports.
BMI Espicom has estimated national medical device markets at ex-factory prices for the 2008-2012 period
in current US dollar and local terms. The markets have been estimated using a trade-based approach,
looking at imports, and then adding in domestic production, minus any exports. Import and export data have
been sourced from national customs authorities, as compiled by the International Trade Centre.
BMI Espicom has estimated production data as including range of factors such as the value of exports, the
known presence of local and multinational manufacturers, sales data when available, and officially
published estimates of production, again when available. Production data have been adjusted to take into
account re-exporting, stockpiling and differences in the definition of domestic production.
BMI Espicom has forecast national medical device markets at ex-factory prices for the 2014-2018 period.
BMI Espicom has derived market estimates in US dollar terms for the base year, which is 2013 for the
purposes of these reports. Compound Annual Growth Rates (CAGRs) in local terms have been calculated
for each product area, major category and sub-category for the 2014-2018 period. These CAGRs have been
applied to the market in local currency terms, and then converted back to US dollar terms, using average
exchange rate projections.
BMI Espicom has calculated CAGRs by looking at a number of factors. These include macro-economic
performance; health expenditure levels; medical device import trends; domestic medical device
manufacturing size; provision of medical personnel, infrastructure and services; national healthcare
development plans; and international aid projects, when applicable.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 144
Trade Code Classifications
International trade is universally classified according to the Harmonised System (HS). This began to be
used in the 1990s, and is overseen by the World Customs Organisation. Medical equipment is generally
well-defined in the HS. There is one major code, HS9018, named Medical Equipment, but there are a
number of other codes for products with a specifically medical use. These are listed in detail the following
table. For the majority of countries, it is not possible to provide a more detailed breakdown than this.
Table: Used HS Trade Codes, 2014
Code Product

'300510 Medical dressings (adhesive)
'300590 Medical dressings (non-adhesive)
'300610 SUTURING MATERIALS
'300620 Blood-grouping reagents
'300630 Contrast media
'300640 Dental cements
'300650 First-aid boxes & kits
'300691 Ostomy products
'370110 Medical x-ray film (flat)
'370210 Medical x-ray film (rolled)
'401511 Surgical gloves
'841920 MEDICAL, SURGICAL STERILISERS
'871310 Wheelchairs, not mechanically propelled
'871390 Wheelchairs, mechanically propelled
'901811 Electrocardiographs
'901812 Ultrasound
'901813 MRI
'901814 Scintigraphic apparatus
'901819 Other electrodiagnostic apparatus
'901820 ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
'901831 Syringes (with/without needles)
'901832 Tubular metal needles/needles for sutures
'901839 Other needles, catheters, cannulae etc
'901841 Dental drills
'901849 Dental instruments
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 145
Used HS Trade Codes, 2014 - Continued
Code Product
'901850 OPHTHALMIC INSTRUMENTS
'901890 OTHER INSTRUMENTS & APPLIANCES
'901910 Mechano-therapy apparatus
'901920 Therapeutic respiration apparatus
'902110 Orthopaedic or fracture appliances
'902121 Artificial teeth
'902129 Other dental fittings
'902131 Artificial joints for orthopaedic purposes
'902139 Artificial parts of the body (excl. artificial teeth and dental fittings)
'902140 Hearing aids
'902150 Pacemakers
'902190 Other portable aids
'902212 CT scanners
'902213 Dental x-ray
'902214 Other medical x-ray apparatus
'902221 A, B, C ray apparatus
'902230 X-ray tubes
'902290 Other imaging parts & accessories
'940210 Dental chairs
'940290 HOSPITAL FURNITURE
BMI Espicom has rearranged the data from its original code order, to create six major product areas:
CONSUMABLES, DIAGNOSTIC IMAGING, DENTAL PRODUCTS, ORTHOPAEDICS &
PROSTHETICS, PATIENT AIDS AND OTHER MEDICAL PRODUCTS. These have been sub-divided
into categories and sub-categories. BMI Espicom has used them to present the medical device market,
import and export data in these reports. Their relation to the trade codes is shown on the following table.
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 146
Table: Rearranged HS Trade Codes, 2014
Code Product


CONSUMABLES


BANDAGES & DRESSINGS
'300510 Medical dressings (adhesive)
'300590 Medical dressings (non-adhesive)

'300610 SUTURING MATERIALS


SYRINGES, NEEDLES & CATHETERS
'901831 Syringes (with/without needles)
'901832 Tubular metal needles/needles for sutures
'901839 Other needles, catheters, cannulae etc


OTHER CONSUMABLES
'300620 Blood-grouping reagents
'300650 First-aid boxes & kits
'300691 Ostomy products
'401511 Surgical gloves


DIAGNOSTIC IMAGING


ELECTRODIAGNOSTIC APPARATUS
'901811 Electrocardiographs
'901812 Ultrasound
'901813 MRI
'901814 Scintigraphic apparatus
'901819 Other electrodiagnostic apparatus


RADIATION APPARATUS
'902212 CT scanners
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 147
Rearranged HS Trade Codes, 2014 - Continued
Code Product
'902214 Other medical x-ray apparatus
'902221 A, B, C ray apparatus


IMAGING PARTS & ACCESSORIES
'300630 Contrast media
'370110 Medical x-ray film (flat)
'370210 Medical x-ray film (rolled)
'902230 X-ray tubes
'902290 Other imaging parts & accessories


DENTAL PRODUCTS


CAPITAL EQUIPMENT
'901841 Dental drills
'940210 Dental chairs
'902213 Dental x-ray


INSTRUMENTS & SUPPLIES
'300640 Dental cements
'901849 Dental instruments

Teeth & other fittings
'902121 Artificial teeth
'902129 Other dental fittings


ORTHOPAEDICS & PROSTHETICS

'902110 FIXATION DEVICES

'902131 ARTIFICIAL JOINTS

'902139 OTHER ARTIFICIAL BODY PARTS

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 148
Rearranged HS Trade Codes, 2014 - Continued
Code Product

PATIENT AIDS


PORTABLE AIDS
'902140 Hearing aids
'902150 Pacemakers
'902190 Other portable aids


THERAPEUTIC APPLIANCES
'901910 Mechano-therapy apparatus
'901920 Therapeutic respiration apparatus


OTHERS


WHEELCHAIRS
'871310 Wheelchairs, not mechanically propelled
'871390 Wheelchairs, mechanically propelled

'901850 OPHTHALMIC INSTRUMENTS

'940290 HOSPITAL FURNITURE

'841920 MEDICAL, SURGICAL STERILISERS

'901820 ULTRA-VIOLET OR INFRA-RED RAY APPARATUS

'901890 OTHER INSTRUMENTS & APPLIANCES
10 digit Blood pressure monitors
10 digit Endoscopy apparatus
10 digit Dialysis apparatus
10 digit Transfusion apparatus
10 digit Anaesthetic apparatus and instruments

Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 149
Rearranged HS Trade Codes, 2014 - Continued
Code Product

TOTAL
Source: International Trade Centre
Risk/Reward Ratings Methodology
BMI Espicom's Risk/Reward Ratings (RRR) provide a comparative regional ranking system evaluating the
ease of doing business and the industry-specific opportunities and limitations for potential investors in a
given medical device market. The RRR system is divided into two distinct categories:
1.Rewards: Evaluation of the medical device industry's size and growth potential in each country, and also
broader industry/country characteristics that may encourage its development. This is further broken down
into two sub-categories:

Industry Rewards (this is an industry specific sub-category taking into account the current industry size,
per capita expenditure, growth forecasts, import reliance and import growth to provide an overall score
for potential returns for companies operating in the medical device industry)

Country Rewards (this is a country specific sub-category whose score factors in demographic indicators
such as urbanisation and population age and growth conditioning the medical device industry)
2.Risks: Evaluation of industry-specific dangers and those emanating from the country's political/economic
profile that call into question the likelihood of anticipated returns being realised over the assessed time
period. This is further broken down into two sub-categories:

Industry Risks (this is an industry specific sub-category whose score covers potential operational risks to
medical device companies operating in the healthcare sector, regulatory issues inhibiting the industry, and
the relative maturity of a market in terms of pricing & reimbursement)

Country Risks (this is a country specific sub-category in which political and economic stability,
legislation and the overall business environment are evaluated to provide an overall score)
A medical device market's RRR score is made up of a sum of the Rewards score (Industry Rewards +
Country Rewards) and the Risks score (Industry Risks + Country Risks), which provides a globally
comparative and numerically-based assessment of a market's attractiveness and highlights the rewards and
risks a company will face in a particular country.
For each category and sub-category, each medical device market is scored out of 100 (100 being the best),
with the overall RRR score being a weighted average. Importantly, as many countries are considered by
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 150
BMI Espicom to be 'emerging markets', our rating is revised on a regular basis. This ensures that the rating
draws on the latest information and data across our broad range of sources, and the expertise of our analysts.
BMI Espicom's approach in assessing the risk/reward balance for medical device companies looking to
launch a product within a market is fourfold:

Firstly, we identify current industry/country trends and forecast industry/country growth that represent
opportunities to companies looking to launch a medical device.

Secondly, we identify industry-specific and country traits that pose or could pose operational risks to
companies looking to launch a medical device.

Thirdly, we attempt, where possible, to identify objective indicators that may serve as proxies for issues/
trends to avoid subjectivity.

Finally, we use BMI's proprietary Country Risk Ratings (CRR) in a nuanced manner to ensure that only
the aspects most relevant to the medical device industry are incorporated. Overall, the system offers an
industry-leading, comparative insight into the opportunities and risks for companies across the globe.
Table: Medical Devices Risk/Reward Ratings Indicators, 2014
Indicator Rationale Weighting

REWARDS ~ 65

Industry Rewards ~ 44
Sales, US$mn Denotes breadth of the medical device market. Larger markets score
higher than smaller ones
20
Sales Per Capita, US$ Denotes depth of the medical device market. High value markets score
higher than low value ones
8
% Forecasted CAGR Denotes the anticipated performance of the medical device market over
the 2013-2018 period. Markets with higher CAGRs score better than those
with lower CAGRs
7
% Import Reliance Denotes import reliance of the medical device market. Highly reliant
markets score higher than lowly reliant markets
3
% Y-T-D Import Growth Denotes year-to-date medical device import growth. Markets with fast-
growing imports score higher than those with slow-growing imports
6

Country Rewards ~ 21
% Urban/Rural Split Evaluates urbanisation as a proxy for development of medical facilities.
Predominantly urban countries score higher than rural countries
8
% Aged 65+ Population Evaluates proportion of the population over 65 years of age as an
expenditure ratio. Countries with ageing populations tend to have higher
per capita medical device expenditure and score higher
8
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 151
Medical Devices Risk/Reward Ratings Indicators, 2014 - Continued
Indicator Rationale Weighting
% Population Growth Evaluates long-term prospects associated to population growth. Fast-
growing countries suggest better long-term growth across the medical
device industry and score higher
5

RISKS ~ 35

Industry Risks ~ 21
Healthcare Access Evaluates health policies, health insurance coverage, health expenditure
and access to health resources, activity and personnel. Markets with a
good healthcare access score higher
7
Regulation Evaluates the strength of the competent authority, national regulations and
regulations aligned regionally, if existing. Markets with a strong regulation
score higher
7
Government Spending/P&R Evaluates the level of government spending on medical devices and the
attractiveness of P&R policies. Markets with good government spending
and friendly P&R policies score higher
7

Country Risks ~ 14
Economic Diligence CRR evaluates the structural balance of the economy, noting issues such
as reliance on single sectors for exports/growth, and past economic
volatility. Countries with a strong economy score higher
3
Policy Continuity CRR evaluates the risk of a sharp change in the broad direction of
government policy. Stable political countries score higher
3
Lack Of Bureaucracy CRR evaluates ease of conducting business in the country. Less
bureaucratic countries score higher
3
Legal Diligence CRR evaluates the strength of legal institutions in the country. Security of
investment can be a key risk in some emerging markets. Countries with
strong legal institutions score higher
3
Business Transparency CRR evaluates the risk of additional illegal costs/possibility of opacity in
tendering/business operations affecting companies' ability to compete.
Countries with business transparency score higher
2
Source: BMI Espicom
Sources
Historical and forecast macro-economic, political, demographic and healthcare data, where indicated, are
sourced from:

Business Monitor International (BMI).
The medical device market reports have been analysed using, where possible, primary qualitative and
quantitative data from local sources. These include:
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 152

multinational medical device companies,

national medical device companies,

national medical device trade associations,

national ministries (or departments) of health, and

national statistical institutes.
The medical device market reports may also make reference to a number of secondary sources, such as
those listed below:

Eurostat, http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home/

Inter-American Development Bank (IDB), http://www.iadb.org

International Trade Centre (ITC), http://www.intracen.org

Organisation for Economic Co-operation and Development (OECD), http://www.oecd.org

United Nations (UN), http://www.un.org

World Bank (WB), http://www.worldbank.org

World Customs Organisation (WCO), http://www.wcoomd.org

World Health Organisation (WHO), http://www.who.org

World Trade Organisation (WTO), http://www.wto.org
Contact
BMI Espicom welcomes feedback on all the medical device market reports. If you have any further
questions, comments or suggestions about the contents of this report, please send them to:
Jamie Davies
Head of Medical Device Market Analysis
[email protected]
Australia Medical Devices Report Q2 2014
© Espicom Business Intelligence Page 153

Sponsor Documents

Or use your account on DocShare.tips

Hide

Forgot your password?

Or register your new account on DocShare.tips

Hide

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close